Adezmapimod
Based on 607 publication(s) in Google Scholar
Adezmapimod (SB 203580) is a selective and ATP-competitive p38 MAPK inhibitor with IC50s of 50 nM and 500 nM for SAPK2a/p38 and SAPK2b/p38β2, respectively. Adezmapimod inhibits LCK, GSK3β and PKBα with IC50s of 100-500-fold higher than that for SAPK2a/p38. Adezmapimod can inhibit p38 MAPK and lead to the inhibition of downstream HSP27 phosphorylation. Adezmapimod does not disrupt JNK activity and is an autophagy and mitophagy activator.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- Reinheit: 99.93%
- CAS. Nr.: 152121-47-6
- Formel: C21H16FN3OS
- Molecular Weight:377.43
-
Speicherung:Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 2 years , -20°C, 1 year
Publications Citing Use of MedChemExpress (MCE) Adezmapimod
More- Signal Transduct Target Ther. 2022 Jul 11;7(1):222. [Abstract]
- Signal Transduct Target Ther. 2020 Aug 25;5(1):163. [Abstract]
- Nat Cancer. 2025 Dec;6(12):1955-1975. [Abstract]
- Nat Immunol. 2023 Nov;24(11):1813-1824. [Abstract]
- Cell Res. 2020 Jul;30(7):574-589. [Abstract]
- Cancer Commun (Lond). 2021 Jan;41(1):62-78. [Abstract]
- Nat Metab. 2024 Apr;6(4):708-723. [Abstract]
- Nat Metab. 2021 Oct;3(10):1357-1371. [Abstract]
- Bioact Mater. 2025 Nov 25:57:646-659. [Abstract]
- Cell Mol Immunol. 2025 Jul;22(7):791-805. [Abstract]
- Cell Mol Immunol. 2023 Feb;20(2):175-188. [Abstract]
- Cell Mol Immunol. 2022 Nov;19(11):1263-1278. [Abstract]
- Clin Mol Hepatol. 2023 Apr;29(2):465-481. [Abstract]
- Mol Cell. 2026 Feb 19;86(4):674-692.e10. [Abstract]
- Mol Cell. 2020 Jan 2;77(1):95-107.e5. [Abstract]
- Cancer Res. 2022 May 16;82(10):1991-2002. [Abstract]
- Sci Immunol. 2022 Jan 21;7(67):eabj5501. [Abstract]
- Hepatology. 2023 Feb 1;77(2):456-465. [Abstract]
- Nat Commun. 2025 Apr 16;16(1):3623. [Abstract]
- Nat Commun. 2025 Mar 15;16(1):2565. [Abstract]
- Nat Commun. 2024 Oct 2;15(1):8540. [Abstract]
- Nat Commun. 2024 Apr 11;15(1):3165. [Abstract]
- Nat Commun. 2018 Apr 30;9(1):1723. [Abstract]
- Cell Death Differ. 2020 Jun;27(6):1938-1951. [Abstract]
- Cell Death Differ. 2019 Nov;26(11):2386-2399. [Abstract]
- Cell Death Differ. 2017 Mar;24(3):492-499. [Abstract]
- Acta Pharm Sin B. 2025 Dec 29.
- Acta Pharm Sin B. 2024 Aug;14(8):3528-3542. [Abstract]
- Acta Pharm Sin B. 2023 Feb;13(2):722-738. [Abstract]
- Autophagy. 2025 Aug 6:1-17. [Abstract]
- Autophagy. 2021 Nov;17(11):3592-3606. [Abstract]
- Autophagy. 2020 Aug;16(8):1413-1435. [Abstract]
- Adv Sci (Weinh). 2026 Mar 20:e16557. [Abstract]
- Adv Sci (Weinh). 2026 Feb;13(12):e10302. [Abstract]
- Adv Sci (Weinh). 2025 Feb 7:e2413324. [Abstract]
- Adv Sci (Weinh). 2024 Dec 30:e2413128. [Abstract]
- Adv Sci (Weinh). 2024 Oct 28:e2406979. [Abstract]
- Leukemia. 2026 May;40(5):955-969. [Abstract]
- Biomaterials. 2024 Mar:305:122462. [Abstract]
- Biomaterials. 2018 Aug;175:19-29. [Abstract]
- J Exp Clin Cancer Res. 2025 Aug 27;44(1):255. [Abstract]
- J Exp Clin Cancer Res. 2022 Dec 29;41(1):364. [Abstract]
- J Exp Clin Cancer Res. 2022 Sep 16;41(1):275. [Abstract]
- Protein Cell. 2019 Mar;10(3):161-177. [Abstract]
- J Nanobiotechnology. 2025 Jul 22;23(1):535. [Abstract]
- J Nanobiotechnology. 2023 Sep 4;21(1):316. [Abstract]
- J Nanobiotechnology. 2022 Mar 27;20(1):162. [Abstract]
- Cell Discov. 2026 Feb 24;12(1):13. [Abstract]
- Sci Adv. 2025 Aug;11(31):eadu4270. [Abstract]
- Carbohydr Polym. 2019 Dec 1;225:115223. [Abstract]
- J Biomed Sci. 2025 Jan 6;32(1):5. [Abstract]
- Redox Biol. 2026 Apr:91:104093. [Abstract]
- Redox Biol. 2023 Feb:59:102594. [Abstract]
- Redox Biol. 2022 Oct:56:102452. [Abstract]
- J Hazard Mater. 2025 Nov 25:501:140617. [Abstract]
- Research (Wash D C). 2025 Oct 9:8:0915. [Abstract]
- MedComm. 2023 Jul 8;4(4):e320. [Abstract]
- Cell Rep Med. 2025 Jan 16:101922. [Abstract]
- J Immunother Cancer. 2024 Oct 23;12(10):e010148. [Abstract]
- Cell Rep Med. 2024 Feb 20;5(2):101388. [Abstract]
- J Immunother Cancer. 2019 Jul 12;7(1):178. [Abstract]
- J Immunother Cancer. 2018 Dec 18;6(1):151. [Abstract]
- Pharmacol Res. 2025 May 6:107763. [Abstract]
- Pharmacol Res. 2018 Jul:133:218-235. [Abstract]
- Cell Mol Biol Lett. 2025 May 14;30(1):59. [Abstract]
- Cancer Lett. 2025 Aug 29:633:218010. [Abstract]
- J Neuroinflammation. 2024 Aug 2;21(1):192. [Abstract]
- J Neuroinflammation. 2024 Jan 8;21(1):13. [Abstract]
- J Neuroinflammation. 2022 Nov 24;19(1):283. [Abstract]
- J Neuroinflammation. 2020 Oct 28;17(1):321. [Abstract]
- J Neuroinflammation. 2018 Jun 15;15(1):184. [Abstract]
- Cancer Lett. 2017 May 1:393:22-32. [Abstract]
- Int J Biol Sci. 2023 Sep 4;19(15):4744-4762. [Abstract]
- Int J Biol Sci. 2022 May 1;18(8):3167-3177. [Abstract]
- Environ Int. 2020 Oct;143:105949. [Abstract]
- Adv Healthc Mater. 2025 Dec 26:e04479. [Abstract]
- Cell Death Dis. 2025 Apr 29;16(1):351. [Abstract]
- Cell Death Dis. 2022 Nov 23;13(11):987. [Abstract]
- Cell Death Dis. 2022 Oct 8;13(10):860. [Abstract]
- Cell Death Dis. 2022 Jul 15;13(7):615. [Abstract]
- Cell Death Dis. 2021 Nov 27;12(12):1113. [Abstract]
- Cell Death Dis. 2021 Jun 2;12(6):570. [Abstract]
- Cell Death Dis. 2021 Jun 7;12(6):582. [Abstract]
- Cell Death Dis. 2019 Jul 8;10(7):520. [Abstract]
- Cell Death Dis. 2019 Mar 15;10(4):255. [Abstract]
- Cell Death Dis. 2016 Jun 23;7(6):e2273. [Abstract]
- Genes Dis. 2025 Nov 6.
- Genome Biol. 2023 Feb 1;24(1):20. [Abstract]
- Proc Natl Acad Sci U S A. 2026 Feb 17;123(7):e2505331123. [Abstract]
- Cell Commun Signal. 2025 Jan 8;23(1):14. [Abstract]
- Cell Commun Signal. 2025 Jan 13;23(1):22. [Abstract]
- Cell Commun Signal. 2024 Jun 3;22(1):307. [Abstract]
- Cell Commun Signal. 2024 Feb 12;22(1):115. [Abstract]
- Chin Herb Med. 2022 Sep 1;14(4):554-562. [Abstract]
- Cell Commun Signal. 2021 Oct 11;19(1):103. [Abstract]
- Int J Biol Macromol. 2026 Mar 3:151196. [Abstract]
- Int J Biol Macromol. 2025 Dec 17;338(Pt 2):149760. [Abstract]
- Int J Biol Macromol. 2025 Aug 25:326:147087. [Abstract]
- Int J Biol Macromol. 2023 Feb 1:227:45-57. [Abstract]
- Int J Biol Macromol. 2020 May 1;150:261-280. [Abstract]
- Acta Pharmacol Sin. 2025 Jun 11. [Abstract]
- Acta Pharmacol Sin. 2022 Sep;43(9):2289-2301. [Abstract]
- Acta Pharmacol Sin. 2017 Aug;38(8):1120-1128. [Abstract]
- Phytomedicine. 2025 May 21:143:156891. [Abstract]
- EMBO Mol Med. 2025 Mar;17(3):535-562. [Abstract]
- Phytomedicine. 2024 Dec:135:156052. [Abstract]
- EMBO Mol Med. 2023 Jan 11;15(1):e16373. [Abstract]
- Phytomedicine. 2022 Apr:98:153928. [Abstract]
- Phytomedicine. 2021 Mar:83:153479. [Abstract]
- Phytomedicine. 2020 Nov;78:153306. [Abstract]
- Phytomedicine. 2020 May 24;75:153247. [Abstract]
- Phytomedicine. 2020 Mar;68:153146. [Abstract]
- Npg Asia Mater. (2019) 11:38
- Phytomedicine. 2018 Mar 15:42:152-163. [Abstract]
- NPJ Parkinsons Dis. 2025 May 6;11(1):114. [Abstract]
- Food Chem X. 2022 Apr 30;14:100321. [Abstract]
- Food Chem X. 2022 Jan 15:13:100211. [Abstract]
- Free Radic Biol Med. 2021 Dec;177:247-259. [Abstract]
- Free Radic Biol Med. 2019 Nov 1:143:275-287. [Abstract]
- Free Radic Biol Med. 2017 Nov:112:49-59. [Abstract]
- New Phytol. 2024 May 13. [Abstract]
- Apoptosis. 2021 Apr;26(3-4):195-208. [Abstract]
- Chemosphere. 2020 Oct;256:127038. [Abstract]
- Sci Total Environ. 2023 Dec 10:903:166449. [Abstract]
- J Eur Acad Dermatol Venereol. 2020 Apr;34(4):862-872. [Abstract]
- Haematologica. 2020 Jan;105(1):124-135. [Abstract]
- J Orthop Translat. 2025 Jun 18:53:112-125. [Abstract]
- Br J Pharmacol. 2020 Nov;177(22):5046-5062. [Abstract]
- Br J Pharmacol. 2018 Dec;175(23):4338-4352. [Abstract]
- Brain Behav Immun. 2024 Jul:119:36-50. [Abstract]
- Biomed Pharmacother. 2024 Jun:175:116637. [Abstract]
- Biomed Pharmacother. 2023 Sep:165:115231. [Abstract]
- Biomed Pharmacother. 2020 Sep;129:110384. [Abstract]
- Biomed Pharmacother. 2020 Mar;123:109752. [Abstract]
- Biomed Pharmacother. 2020 Jan;121:109304. [Abstract]
- Biomed Pharmacother. 2019 Dec;120:109489. [Abstract]
- J Transl Med. 2019 Oct 4;17(1):335. [Abstract]
- Biomed Pharmacother. 2018 Dec:108:1294-1302. [Abstract]
- Food Sci Hum Wellness. 2025.
- Chem Sci. 2018 Jan 31;9(10):2674-2689. [Abstract]
- Oncogene. 2025 May;44(16):1078-1092. [Abstract]
- Environ Pollut. 2022 Dec 15:315:120234. [Abstract]
- Stem Cell Res Ther. 2022 Jan 21;13(1):22. [Abstract]
- Oncogene. 2022 Feb;41(6):907-919. [Abstract]
- Stem Cell Res Ther. 2021 May 20;12(1):295. [Abstract]
- Environ Pollut. 2021 Jan 1;268(Pt B):115748. [Abstract]
- Environ Pollut. 2020 Jan;256:113375. [Abstract]
- Oncogene. 2017 Apr;36(15):2095-2104. [Abstract]
- PLoS Biol. 2018 May 11;16(5):e2004225. [Abstract]
- Aging Cell. 2022 Jul;21(7):e13659. [Abstract]
- Aging Cell. 2020 Oct;19(10):e13217. [Abstract]
- Cell Death Discov. 2025 Feb 18;11(1):64. [Abstract]
- Curr Res Food Sci. 2023 Jan 16:6:100447. [Abstract]
- Cell Death Discov. 2019 Aug 5:5:125. [Abstract]
- Arch Toxicol. 2023 Jun;97(6):1783-1794. [Abstract]
- Cell Rep. 2022 Dec 27;41(13):111891. [Abstract]
- Cell Rep. 2022 Mar 15;38(11):110520. [Abstract]
- Cell Rep. 2020 Jan 14;30(2):497-509.e4. [Abstract]
- Neural Regen Res. 2023 Aug;18(8):1802-1808. [Abstract]
- Antioxidants (Basel). 2024 Mar 13;13(3):343. [Abstract]
- Antioxidants (Basel). 2023 Mar 30;12(4):838. [Abstract]
- Antioxidants (Basel). 2022 Mar 31;11(4):682. [Abstract]
- Antioxidants (Basel). 2021 Jun 29;10(7):1049. [Abstract]
- Antioxidants (Basel). 2021 Mar 13;10(3):443. [Abstract]
- Int J Nanomedicine. 2024 Jul 3:19:6659-6676. [Abstract]
- Int J Radiat Oncol Biol Phys. 2023 Apr 1;115(5):1229-1243. [Abstract]
- J Cell Biol. 2021 Feb 1;220(2):e201911025. [Abstract]
- Elife. 2016 Apr 11;5:e14087. [Abstract]
- Phytother Res. 2025 Oct 6. [Abstract]
- Phytother Res. 2023 Feb;37(2):689-701. [Abstract]
- J Agric Food Chem. 2024 Nov 20;72(46):25601-25619. [Abstract]
- J Agric Food Chem. 2024 Jul 31;72(30):16739-16748. [Abstract]
- J Agric Food Chem. 2024 Jun 7. [Abstract]
- Cell Mol Life Sci. 2023 Jun 21;80(7):186. [Abstract]
- J Agric Food Chem. 2023 Jun 21;71(24):9381-9390. [Abstract]
- J Agric Food Chem. 2023 Feb 8. [Abstract]
- J Agric Food Chem. 2022 Apr 13;70(14):4328-4341. [Abstract]
- EMBO Rep. 2021 Jul 5;22(7):e51678. [Abstract]
- Cell Mol Life Sci. 2018 Jul;75(14):2627-2641. [Abstract]
- J Agric Food Chem. 2018 Jun 27;66(25):6317-6325. [Abstract]
- JCI Insight. 2025 Nov 25:e196605. [Abstract]
- Ecotoxicol Environ Saf. 2025 Jun 24:302:118576. [Abstract]
- Ecotoxicol Environ Saf. 2023 Sep 15:263:115247. [Abstract]
- Ecotoxicol Environ Saf. 2020 Mar 1;190:110133. [Abstract]
- Cancer Cell Int. 2025 Oct 14;25(1):349. [Abstract]
- Food Biosci. 7 May 2022, 101766.
- Front Immunol. 2021 Jul 28:12:688294. [Abstract]
- Front Immunol. 2021 Jul 7:12:692286. [Abstract]
- Food Biosci. 2021, 101268.
- Front Immunol. 2021 Apr 1:12:584097. [Abstract]
- Front Immunol. 2018 Dec 7:9:2854. [Abstract]
- Front Immunol. 2018 Jun 5:9:1225. [Abstract]
- Front Immunol. 2017 Oct 10:8:1278. [Abstract]
- Int J Mol Med. 2026 Jan;57(1):21. [Abstract]
- Int J Mol Med. 2023 Aug;52(2):67. [Abstract]
- Int J Mol Med. 2021 Jan;47(1):243-255. [Abstract]
- Chin Med. 2026 Jan 8;21(1):16. [Abstract]
- Chin Med. 2025 Oct 5;20(1):159. [Abstract]
- J Invest Dermatol. 2022 Oct;142(10):2591-2602.e8. [Abstract]
- J Invest Dermatol. 2022 Feb;142(2):303-313.e9. [Abstract]
- Chin Med. 2021 Jul 19;16(1):58. [Abstract]
- J Invest Dermatol. 2019 Dec;139(12):2488-2496.e4. [Abstract]
- Biochem Pharmacol. 2025 Dec 18:245:117656. [Abstract]
- Biochem Pharmacol. 2025 Jun 6:239:117032. [Abstract]
- Biochem Pharmacol. 2024 May:223:116194. [Abstract]
- Biochem Pharmacol. 2024 Mar:221:116047. [Abstract]
- Cell Prolif. 2021 Jan;54(1):e12933. [Abstract]
- Cell Prolif. 2019 Nov;52(6):e12691. [Abstract]
- Acta Physiol (Oxf). 2018 Feb;222(2). [Abstract]
- Am J Chin Med. 2025;53(7):2277-2305. [Abstract]
- J Dent. 2025 Oct:161:105978. [Abstract]
- ACS Biomater Sci Eng. 2021 Jul 12;7(7):3399-3408. [Abstract]
- J Ethnopharmacol. 2026 May 10:362:121364. [Abstract]
- J Ethnopharmacol. 2026 Apr 24:361:121268. [Abstract]
- J Ethnopharmacol. 2025 Jul 11;353(Pt A):120282. [Abstract]
- J Ethnopharmacol. 2025 Aug 29:352:120267. [Abstract]
- Inflamm Res. 2025 Feb 19;74(1):42. [Abstract]
- J Ethnopharmacol. 2024 Jul 15:118580. [Abstract]
- J Ethnopharmacol. 2024 Jun 14:118421. [Abstract]
- J Ethnopharmacol. 2024 May 16:118355. [Abstract]
- J Ethnopharmacol. 2024 May 10:325:117755. [Abstract]
- Chem Biol Interact. 2021 Oct 1:348:109634. [Abstract]
- J Ethnopharmacol. 2021 Nov 15:280:114414. [Abstract]
- Food Funct. 2021 May 11;12(9):3898-3918. [Abstract]
- Mol Ther Oncolytics. 2022 Aug 5:26:372-386. [Abstract]
- Cells. 2022 Feb 18;11(4):723. [Abstract]
- Cancer Immunol Immunother. 2026 Mar 17;75(4):112. [Abstract]
- Commun Biol. 2025 Dec 13. [Abstract]
- Life Sci. 2025 Apr 23:123663. [Abstract]
- Commun Biol. 2024 Nov 5;7(1):1438. [Abstract]
- Drug Des Devel Ther. 2024 Nov 27:18:5445-5459. [Abstract]
- Life Sci. 2024 Dec 1:358:123163. [Abstract]
- Life Sci. 2024 Jun 22:122857. [Abstract]
- Commun Biol. 2024 Jan 5;7(1):18. [Abstract]
- Glia. 2023 Jul;71(7):1648-1666. [Abstract]
- Commun Biol. 2022 Jul 22;5(1):726. [Abstract]
- Life Sci. 2022 Feb 15:291:120258. [Abstract]
- J Clin Endocrinol Metab. 2021 Jan 23;106(2):337-350. [Abstract]
- Life Sci. 2020 Nov 15;261:118465. [Abstract]
- Life Sci. 2020 Apr 1;246:117396. [Abstract]
- Inflammation. 2024 Sep 20. [Abstract]
- Respir Res. 2023 Apr 7;24(1):103. [Abstract]
- Respir Res. 2022 Jan 11;23(1):6. [Abstract]
- Respir Res. 2021 Aug 3;22(1):216. [Abstract]
- CNS Neurosci Ther. 2020 Sep;26(9):913-924. [Abstract]
- PLoS Pathog. 2025 Oct 27;21(10):e1013623. [Abstract]
- PLoS Pathog. 2024 Dec 9;20(12):e1012744. [Abstract]
- Int J Mol Sci. 2024 Dec 27;26(1):143. [Abstract]
- Int J Mol Sci. 2023 Jul 6;24(13):11168. [Abstract]
- Chin J Nat Med. 2023 Jan;21(1):36-46. [Abstract]
- Int J Mol Sci. 2022 Nov 25;23(23):14730. [Abstract]
- Int J Mol Sci. 2022 Nov 16;23(22):14141. [Abstract]
- Int J Mol Sci. 2022 Oct 13;23(20):12219. [Abstract]
- Int J Mol Sci. 2022 Mar 25;23(7):3589. [Abstract]
- Chin J Nat Med. 2020 Oct;18(10):738-748. [Abstract]
- Front Pharmacol. 2025 Sep 25:16:1540092. [Abstract]
- Front Pharmacol. 2021 May 18;12:644116. [Abstract]
- Front Pharmacol. 2021 Apr 30:12:644886. [Abstract]
- Front Cell Infect Microbiol. 2019 Jul 15:9:253. [Abstract]
- Int Immunopharmacol. 2026 Jan 1;168(Pt 2):115903. [Abstract]
- Eur J Pharmacol. 2025 Sep 15:1003:177897. [Abstract]
- Int Immunopharmacol. 2025 May 28:159:114959. [Abstract]
- Int Immunopharmacol. 2025 Apr 10:155:114550. [Abstract]
- Int Immunopharmacol. 2025 Apr 4:151:114322. [Abstract]
- Int Immunopharmacol. 2025 Jan 17:148:113972. [Abstract]
- Int Immunopharmacol. 2024 Sep 19;142(Pt B):113151. [Abstract]
- Int Immunopharmacol. 2024 Jul 1:138:112592. [Abstract]
- Int Immunopharmacol. 2024 Jun 15:134:112143. [Abstract]
- Int Immunopharmacol. 2024 Jan 25:127:111355. [Abstract]
- Am J Physiol Cell Physiol. 2023 Nov 1;325(5):C1228-C1243. [Abstract]
- Int Immunopharmacol. 2023 Jul:120:110287. [Abstract]
- Am J Physiol Cell Physiol. 2022 Jul 1;323(1):C133-C144. [Abstract]
- Eur J Pharmacol. 2022 Jul 5:926:175034. [Abstract]
- Int Immunopharmacol. 2022 Jun:107:108643. [Abstract]
- Int Immunopharmacol. 2021 Dec;101(Pt A):108264. [Abstract]
- Eur J Pharmacol. 2021 Sep 5:906:174270. [Abstract]
- Eur J Pharmacol. 2021 May 5:898:173982. [Abstract]
- Int Immunopharmacol. 2020 Nov;88:106949. [Abstract]
- Int Immunopharmacol. 2020 Nov;88:106823. [Abstract]
- Invest Ophthalmol Vis Sci. 2020 Jul 1;61(8):28. [Abstract]
- Biosci Rep. 2020 May 29;40(5):BSR20193256. [Abstract]
- Int Immunopharmacol. 2020 Jun;83:106473. [Abstract]
- Int Immunopharmacol. 2019 Dec;77:105940. [Abstract]
- Int Immunopharmacol. 2019 Jul:72:252-257. [Abstract]
- Int J Cancer. 2018 Aug 1;143(3):645-656. [Abstract]
- Am J Physiol Cell Physiol. 2018 Aug 1;315(2):C225-C235. [Abstract]
- J Mol Cell Cardiol. 2015 Dec;89(Pt B):268-79. [Abstract]
- Arthritis Res Ther. 2025 May 31;27(1):118. [Abstract]
- Neuropharmacology. 2025 Apr 16:110469. [Abstract]
- Molecules. 2022 Feb 27;27(5):1577. [Abstract]
- Front Endocrinol. 2021 Mar 12:12:629554. [Abstract]
- Toxicology. 2021 Apr 15:453:152721. [Abstract]
- Artif Cell Nanomed B. 2019 Dec;47(1):3087-3093. [Abstract]
- Artif Cells Nanomed Biotechnol. 2019 Dec;47(1):685-695. [Abstract]
- J Dairy Sci. 2025 Apr 28:S0022-0302(25)00284-X. [Abstract]
- J Dairy Sci. 2025 Mar;108(3):2152-2168. [Abstract]
- J Integr Agric. 2023 Feb 24.
- J Dairy Sci. 2020 Dec;103(12):11636-11652. [Abstract]
- Mol Neurobiol. 2025 Jul;62(7):9290-9305. [Abstract]
- Front Cell Dev Biol. 2021 Nov 5:9:741060. [Abstract]
- Front Cell Dev Biol. 2021 Jun 18;9:659389. [Abstract]
- Front Cell Dev Biol. 2021 Feb 11:9:570451. [Abstract]
- Aquat Toxicol. 2018 Jun:199:116-126. [Abstract]
- FASEB J. 2026 Jan 15;40(1):e71364. [Abstract]
- Drug Dev Res. 2025 Nov;86(7):e70183. [Abstract]
- Poult Sci. 2025 Oct 3;104(12):105940. [Abstract]
- FASEB J. 2025 Sep 30;39(18):e71045. [Abstract]
- FASEB J. 2025 Aug 31;39(16):e70945. [Abstract]
- FASEB J. 2025 Mar 31;39(6):e70393. [Abstract]
- Poult Sci. 2024 Oct;103(10):104052. [Abstract]
- Drug Dev Res. 2022 Nov;83(7):1683-1696. [Abstract]
- Bioengineered. 2022 Apr;13(4):8747-8758. [Abstract]
- Stem Cell Rev Rep. 2022 Aug;18(6):2074-2087. [Abstract]
- Biochim Biophys Acta Mol Basis Dis. 2022 May 1;1868(5):166369. [Abstract]
- Mediators Inflamm. 2020 Nov 3;2020:8925973. [Abstract]
- FASEB J. 2020 Nov;34(11):14892-14904. [Abstract]
- J Cell Mol Med. 2020 Sep;24(18):10935-10945. [Abstract]
- J Cell Mol Med. 2020 Aug;24(16):9300-9312. [Abstract]
- FASEB J. 2020 Jun;34(6):8442-8458. [Abstract]
- Mol Nutr Food Res. 2019 Dec;63(24):e1900601. [Abstract]
- J Cell Mol Med. 2019 May;23(5):3357-3368. [Abstract]
- J Cell Mol Med. 2018 Nov;22(11):5450-5467. [Abstract]
- FASEB J. 2019 Feb;33(2):2435-2450. [Abstract]
- iScience. 2026 Mar 13;29(5):115362. [Abstract]
- iScience. 2025 Nov 17;28(12):114098. [Abstract]
- iScience. 2025 Aug 19;28(9):113396. [Abstract]
- J Inflamm Res. 2025 Sep 29:18:13433-13452. [Abstract]
- iScience. 2025 Apr 24;28(6):112501. [Abstract]
- iScience. 2025 Apr 22;28(5):112502. [Abstract]
- Toxics. 2024 Oct 25;12(11):779. [Abstract]
- iScience. 2024 Sep 12;27(10):110873. [Abstract]
- J Lipid Res. 2024 Aug 16:100623. [Abstract]
- Toxics. 2022 May 27;10(6):285. [Abstract]
- Nutr Metab. 2021 Nov 21;18(1):100. [Abstract]
- J Inflamm Res. 2021 Mar 23;14:1007-1017. [Abstract]
- Eye Vis (Lond). 2026 Feb 2;13(1):7. [Abstract]
- Neurochem Int. 2025 Sep 26:106061. [Abstract]
- Neurochem Int. 2025 Oct:189:106024. [Abstract]
- Antiviral Res. 2022 Dec:208:105463. [Abstract]
- AAPS PharmSciTech. 2022 Mar 14;23(3):83. [Abstract]
- Toxins. 2022 Jan 1;14(1):29. [Abstract]
- Neurochem Int. 2022 Jan:152:105221. [Abstract]
- Toxins. 2021 Jun 13;13(6):422. [Abstract]
- J Cell Physiol. 2020 Oct;235(10):6563-6573. [Abstract]
- J Funct Foods. 2019, 103562.
- J Cell Physiol. 2019 Dec;234(12):23302-23314. [Abstract]
- Sci Rep. 2026 Jun 23. [Abstract]
- Sci Rep. 2026 May 11. [Abstract]
- Sci Rep. 2025 Nov 17;15(1):40227. [Abstract]
- Sci Rep. 2025 Oct 21;15(1):36751. [Abstract]
- Aquaculture. 2025 Sep 15.
- JOR Spine. 2024 Apr 17;7(2):e1325. [Abstract]
- Aquaculture. 2023 Dec 15, 577, 739927.
- Aging (Albany NY). 2022 Aug 5;14(15):6149-6168. [Abstract]
- Sci Rep. 2022 Feb 23;12(1):3053. [Abstract]
- Aging (Albany NY). 2021 May 6;13(10):13788-13806. [Abstract]
- Aging (Albany NY). 2021 May 11;13(9):12780-12799. [Abstract]
- Aging. 2020 Nov 20;12(23):24208-24218. [Abstract]
- Biomedicines. 2020 Nov 9;8(11):485. [Abstract]
- J Biol Chem. 2019 Apr 19;294(16):6531-6549. [Abstract]
- Sci Rep. 2017 Oct 19;7(1):13571. [Abstract]
- J Virol. 2026 Mar 24;100(3):e0195225. [Abstract]
- J Pharmacol Exp Ther. 2025 Oct 8;392(11):103744. [Abstract]
- J Virol. 2025 Aug 19;99(8):e0065525. [Abstract]
- Food Sci Nutr. 2025 Feb 25;13(3):e4687. [Abstract]
- Neurochem Res. 2024 Nov 19;50(1):21. [Abstract]
- J Virol. 2024 Feb 20;98(2):e0194823. [Abstract]
- J Virol. 2023 Jun 29;97(6):e0028423. [Abstract]
- Chem Res Toxicol. 2022 Mar 21;35(3):422-430. [Abstract]
- J Periodontol. 2022 Mar;93(3):e60-e72. [Abstract]
- Neurochem Res. 2020 Sep;45(9):2052-2064. [Abstract]
- J Periodontol. 2020 Aug;91(8):1085-1097. [Abstract]
- J Photochem Photobiol B. 2025 Dec 13:274:113340. [Abstract]
- Cell Signal. 2025 Oct 18:112174. [Abstract]
- ACS Pharmacol Transl Sci. 2025 Jul 7;8(8):2612-2629. [Abstract]
- Cell Signal. 2025 Jun 25:111962. [Abstract]
- Mol Cell Biochem. 2025 May;480(5):3133-3145. [Abstract]
- Cell Signal. 2025 Jan:125:111504. [Abstract]
- Food Sci Anim Resour. 2024 Sep;44(5):1167-1180. [Abstract]
- Biochim Biophys Acta Mol Cell Res. 2023 Oct;1870(7):119540. [Abstract]
- Food Sci Anim Resour. 2022 Nov;42(6):942-952. [Abstract]
- Mol Cell Biochem. 2022 Apr;477(4):1009-1022. [Abstract]
- Cell Signal. 2021 Sep:85:110060. [Abstract]
- Biochim Biophys Acta Mol Cell Res. 2021 Sep;1868(10):119083. [Abstract]
- Brain Res Bull. 2021 Aug:173:162-173. [Abstract]
- Cytokine. 2021 Jun:142:155502. [Abstract]
- Cell Signal. 2020 Mar;67:109522. [Abstract]
- Cell Signal. 2019 Feb:54:17-26. [Abstract]
- Cell Signal. 2016 Feb;28(2):81-93. [Abstract]
- Mol Cell Endocrinol. 2026 Jun:616:112743. [Abstract]
- Biol Trace Elem Res. 2024 Jun;202(6):2598-2615. [Abstract]
- Stem Cells. 2022 Sep 26;40(9):857-869. [Abstract]
- Stem Cells. 2022 May 27;40(5):508-522. [Abstract]
- J Proteome Res. 2021 May 7;20(5):2329-2339. [Abstract]
- J Immunol Res. 2020 Feb 10;2020:6457879. [Abstract]
- Stem Cells. 2020 Jan;38(1):134-145. [Abstract]
- Mol Cell Endocrinol. 2019 Apr 5:485:35-43. [Abstract]
- Mol Cell Endocrinol. 2018 Jul 15:470:38-47. [Abstract]
- J Endod. 2018 May;44(5):751-758. [Abstract]
- Mol Hum Reprod. 2026 Apr 11;32(2):gaag019. [Abstract]
- J Endocrinol Invest. 2025 Jan;48(1):67-80. [Abstract]
- Food Chem Toxicol. 2024 Apr:186:114561. [Abstract]
- Food Chem Toxicol. 2023 Aug:178:113870. [Abstract]
- Food Chem Toxicol. 2023 Jun:176:113784. [Abstract]
- Food Chem Toxicol. 2023 Jan:171:113550. [Abstract]
- Viruses. 2022 Jul 7;14(7):1485. [Abstract]
- Viruses. 2022 Jul 2;14(7):1465. [Abstract]
- Mol Med Rep. 2022 Jun;25(6):215. [Abstract]
- Microb Pathog. 2022 Jan:162:105219. [Abstract]
- Vet Res. 2021 Oct 21;52(1):135. [Abstract]
- Mol Med Rep. 2021 Oct;24(4):709. [Abstract]
- Microb Pathog. 2021 Oct:159:105136. [Abstract]
- Parasit Vectors. 2021 Jul 8;14(1):358. [Abstract]
- Food Chem Toxicol. 2021 Feb:148:111925. [Abstract]
- Mol Med Rep. 2020 Jul;22(1):566-574. [Abstract]
- Mol Med Rep. 2019 Nov;20(5):4576-4586. [Abstract]
- Am J Physiol Renal Physiol. 2026 Feb 1;330(2):F269-F284. [Abstract]
- Andrology. 2025 Jun 16. [Abstract]
- Acta Biochim Biophys Sin (Shanghai). 2025 May 15. [Abstract]
- J Immunol. 2024 Jun 15;212(12):1877-1890. [Abstract]
- BMC Cancer. 2023 Nov 14;23(1):1108. [Abstract]
- BMC Complement Med Ther. 2022 Apr 6;22(1):100. [Abstract]
- J Periodontal Res. 2022 Jan;57(1):195-204. [Abstract]
- Toxicol Appl Pharmacol. 2021 May 1:418:115484. [Abstract]
- Phytochemistry. 2020 Dec;180:112531. [Abstract]
- Nanotoxicology. 2020 Jun;14(5):667-682. [Abstract]
- Vaccines. 2019 Dec 14;7(4):216. [Abstract]
- Toxicol Appl Pharmacol. 2019 Nov 1:382:114703. [Abstract]
- BMC Complement Altern Med. 2019 Aug 29;19(1):233. [Abstract]
- Toxicol Appl Pharmacol. 2019 Mar 1:366:83-95. [Abstract]
- Am J Physiol Gastrointest Liver Physiol. 2026 May 1;330(5):G532-G548. [Abstract]
- Front Oncol. 2020 Sep 30;10:523577. [Abstract]
- J Pharm Pharmacol. 2026 Feb 7;78(2):rgag010. [Abstract]
- J Physiol Sci. 2024 Oct 3;74(1):49. [Abstract]
- Environ Toxicol. 2025 Jan;40(1):88-100. [Abstract]
- Environ Toxicol. 2023 Nov;38(11):2621-2631. [Abstract]
- J Pharm Pharmacol. 2023 Jun 5;75(6):828-836. [Abstract]
- Environ Toxicol. 2023 Jan;38(1):90-100. [Abstract]
- Nitric Oxide. 2022 Dec 1:129:41-52. [Abstract]
- Pharmacology. 2022;107(1-2):14-27. [Abstract]
- Environ Toxicol. 2021 Feb;36(2):276-286. [Abstract]
- J Neurol Sci. 2020 Mar 15;410:116679. [Abstract]
- Hum Mol Genet. 2017 Sep 15;26(18):3553-3563. [Abstract]
- Front Biosci (Landmark Ed). 2026 Mar 19;31(3):47627. [Abstract]
- J Leukoc Biol. 2025 May 21:qiaf070. [Abstract]
- Naunyn Schmiedebergs Arch Pharmacol. 2025 Apr 14. [Abstract]
- Front Biosci (Landmark Ed). 2025 Mar 6;30(3):36255. [Abstract]
- Naunyn Schmiedebergs Arch Pharmacol. 2025 Mar;398(3):3001-3014. [Abstract]
- Int J Food Sci Tech. 2024 Jul 18.
- Front Biosci (Landmark Ed). 2023 Dec 1;28(12):325. [Abstract]
- J Leukoc Biol. 2023 Sep 1;114(3):266-279. [Abstract]
- Curr Issues Mol Biol. 2025 Apr 7;47(4):253. [Abstract]
- Curr Issues Mol Biol. 2024 Dec 31;47(1):16. [Abstract]
- Arch Biochem Biophys. 2024 Dec 9:110255. [Abstract]
- Curr Res Toxicol. 2024 Oct 24:7:100199. [Abstract]
- Arch Biochem Biophys. 2023 Jan 15:734:109486. [Abstract]
- Diabetes Metab Syndr Obes. 2021 Nov 12;14:4523-4534. [Abstract]
- Mol Immunol. 2021 Mar:131:97-111. [Abstract]
- Bioorg Med Chem. 2020 Jul 1;28(13):115547 [Abstract]
- Mol Immunol. 2018 Nov:103:133-143. [Abstract]
- Mol Immunol. 2017 Jul:87:161-170. [Abstract]
- Free Radic Res. 2025 May-Jul;59(6-7):518-530. [Abstract]
- Cell Immunol. 2024 Nov-Dec:405-406:104884. [Abstract]
- Cell Immunol. 2024 Jun 17:401-402:104843. [Abstract]
- Toxicol Lett. 2023 Aug 1:384:73-85. [Abstract]
- Mycopathologia. 2021 Jun;186(3):341-354. [Abstract]
- Endocrine. 2020 Apr;68(1):103-115. [Abstract]
- Peptides. 2019 Sep:119:170120. [Abstract]
- Mol Biol Rep. 2026 Mar 4;53(1):459. [Abstract]
- J Appl Toxicol. 2025 Sep;45(9):1694-1704. [Abstract]
- Mol Biol Rep. 2024 Nov 8;51(1):1134. [Abstract]
- Brain Sci. 2024 Apr 14;14(4):380. [Abstract]
- Int J Biochem Cell Biol. 2024 Apr:169:106549. [Abstract]
- Brain Sci. 2023 Jul 11;13(7):1058. [Abstract]
- Onco Targets Ther. 2021 Oct 22;14:5131-5144. [Abstract]
- Int J Biochem Cell Biol. 2021 Aug:137:106036. [Abstract]
- Int J Biochem Cell Biol. 2021 Jul:136:106003. [Abstract]
- Neuroscience. 2021 Apr 1:459:104-117. [Abstract]
- Exp Physiol. 2021 Feb;106(2):438-449. [Abstract]
- Infect Immun. 2021 Feb 16;89(3):e00680-20. [Abstract]
- J Cell Biochem. 2019 May;120(5):8561-8569. [Abstract]
- J Cell Biochem. 2018 Nov;119(10):8450-8459. [Abstract]
- BMC Pulm Med. 2018 Nov 27;18(1):178. [Abstract]
- Vet Microbiol. 2025 Dec 29:313:110858. [Abstract]
- Vet Microbiol. 2025 Sep 11:310:110726. [Abstract]
- Immun Inflamm Dis. 2024 Sep;12(9):e70012. [Abstract]
- BMC Immunol. 2023 Nov 8;24(1):43. [Abstract]
- Exp Eye Res. 2023 Mar:228:109388. [Abstract]
- Anal Cell Pathol. 2022 Sep 27;2022:9358583. [Abstract]
- Vet Microbiol. 2021 May:256:109061. [Abstract]
- DNA Cell Biol. 2024 Sep;43(9):474-481. [Abstract]
- Int J Immunopathol Pharmacol. 2024 Jan-Dec:38:3946320241249445. [Abstract]
- Acupunct Med. 2021 Dec;39(6):708-715. [Abstract]
- J Microbiol. 2021 Aug;59(8):771-781. [Abstract]
- PLoS One. 2020 Sep 3;15(9):e0235824. [Abstract]
- Theriogenology. 2025 Dec 18:252:117791. [Abstract]
- Tissue Cell. 2024 Jul 25:90:102496. [Abstract]
- Chin J Integr Med. 2024 Sep;30(9):818-825. [Abstract]
- Fundam Clin Pharmacol. 2020 Oct;34(5):591-602. [Abstract]
- Chem Biodivers. 2019 Aug;16(8):e1900325. [Abstract]
- Toxicon. 2024 May 11:244:107757. [Abstract]
- PeerJ. 2023 Aug 23:11:e15890. [Abstract]
- Dev Comp Immunol. 2022 Feb:127:104292. [Abstract]
- Virology. 2017 Aug:508:150-158. [Abstract]
- J Oral Pathol Med. 2024 May 19. [Abstract]
- Exp Ther Med. 2023 Mar 14;25(4):188. [Abstract]
- Exp Ther Med. 2022 Jan;23(1):11. [Abstract]
- Exp Ther Med. 2021 Dec;22(6):1461. [Abstract]
- Exp Ther Med. 2021 Dec;22(6):1440. [Abstract]
- Exp Ther Med. 2021 May;21(5):468. [Abstract]
- Exp Ther Med. 2020 Mar;19(3):2243-2251. [Abstract]
- Exp Ther Med. 2020 Mar;19(3):1824-1834. [Abstract]
- FEBS Open Bio. 2020 Mar;10(3):434-443. [Abstract]
- Biomed Res Int. 2019 Jul 10:2019:5347804. [Abstract]
- J Mol Histol. 2025 Jul 31;56(4):246. [Abstract]
- Anticancer Drugs. 2025 Apr 1;36(4):319-327. [Abstract]
- Biochem Bioph Res Co. 2020 Oct 15;531(2):187-194. [Abstract]
- Oncol Lett. 2020 Apr;19(4):3269-3277. [Abstract]
- Eur Arch Otorhinolaryngol. 2019 Mar;276(3):767-774. [Abstract]
- Arch Oral Biol. 2026 Mar:183:106496. [Abstract]
- Future Sci OA. 2025 Dec;11(1):2455906. [Abstract]
- Connect Tissue Res. 2024 May 16:1-12. [Abstract]
- Can Respir J. 2022 Oct 10:2022:6879539. [Abstract]
- Med Sci Monit. 2020 Aug 7:26:e925298. [Abstract]
- Med Sci Monit. 2019 Jun 21:25:4609-4616. [Abstract]
- Biochem Cell Biol. 2017 Feb;95(1):64-68. [Abstract]
- Neurosci Lett. 2024 Jan 18:820:137611. [Abstract]
- Cell Physiol Biochem. 2018;46(5):1779-1792. [Abstract]
- Cancer Rep (Hoboken). 2025 Mar;8(3):e70179. [Abstract]
- J Interferon Cytokine Res. 2021 Dec;41(12):439-449. [Abstract]
- J Clin Neurosci. 2020 Aug;78:365-370. [Abstract]
- J Interferon Cytokine Res. 2019 Apr;39(4):224-232. [Abstract]
- Genes Genomics. 2026 Jan 14. [Abstract]
- Cytotechnology. 2026 Feb;78(1):3. [Abstract]
- Eur J Integr Med. 2024 Sep 8.
- J Surg Res. 2024 Jul 22:301:413-422. [Abstract]
- Cell J. 2022 Dec 1;24(12):732-740. [Abstract]
- Biol Pharm Bull. 2022 Aug 1;45(8):1061-1068. [Abstract]
- Reprod Domest Anim. 2021 Aug;56(8):1066-1084. [Abstract]
- Am J Transl Res. 2020 Jul 15;12(7):3577-3595. [Abstract]
- Am J Transl Res. 2020 Feb 15;12(2):478-492. [Abstract]
- Cell Microbiol. 2019 Sep;21(9):e13064. [Abstract]
- Am J Transl Res. 2019 Feb 15;11(2):806-818. [Abstract]
- J Vet Sci. 2023 Sep;24(5):e72. [Abstract]
- J Cardiothorac Surg. 2021 May 10;16(1):127. [Abstract]
- Mol Cell Toxicol (2019) 15:209-219
- J Asian Nat Prod Res. 2020 Sep;22(9):850-863. [Abstract]
- Biomed Res. 2017; 28 (8): 3383-3386
- J Vet Med Sci. 2023 Jul 1;85(7):721-726. [Abstract]
- Pharmacogn Mag. 2025 May 27.
- Int J Clin Exp Med. 2017;10(9):13542-13549.
- bioRxiv. 2026 Feb 10.
- Res Sq. 2026 Jan 9.
- bioRxiv. 2026 Jan 25.
- SSRN. 2025 Oct 9.
- Res Sq. 2025 Aug 08.
- Josip Juraj Strossmayer University of Osijek. 2025.
- Washington State University. 2025.
- University of Minnesota. 2025.
- bioRxiv. 2025 January 18.
- Research Square Preprint. 2024 Aug 21.
- Res Sq. 2024 Oct 15.
- Authorea. 2024 Jul 13.
- Res Sq. 2024 Jun 19.
- bioRxiv. 2024 May 2.
- Research Square Preprint. 2024 Mar 29.
- SSRN. 2024 Feb 15.
- Pak J Zool. 2023 Nov 17.
- Research Square Preprint. 2023 Nov 10.
- bioRxiv. 2023 Sep 29:2023.09.27.559864. [Abstract]
- bioRxiv. 2023 Aug 14.
- SSRN. 2023 May 8.
- bioRxiv. 2023 Mar 24.
- Authorea. 2022.
- Authorea. 2022.
- Research Square Print. November 29th, 2022.
- Research Square Print. November 15th, 2022
- Research Square Print. September 20th, 2022.
- Research Square Print. 2022 Aug.
- Oxid Med Cell Longev. 2022 Jun 22:2022:2333848. [Abstract]
- Research Square Preprint. 2022 May.
- Oxid Med Cell Longev. 2022 Mar 10:2022:1863098. [Abstract]
- Int J Biol Sci. 2022 Jan 16;18(4):1363-1380. [Abstract]
- Research Square Preprint. 2022 Feb.
- Research Square Preprint. 2022 Jan.
- bioRxiv. January 18, 2022.
- Research Square Preprint. 2021 Dec.
- SSRN. 8 Nov 2021.
- Research Square Preprint. 2021 Oct.
- Research Square Preprint. 2021 Sep.
- Research Square Preprint. 2021 Sep.
- Research Square Preprint. 2021 May.
- Research Square Preprint. 2021 May.
- Research Square Preprint. 2021 Jan.
- Universidad de Granada. 2020 Sep.
- bioRxiv. 2020 Jun.
- Ann Transl Med. 2019 Dec;7(23):758. [Abstract]
- Eur Rev Med Pharmacol Sci. 2019 Aug;23(3 Suppl):1-8. [Abstract]
- Patent. US20180263995A1.
- Dis Markers. 2018 Apr 17:2018:7413027. [Abstract]
- Neuropsychiatry (London). 2018;8(4);1132-1139.
- Patent. US20170349880A1.
- Oncotarget. 2017 Oct 19;8(60):101965-101983. [Abstract]
- Manchester Metropolitan University. 2017 May.
- Oxid Med Cell Longev. 2017:2017:6175841. [Abstract]
- China Biotechnology. 2017, 37(12): 40-48.
- Chin Arch Otolaryngol Head Neck Surg. 2016,23(01):49-52.
-
RT-PCR
-
WB
-
RT-PCR
-
WB
-
WB
Biologische Aktivität
|
p38 50 nM (IC50) |
p38β2 500 nM (IC50) |
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| BMDC | IC50 |
3.45 μM
Compound: SB203580
|
Antiinflammatory activity in C57BL/6 mouse BMDCs assessed as inhibition of LPS-stimulated IL12 production treated 1 hr before LPS challenge measured 18 hrs post stimulation by ELISA
Antiinflammatory activity in C57BL/6 mouse BMDCs assessed as inhibition of LPS-stimulated IL12 production treated 1 hr before LPS challenge measured 18 hrs post stimulation by ELISA
|
[PMID: 23484668] |
| BMDC | IC50 |
3.5 μM
Compound: SB203580
|
Antiinflammatory activity in C57BL/6 mouse BMDC cells assessed as inhibition of LPS-induced IL-6 production preincubated for 1 hr prior to LPS-stimulation measured after 18 hrs by ELISA
Antiinflammatory activity in C57BL/6 mouse BMDC cells assessed as inhibition of LPS-induced IL-6 production preincubated for 1 hr prior to LPS-stimulation measured after 18 hrs by ELISA
|
[PMID: 24047259] |
| BMDC | IC50 |
3.5 μM
Compound: SB203580
|
Anti-inflammatory activity in C57BL/6 mouse BMDC assessed as inhibition of LPS-induced IL-6 production pretreated for 1 hr followed by LPS-stimulation after 18 hrs by ELISA
Anti-inflammatory activity in C57BL/6 mouse BMDC assessed as inhibition of LPS-induced IL-6 production pretreated for 1 hr followed by LPS-stimulation after 18 hrs by ELISA
|
[PMID: 28009172] |
| BMDC | IC50 |
3.53 μM
Compound: SB203580
|
Antiinflammatory activity in C57BL/6 mouse BMDC assessed as inhibition of LPS-stimulated IL-6 production preincubated for 1 hr before LPS-stimulation measured after 16 hrs by ELISA
Antiinflammatory activity in C57BL/6 mouse BMDC assessed as inhibition of LPS-stimulated IL-6 production preincubated for 1 hr before LPS-stimulation measured after 16 hrs by ELISA
|
[PMID: 22071304] |
| BMDC | IC50 |
3.56 μM
Compound: SB203580
|
Antiinflammatory activity against in C57BL/6 mouse BMDC assessed as inhibition of LPS-stimulated IL6 production compound pre-incubated for 1 hr before LPS challenge by ELISA
Antiinflammatory activity against in C57BL/6 mouse BMDC assessed as inhibition of LPS-stimulated IL6 production compound pre-incubated for 1 hr before LPS challenge by ELISA
|
[PMID: 23200246] |
| BMDC | IC50 |
5 μM
Compound: SB203580
|
Antiinflammatory activity in wild-type C57BL/6 mouse BMDCs assessed as inhibition of IL-12 p40 production incubated for 1 hr prior to LPS challenge measured after 16 hrs by ELISA
Antiinflammatory activity in wild-type C57BL/6 mouse BMDCs assessed as inhibition of IL-12 p40 production incubated for 1 hr prior to LPS challenge measured after 16 hrs by ELISA
|
[PMID: 23395633] |
| BMDC | IC50 |
5 μM
Compound: SB203580
|
Antiinflammatory activity in C57BL/6 mouse BMDC cells assessed as inhibition of LPS-induced IL-12 p40 production preincubated for 1 hr prior to LPS-stimulation measured after 18 hrs by ELISA
Antiinflammatory activity in C57BL/6 mouse BMDC cells assessed as inhibition of LPS-induced IL-12 p40 production preincubated for 1 hr prior to LPS-stimulation measured after 18 hrs by ELISA
|
[PMID: 24047259] |
| BMDC | IC50 |
5 μM
Compound: SB203580
|
Anti-inflammatory activity in C57BL/6 mouse BMDC assessed as inhibition of LPS-induced IL12 p40 production pretreated for 1 hr followed by LPS-stimulation after 18 hrs by ELISA
Anti-inflammatory activity in C57BL/6 mouse BMDC assessed as inhibition of LPS-induced IL12 p40 production pretreated for 1 hr followed by LPS-stimulation after 18 hrs by ELISA
|
[PMID: 28009172] |
| BMDC | IC50 |
5.02 μM
Compound: SB203580
|
Antiinflammatory activity in C57BL/6 mouse BMDC assessed as inhibition of LPS-stimulated IL-12p40 production preincubated for 1 hr before LPS-stimulation measured after 16 hrs by ELISA
Antiinflammatory activity in C57BL/6 mouse BMDC assessed as inhibition of LPS-stimulated IL-12p40 production preincubated for 1 hr before LPS-stimulation measured after 16 hrs by ELISA
|
[PMID: 22071304] |
| BMDC | IC50 |
5.21 μM
Compound: SB203580
|
Antiinflammatory activity in C57BL/6 mouse BMDCs assessed as inhibition of LPS-stimulated IL-12p40 production treated 1 hr before LPS challenge measured 18 hrs post stimulation by ELISA
Antiinflammatory activity in C57BL/6 mouse BMDCs assessed as inhibition of LPS-stimulated IL-12p40 production treated 1 hr before LPS challenge measured 18 hrs post stimulation by ELISA
|
[PMID: 23484668] |
| BMDC | IC50 |
5.67 μM
Compound: SB203580
|
Antiinflammatory activity against in C57BL/6 mouse BMDC assessed as inhibition of LPS-stimulated IL12 production compound pre-incubated for 1 hr before LPS challenge by ELISA
Antiinflammatory activity against in C57BL/6 mouse BMDC assessed as inhibition of LPS-stimulated IL12 production compound pre-incubated for 1 hr before LPS challenge by ELISA
|
[PMID: 23200246] |
| BMDC | IC50 |
7.2 μM
Compound: SB203580
|
Anti-inflammatory activity in C57BL/6 mouse BMDC assessed as inhibition of LPS-induced TNFalpha production pretreated for 1 hr followed by LPS-stimulation after 18 hrs by ELISA
Anti-inflammatory activity in C57BL/6 mouse BMDC assessed as inhibition of LPS-induced TNFalpha production pretreated for 1 hr followed by LPS-stimulation after 18 hrs by ELISA
|
[PMID: 28009172] |
| BMDC | IC50 |
7.24 μM
Compound: SB203580
|
Antiinflammatory activity in C57BL/6 mouse BMDC assessed as inhibition of LPS-stimulated TNF-alpha production preincubated for 1 hr before LPS-stimulation measured after 16 hrs by ELISA
Antiinflammatory activity in C57BL/6 mouse BMDC assessed as inhibition of LPS-stimulated TNF-alpha production preincubated for 1 hr before LPS-stimulation measured after 16 hrs by ELISA
|
[PMID: 22071304] |
| BMDC | IC50 |
7.37 μM
Compound: SB203580
|
Antiinflammatory activity against in C57BL/6 mouse BMDC assessed as inhibition of LPS-stimulated TNFalpha production compound pre-incubated for 1 hr before LPS challenge by ELISA
Antiinflammatory activity against in C57BL/6 mouse BMDC assessed as inhibition of LPS-stimulated TNFalpha production compound pre-incubated for 1 hr before LPS challenge by ELISA
|
[PMID: 23200246] |
| BMDC | IC50 |
7.5 μM
Compound: SB203580
|
Antiinflammatory activity in C57BL/6 mouse BMDC cells assessed as inhibition of LPS-induced TNFalpha production preincubated for 1 hr prior to LPS-stimulation measured after 18 hrs by ELISA
Antiinflammatory activity in C57BL/6 mouse BMDC cells assessed as inhibition of LPS-induced TNFalpha production preincubated for 1 hr prior to LPS-stimulation measured after 18 hrs by ELISA
|
[PMID: 24047259] |
| BMDC | IC50 |
7.53 μM
Compound: SB203580
|
Antiinflammatory activity in C57BL/6 mouse BMDCs assessed as inhibition of LPS-stimulated TNF-alpha production treated 1 hr before LPS challenge measured 18 hrs post stimulation by ELISA
Antiinflammatory activity in C57BL/6 mouse BMDCs assessed as inhibition of LPS-stimulated TNF-alpha production treated 1 hr before LPS challenge measured 18 hrs post stimulation by ELISA
|
[PMID: 23484668] |
| HEK293 | EC50 |
0.06 μM
Compound: SB 203580
|
Inhibition of recombinant Nanoluc-tagged p38alpha (unknown origin) expressed in HEK293 cells incubated for 2 to 3 mins by NanoBRET assay
Inhibition of recombinant Nanoluc-tagged p38alpha (unknown origin) expressed in HEK293 cells incubated for 2 to 3 mins by NanoBRET assay
|
[PMID: 31520926] |
| HEK293 | IC50 |
250 nM
Compound: 2; SB-203580
|
Inhibition of RIP2K in MDP-stimulated HEK-293 cells over-expressing NOD2 assessed as IL8 secretion
Inhibition of RIP2K in MDP-stimulated HEK-293 cells over-expressing NOD2 assessed as IL8 secretion
|
[PMID: 27109867] |
| HEK293 | IC50 |
6310 nM
Compound: 2; SB-203580
|
Inhibition of RIP2K in Pam2CSK4-stimulated HEK-293 cells over-expressing TLR2 assessed as IL8 secretion
Inhibition of RIP2K in Pam2CSK4-stimulated HEK-293 cells over-expressing TLR2 assessed as IL8 secretion
|
[PMID: 27109867] |
| HeLa | IC50 |
0.1 μM
Compound: SB-203580
|
Inhibition of Tat-induced HIV1 LTR transactivation in human HeLa cells assessed as CAT expression after 2 days
Inhibition of Tat-induced HIV1 LTR transactivation in human HeLa cells assessed as CAT expression after 2 days
|
[PMID: 18926711] |
| HL-60 | IC50 |
50.5 μM
Compound: SB-203580
|
Antiinflammatory activity in PMA-stimulated human HL60 cells assessed as inhibition of LPS-induced TNFalpha production preincubated for 30 mins before LPS challenge measured after 24 hrs by ELISA
Antiinflammatory activity in PMA-stimulated human HL60 cells assessed as inhibition of LPS-induced TNFalpha production preincubated for 30 mins before LPS challenge measured after 24 hrs by ELISA
|
[PMID: 22621841] |
| HL-60 | IC50 |
52.2 μM
Compound: SB203580
|
Antiinflammatory activity in human HL-60 derived macrophage-like cells assessed as inhibition of LPS-induced IL-6 production treated 30 mins before LPS stimulation measured after 24 hrs by ELISA
Antiinflammatory activity in human HL-60 derived macrophage-like cells assessed as inhibition of LPS-induced IL-6 production treated 30 mins before LPS stimulation measured after 24 hrs by ELISA
|
[PMID: 23811089] |
| HL-60 | IC50 |
52.2 μM
Compound: SB-203580
|
Antiinflammatory activity in PMA-stimulated human HL60 cells assessed as inhibition of LPS-induced IL-6 production preincubated for 30 mins before LPS challenge measured after 24 hrs by ELISA
Antiinflammatory activity in PMA-stimulated human HL60 cells assessed as inhibition of LPS-induced IL-6 production preincubated for 30 mins before LPS challenge measured after 24 hrs by ELISA
|
[PMID: 22621841] |
| HL-60 | IC50 |
8.6 μM
Compound: SB203580
|
Antiinflammatory activity in human HL-60 derived macrophage-like cells assessed as inhibition of LPS-induced TNFalpha production treated 30 mins before LPS stimulation measured after 24 hrs by ELISA
Antiinflammatory activity in human HL-60 derived macrophage-like cells assessed as inhibition of LPS-induced TNFalpha production treated 30 mins before LPS stimulation measured after 24 hrs by ELISA
|
[PMID: 23811089] |
| L132 | CC50 |
>10 μM
Compound: 81; SB203580
|
Cytotoxicity against human L132 cells
Cytotoxicity against human L132 cells
|
[PMID: 33539089] |
| PBMC | IC50 |
>10 μM
Compound: SB-203580
|
Antiinflammatory activity in human PBMCs assessed as inhibition of LPS-induced IL6 release incubated for 15 mins prior to LPS challenge measured after 24 hrs by HTRF assay
Antiinflammatory activity in human PBMCs assessed as inhibition of LPS-induced IL6 release incubated for 15 mins prior to LPS challenge measured after 24 hrs by HTRF assay
|
[PMID: 23411072] |
| PBMC | IC50 |
0.34 μM
Compound: SB-203580
|
Antiinflammatory activity in human PBMCs assessed as inhibition of LPS-induced IL1-beta release incubated for 15 mins prior to LPS challenge measured after 24 hrs by HTRF assay
Antiinflammatory activity in human PBMCs assessed as inhibition of LPS-induced IL1-beta release incubated for 15 mins prior to LPS challenge measured after 24 hrs by HTRF assay
|
[PMID: 23411072] |
| PBMC | IC50 |
1 μM
Compound: SB-203580
|
Antiinflammatory activity in human PBMCs assessed as inhibition of LPS-induced TNFalpha release incubated for 15 mins prior to LPS challenge measured after 24 hrs by HTRF assay
Antiinflammatory activity in human PBMCs assessed as inhibition of LPS-induced TNFalpha release incubated for 15 mins prior to LPS challenge measured after 24 hrs by HTRF assay
|
[PMID: 23411072] |
| PBMC | IC50 |
160 nM
Compound: 4
|
Inhibition of staphylococcal enterotoxin B(SEB) stimulated tumor necrosis factor alpha (TNF-alpha) production by human peripheral blood mononuclear cells(PBMCs)
Inhibition of staphylococcal enterotoxin B(SEB) stimulated tumor necrosis factor alpha (TNF-alpha) production by human peripheral blood mononuclear cells(PBMCs)
|
[PMID: 9784093] |
| PBMC | IC50 |
25 nM
Compound: 4
|
Inhibition of LPS-stimulated TH+NF-alphs production by human peripheral blood mononuclear cells (PBMCs)
Inhibition of LPS-stimulated TH+NF-alphs production by human peripheral blood mononuclear cells (PBMCs)
|
[PMID: 9784093] |
| PBMC | IC50 |
48 nM
Compound: 4
|
Inhibition of LPS-induced IL1-beta production in human peripheral blood mononuclear cells(PBMCs)
Inhibition of LPS-induced IL1-beta production in human peripheral blood mononuclear cells(PBMCs)
|
[PMID: 9784093] |
| Peritoneal macrophage cell | IC50 |
0.22 μM
Compound: 10, SB-203580
|
Antiinflammatory activity in BALB/c mouse peritoneal macrophages assessed as inhibition of LPS-induced TNFalpha production treated 1 hr before LPS challenge measured after 24 hrs by ELISA
Antiinflammatory activity in BALB/c mouse peritoneal macrophages assessed as inhibition of LPS-induced TNFalpha production treated 1 hr before LPS challenge measured after 24 hrs by ELISA
|
[PMID: 22647219] |
| Platelet | IC50 |
200 nM
Compound: K00038
|
Inhibition of collagen-induced human platelet aggregation
Inhibition of collagen-induced human platelet aggregation
|
[PMID: 18077363] |
| RBL-1 | IC50 |
58 μM
Compound: 2
|
Inhibitory activity against 5-lipoxygenase enzyme from RBL-1 cells
Inhibitory activity against 5-lipoxygenase enzyme from RBL-1 cells
|
10.1016/0960-894X(95)00189-Z |
| Sf9 | IC50 |
0.035 μM
Compound: SB203580
|
Inhibition of recombinant human full-length N-terminal GST-tagged P38 alpha MAPK expressed in baculovirus infected Sf9 insect cells using p38 peptide as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins in presen
Inhibition of recombinant human full-length N-terminal GST-tagged P38 alpha MAPK expressed in baculovirus infected Sf9 insect cells using p38 peptide as substrate preincubated for 15 mins followed by substrate addition and measured after 60 mins in presen
|
[PMID: 31445234] |
| Sf9 | IC50 |
10 nM
Compound: 2, SB-203580
|
Inhibition of full-length FLAG-6His-TEV tagged human RIP2 expressed in Sf9 cells assessed as reduction in autophosphorylation pre-incubated for 30 mins followed by incubation with ATP for 2 hrs by ADP-Glo assay
Inhibition of full-length FLAG-6His-TEV tagged human RIP2 expressed in Sf9 cells assessed as reduction in autophosphorylation pre-incubated for 30 mins followed by incubation with ATP for 2 hrs by ADP-Glo assay
|
[PMID: 26455654] |
| Sf9 | IC50 |
200 nM
Compound: 2, SB-203580
|
Inhibition of full-length FLAG-6His-TEV tagged human RIP2 expressed in Sf9 cells by fluorescent polarization assay
Inhibition of full-length FLAG-6His-TEV tagged human RIP2 expressed in Sf9 cells by fluorescent polarization assay
|
[PMID: 26455654] |
| SW1353 | IC50 |
0.05 μM
Compound: 1
|
Compound was evaluated for its ability to inhibit IL-6 production in SW1353 cells treated with cytokines IL-1 and TNF
Compound was evaluated for its ability to inhibit IL-6 production in SW1353 cells treated with cytokines IL-1 and TNF
|
[PMID: 10999467] |
| SW1353 | IC50 |
50 nM
Compound: 1
|
Inhibition of IL-6 production by SW1353 cells treated with both cytokines IL-1 and TNF-alpha.
Inhibition of IL-6 production by SW1353 cells treated with both cytokines IL-1 and TNF-alpha.
|
[PMID: 11140741] |
| SW1353 | IC50 |
50 nM
Compound: 1
|
Inhibition of TNF and IL-1 induced IL-6 production in human chondro-sarcoma SW 1353 cells
Inhibition of TNF and IL-1 induced IL-6 production in human chondro-sarcoma SW 1353 cells
|
[PMID: 10999468] |
| THP-1 | EC50 |
60 nM
Compound: 1
|
Inhibition of LPS-induced tumor necrosis factor-alpha (TNF-alpha) production in THP-1 cells
Inhibition of LPS-induced tumor necrosis factor-alpha (TNF-alpha) production in THP-1 cells
|
[PMID: 12086485] |
| THP-1 | IC50 |
0.016 μM
Compound: SB-203580
|
Inhibition of LPS-induced TNFalpha production in human THP1 cells
Inhibition of LPS-induced TNFalpha production in human THP1 cells
|
[PMID: 18325768] |
| THP-1 | IC50 |
0.07 μM
Compound: SB-203580
|
Inhibition of tumor necrosis factor alpha release by THP-1 cells
Inhibition of tumor necrosis factor alpha release by THP-1 cells
|
[PMID: 15658855] |
| THP-1 | IC50 |
20 nM
Compound: SB 203580
|
Inhibition of LPS-induced TNFalpha production in human THP1 cells incubated for 1 hr followed by LPS stimulation and measured after 4 hrs by TR-FRET method
Inhibition of LPS-induced TNFalpha production in human THP1 cells incubated for 1 hr followed by LPS stimulation and measured after 4 hrs by TR-FRET method
|
[PMID: 31520926] |
| THP-1 | IC50 |
50 nM
Compound: K00038
|
Inhibition of LPS-stimulated IL1 production in human THP1 cells
Inhibition of LPS-stimulated IL1 production in human THP1 cells
|
[PMID: 18077363] |
| THP-1 | IC50 |
50 nM
Compound: K00038
|
Inhibition of LPS-stimulated TNFalpha production in human THP1 cells
Inhibition of LPS-stimulated TNFalpha production in human THP1 cells
|
[PMID: 18077363] |
| THP-1 | IC50 |
72 nM
Compound: SB-203580
|
Inhibitory activity against TNF-alpha production using lipopolysaccharide stimulated human monocytic cells
Inhibitory activity against TNF-alpha production using lipopolysaccharide stimulated human monocytic cells
|
[PMID: 12729637] |
| THP-1 | IC50 |
72 nM
Compound: SB-203580
|
Inhibitory activity against LPS-stimulated TNF-alpha production in human monocytic cells (THP-1)
Inhibitory activity against LPS-stimulated TNF-alpha production in human monocytic cells (THP-1)
|
[PMID: 15139749] |
| THP-1 | IC50 |
72 nM
Compound: SB-203580
|
Inhibitory activity against lipopolysaccharide stimulated TNF-alpha production in THP-1 cells (human monocytic cells)
Inhibitory activity against lipopolysaccharide stimulated TNF-alpha production in THP-1 cells (human monocytic cells)
|
[PMID: 15837310] |
| THP-1 | IC50 |
72 nM
Compound: SB-203580
|
Inhibition of LPS-stimulated TNFalpha production in THP1 cells
Inhibition of LPS-stimulated TNFalpha production in THP1 cells
|
[PMID: 16750367] |
| THP-1 | IC50 |
72 μM
Compound: SB-203580
|
Concentration required to inhibit production of Tumor necrosis factor, alpha in LPS-stimulated human monocytic cells (THP-1)
Concentration required to inhibit production of Tumor necrosis factor, alpha in LPS-stimulated human monocytic cells (THP-1)
|
[PMID: 15341957] |
Adezmapimod (SB 203580) (preincubated with 0-30 μM for 1 h and cultured for 24 h in the presence of 20 ng/mL IL-2) prevents the IL-2-induced proliferation of primary human T cells, murine CT6 T cells, or BAF F7 B cells with an IC50 of 3-5 μM[1].
SB203580 blocks PKB phosphorylation (IC50 3-5 μM). SB203580 inhibitsthe phosphorylation of Ser473 in a dose-dependent manner in both CT6 and activated human T cells and IL-2-responsive BA/F3 F7 B cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:CT6, BA/F3 cell line F7, and PBMC/T cells
-
Concentration:0-30 μM
-
Incubation Time:Preincubated with 0-30 μM SB203580 for 1 h and cultured for 24 h in the presence of 20 ng/mL IL-2
-
Result:Prevented the IL-2-induced proliferation of primary human T cells, murine CT6 T cells, or BAF F7 B cells with an IC50 of 3-5 μM.
-
Cell Line:CT6 cells, activated human T cells, and BA/F3 F7 cells
-
Concentration:0-30 μM
-
Incubation Time:Preincubated with 0-30 μM SB203580 for 1 h before stimulating with 20 ng/mL IL-2 for 5 min
-
Result:Inhibited the phosphorylation of PKB at Ser473 in a dose-dependent manner.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Six-week-old female atymic Nu/Nu mice CAL27 p38WT and p38TM tumors[1]
-
Dosage:5 mg/kg/day
-
Administration:Intra peritoneal injected daily for 16 consecutive days
-
Result:After 2 weeks treatment, CAL27 p38WT tumors were significantly smaller; CAL27 p38TM tumors were not affected by the p38 inhibitor (n=10).
Chemical Information
-
CAS. Nr. 152121-47-6
-
Appearance Solid
-
Molecular Weight 377.43
-
Formel C21H16FN3OS
-
Color White to light yellow
-
SMILES
O=S(C1=CC=C(C2=NC(C3=CC=C(F)C=C3)=C(C4=CC=NC=C4)N2)C=C1)C
-
Synonyms
SB 203580; RWJ 64809
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Powder -20°C 3 years 4°C 2 years In solvent -80°C 2 years -20°C 1 year
Publications (607)
-
Journal Impact Factor
-
Most Recent
-
Signal Transduct Target Ther
Dihydroartemisinin regulates immune cell heterogeneity by triggering a cascade reaction of CDK and MAPK phosphorylation. [Abstract]2022 Jul 11;7(1):222. PMID: 35811310 -
Signal Transduct Target Ther
TIPE-mediated up-regulation of MMP-9 promotes colorectal cancer invasion and metastasis through MKK-3/p38/NF-κB pro-oncogenic signaling pathway. [Abstract]2020 Aug 25;5(1):163. PMID: 32843639 -
Nat Cancer
MEF2D-expressing cancer precursors reprogram tissue-resident macrophages to support liver tumorigenesis. [Abstract]2025 Dec;6(12):1955-1975. PMID: 41131393 -
Nat Immunol
The ligation between ERMAP, galectin-9 and dectin-2 promotes Kupffer cell phagocytosis and antitumor immunity. [Abstract]2023 Nov;24(11):1813-1824. PMID: 37813965 -
Cell Res
Elimination of senescent cells by β-galactosidase-targeted prodrug attenuates inflammation and restores physical function in aged mice. [Abstract]2020 Jul;30(7):574-589. PMID: 32341413 -
Cancer Commun (Lond)
The EGFR-P38 MAPK axis up-regulates PD-L1 through miR-675-5p and down-regulates HLA-ABC via hexokinase-2 in hepatocellular carcinoma cells. [Abstract]2021 Jan;41(1):62-78. PMID: 34236149
Adezmapimod purchased from MedChemExpress. Usage Cited in: Cancer Commun (Lond). 2021 Jan;41(1):62-78. [Abstract]
Cells pre-treated with P38 inhibitor SB203580 (SB2, 10 μmol/L) for 6 h were further stimulated with EGF (20 ng/mL) for 24 h, then PD-L1 and HLA-B transcription was detected by qRT-PCR.
Adezmapimod purchased from MedChemExpress. Usage Cited in: Cancer Commun (Lond). 2021 Jan;41(1):62-78. [Abstract]
Cells pre-treated with P38 inhibitor SB203580 (SB2, 10 μmol/L) for 6 h were further stimulated with EGF (20 ng/mL) for 24 h, then PD-L1 and HLA-ABC protein levels were measured by Western blotting.
Adezmapimod purchased from MedChemExpress. Usage Cited in: Cancer Commun (Lond). 2021 Jan;41(1):62-78. [Abstract]
Cells were pre-treated with SB203580 (Adezmapimod) (10 μmol/L) or dimethylsulfoxide (DMSO) for 6 h, and then co-stimulated with or without EGF for an additional 24 h, next cells were further treated with actinomycin D (5 μg/mL) for 0-120 min, and cellular PD-L1 mRNA expression was detected by qRT-PCR.
-
Nat Metab
2024 Apr;6(4):708-723. PMID: 38499763 -
Nat Metab
The alternative activity of nuclear PHGDH contributes to tumour growth under nutrient stress. [Abstract]2021 Oct;3(10):1357-1371. PMID: 34663976 -
Bioact Mater
Food-derived β-lactoglobulin nanofibrils: An efficacy, safe, and scalable solution to overcome oral insulin delivery challenges. [Abstract]2025 Nov 25:57:646-659. PMID: 41377894 -
Cell Mol Immunol
γδ+ T-cell-derived IL-17A stimulates airway epithelial/stromal cells to secrete G-CSF, promoting lung-specific pathogenic Siglec-F+ neutrophil development in PPE-induced emphysema. [Abstract]2025 Jul;22(7):791-805. PMID: 40461699 -
Cell Mol Immunol
β-adrenoreceptor-triggered PKA activation negatively regulates the innate antiviral response. [Abstract]2023 Feb;20(2):175-188. PMID: 36600052 -
Cell Mol Immunol
2022 Nov;19(11):1263-1278. PMID: 36180780 -
Clin Mol Hepatol
Taurocholic Acid Promotes Hepatic Stellate Cell Activation via S1PR2/p38 MAPK/YAP Signaling under Cholestatic Conditions. [Abstract]2023 Apr;29(2):465-481. PMID: 36800698 -
Mol Cell
HSPA1A and DNAJB1 regulate NELF condensate dynamics to safeguard transcriptional recovery under heat stress. [Abstract]2026 Feb 19;86(4):674-692.e10. PMID: 41653920 -
Mol Cell
PTPS Facilitates Compartmentalized LTBP1 S-Nitrosylation and Promotes Tumor Growth under Hypoxia. [Abstract]2020 Jan 2;77(1):95-107.e5. PMID: 31628042 -
Cancer Res
Thymosin α-1 Reverses M2 Polarization of Tumor-Associated Macrophages during Efferocytosis. [Abstract]2022 May 16;82(10):1991-2002. PMID: 35364609 -
Sci Immunol
SLAMF3 and SLAMF4 are immune checkpoints that constrain macrophage phagocytosis of hematopoietic tumors. [Abstract]2022 Jan 21;7(67):eabj5501. PMID: 35061505 -
Hepatology
Eosinophils protect against acetaminophen-induced liver injury through cyclooxygenase-mediated IL-4/IL-13 production. [Abstract]2023 Feb 1;77(2):456-465. PMID: 35714036 -
Nat Commun
Josephin Domain Containing 2 (JOSD2) inhibition as Pan-KRAS-mutation-targeting strategy for colorectal cancer. [Abstract]2025 Apr 16;16(1):3623. PMID: 40240366 -
Nat Commun
Single-cell and chromatin accessibility profiling reveals regulatory programs of pathogenic Th2 cells in allergic asthma. [Abstract]2025 Mar 15;16(1):2565. PMID: 40089475 -
Nat Commun
Intrinsic temperature increase drives lipid metabolism towards ferroptosis evasion and chemotherapy resistance in pancreatic cancer. [Abstract]2024 Oct 2;15(1):8540. PMID: 39358362 -
Nat Commun
Deficiency of the HGF/Met pathway leads to thyroid dysgenesis by impeding late thyroid expansion. [Abstract]2024 Apr 11;15(1):3165. PMID: 38605010 -
Nat Commun
The senescence-associated secretory phenotype is potentiated by feedforward regulatory mechanisms involving Zscan4 and TAK1. [Abstract]2018 Apr 30;9(1):1723. PMID: 29712904 -
Cell Death Differ
Deubiquitinating enzyme USP33 restrains docetaxel-induced apoptosis via stabilising the phosphatase DUSP1 in prostate cancer. [Abstract]2020 Jun;27(6):1938-1951. PMID: 31857702 -
Cell Death Differ
E3 ubiquitin ligase Nedd4 is a key negative regulator for non-canonical inflammasome activation. [Abstract]2019 Nov;26(11):2386-2399. PMID: 30816303 -
Cell Death Differ
A negative feedback loop of ICER and NF-κB regulates TLR signaling in innate immune responses. [Abstract]2017 Mar;24(3):492-499. PMID: 28009352
Adezmapimod purchased from MedChemExpress. Usage Cited in: Cell Death Differ. 2017 Mar;24(3):492-499. [Abstract]
LPS stimulates ICER expression via p38-CREB pathway. Effect of MAPK and IKK inhibitors on LPS-induced CREB phosphorylation in peritoneal macrophages.
-
-
Acta Pharm Sin B
Semi-synthetic chondroitin sulfate CS-semi5 upregulates miR-122-5p, conferring a therapeutic effect on osteoarthritis via the p38/MMP13 pathway. [Abstract]2024 Aug;14(8):3528-3542. PMID: 39220883 -
Acta Pharm Sin B
A novel and low-toxic peptide DR3penA alleviates pulmonary fibrosis by regulating the MAPK/miR-23b-5p/AQP5 signaling axis. [Abstract]2023 Feb;13(2):722-738. PMID: 36873181 -
Autophagy
Dysfunctional autophagy triggers STING1 activation to exacerbate cartilage degeneration in obesity-associated osteoarthritis. [Abstract]2025 Aug 6:1-17. PMID: 40728163 -
Autophagy
Cannabidiol inhibits human glioma by induction of lethal mitophagy through activating TRPV4. [Abstract]2021 Nov;17(11):3592-3606. PMID: 33629929 -
Autophagy
Manipulation of Mitophagy by "All-in-One" nanosensitizer augments sonodynamic glioma therapy. [Abstract]2020 Aug;16(8):1413-1435. PMID: 31674265 -
Adv Sci (Weinh)
ETV4 Promotes Colorectal Cancer Progression by Reprogramming Asparagine Metabolism to Remodel the Stromal Microenvironment. [Abstract]2026 Mar 20:e16557. PMID: 41861091 -
Adv Sci (Weinh)
Single-Nucleus Multi-Omics Reveals Hypoxia-Driven Angiogenic Programs and Their Epigenetic Control in Sinonasal Squamous Cell Carcinoma. [Abstract]2026 Feb;13(12):e10302. PMID: 41498635 -
Adv Sci (Weinh)
Targeting the E Prostanoid Receptor EP4 Mitigates Cardiac Fibrosis Induced by β-Adrenergic Activation. [Abstract]2025 Feb 7:e2413324. PMID: 39921269 -
Adv Sci (Weinh)
The Gut Microbiota Affects Anti-TNF Responsiveness by Activating the NAD+ Salvage Pathway in Ulcerative Colitis. [Abstract]2024 Dec 30:e2413128. PMID: 39739648 -
Adv Sci (Weinh)
EPO Deficiency Upregulates GADD45b/p38 MAPK Axis, Mediating Schizophrenia-Related Synaptic and Cognitive Impairments. [Abstract]2024 Oct 28:e2406979. PMID: 39467064 -
Leukemia
BCR::ABL1 tyrosine kinase inhibitors induce ribosome collisions to activate ZAK-dependent ribotoxic stress and apoptosis in chronic myeloid leukemia. [Abstract]2026 May;40(5):955-969. PMID: 41912913 -
Biomaterials
FAK-p38 signaling serves as a potential target for reverting matrix stiffness-modulated liver sinusoidal endothelial cell defenestration. [Abstract]2024 Mar:305:122462. PMID: 38171118 -
Biomaterials
Gold and gold-silver alloy nanoparticles enhance the myogenic differentiation of myoblasts through p38 MAPK signaling pathway and promote in vivo skeletal muscle regeneration. [Abstract]2018 Aug;175:19-29. PMID: 29793089
Adezmapimod purchased from MedChemExpress. Usage Cited in: Biomaterials. 2018 Aug;175:19-29. [Abstract]
Western blotting analysis showing the related protein expression (MHC, MyoD, p38α, phospho-p38α) of C2C12 myoblasts after incubated for 6 days in DM containing 40 μg/mL AuNPs and Au-AgNPs in the presence or absence of SB203580 (SB).
-
J Exp Clin Cancer Res
Vinburnine potentiates anti-PD1 immunotherapy in melanoma through IL-24 secretion via P38/MAPK/ATF3 signaling. [Abstract]2025 Aug 27;44(1):255. PMID: 40866941 -
J Exp Clin Cancer Res
RNF31 represses cell progression and immune evasion via YAP/PD-L1 suppression in triple negative breast Cancer. [Abstract]2022 Dec 29;41(1):364. PMID: 36581998 -
J Exp Clin Cancer Res
HGF-mediated elevation of ETV1 facilitates hepatocellular carcinoma metastasis through upregulating PTK2 and c-MET. [Abstract]2022 Sep 16;41(1):275. PMID: 36109787 -
Protein Cell
Chemical genomics reveals inhibition of breast cancer lung metastasis by Ponatinib via c-Jun. [Abstract]2019 Mar;10(3):161-177. PMID: 29667003 -
J Nanobiotechnology
A fibrin gel-loaded Gouqi-derived nanovesicle (GqDNV) repairs the heart after myocardial infarction by inhibiting p38 MAPK/NF-κB p65 pathway. [Abstract]2025 Jul 22;23(1):535. PMID: 40696398 -
J Nanobiotechnology
Metal-organic framework materials promote neural differentiation of dental pulp stem cells in spinal cord injury. [Abstract]2023 Sep 4;21(1):316. PMID: 37667307 -
J Nanobiotechnology
In situ construction of flower-like nanostructured calcium silicate bioceramics for enhancing bone regeneration mediated via FAK/p38 signaling pathway. [Abstract]2022 Mar 27;20(1):162. PMID: 35351145 -
Cell Discov
ASCT2 palmitoylation regulated by JNK1-ZDHHC14 axis orchestrates glutamine metabolism and NSCLC progression. [Abstract]2026 Feb 24;12(1):13. PMID: 41730846 -
Sci Adv
Neuronal Reg3β/macrophage TNF-α-mediated positive feedback signaling contributes to pain chronicity in a rat model of CRPS-I. [Abstract]2025 Aug;11(31):eadu4270. PMID: 40749060 -
Carbohydr Polym
Polysaccharide enhanced NK cell cytotoxicity against pancreatic cancer via TLR4/MAPKs/NF-κB pathway in vitro/vivo. [Abstract]2019 Dec 1;225:115223. PMID: 31521276 -
J Biomed Sci
Fusobacterium nucleatum promotes colorectal cancer liver metastasis via miR-5692a/IL-8 axis by inducing epithelial-mesenchymal transition. [Abstract]2025 Jan 6;32(1):5. PMID: 39757156 -
Redox Biol
PP4 modulates macrophage-neutrophil crosstalk to restrict CCL5 -driven NETosis in sepsis. [Abstract]2026 Apr:91:104093. PMID: 41723906 -
Redox Biol
Diminished α7 nicotinic acetylcholine receptor (α7nAChR) rescues amyloid-β induced atrial remodeling by oxi-CaMKII/MAPK/AP-1 axis-mediated mitochondrial oxidative stress. [Abstract]2023 Feb:59:102594. PMID: 36603528 -
Redox Biol
Chenodeoxycholic acid suppresses AML progression through promoting lipid peroxidation via ROS/p38 MAPK/DGAT1 pathway and inhibiting M2 macrophage polarization. [Abstract]2022 Oct:56:102452. PMID: 36084349 -
J Hazard Mater
Antimony induces oxidative stress to impair enteroendocrine cells and disrupt glucose homeostasis. [Abstract]2025 Nov 25:501:140617. PMID: 41337963 -
Research (Wash D C)
Gene Signature-Based Drug Screening Reveals Ponatinib Enhances Immunotherapy Efficacy in Triple-Negative Breast Cancer by Reversing MDSC-Mediated Immunosuppressive Tumor Microenvironment. [Abstract]2025 Oct 9:8:0915. PMID: 41079672 -
MedComm
Identification of circulating T-cell immunoglobulin and mucin domain 4 as a potential biomarker for coronary heart disease. [Abstract]2023 Jul 8;4(4):e320. PMID: 37426678 -
Cell Rep Med
MFGE8 induces anti-PD-1 therapy resistance by promoting extracellular vesicle sorting of PD-L1. [Abstract]2025 Jan 16:101922. PMID: 39842432 -
J Immunother Cancer
Targeting CD93 on monocytes revitalizes antitumor immunity by enhancing the function and infiltration of CD8+ T cells. [Abstract]2024 Oct 23;12(10):e010148. PMID: 39448202 -
Cell Rep Med
Cholinergic signaling via muscarinic M1 receptor confers resistance to docetaxel in prostate cancer. [Abstract]2024 Feb 20;5(2):101388. PMID: 38262412 -
J Immunother Cancer
Tumor-released autophagosomes induces CD4+ T cell-mediated immunosuppression via a TLR2-IL-6 cascade. [Abstract]2019 Jul 12;7(1):178. PMID: 31300052 -
J Immunother Cancer
Tumor cell-released autophagosomes (TRAPs) promote immunosuppression through induction of M2-like macrophages with increased expression of PD-L1. [Abstract]2018 Dec 18;6(1):151. PMID: 30563569 -
Pharmacol Res
The potential of TAOK1 as a new therapeutic target for the treatment of cancer cachexia-associated muscle atrophy. [Abstract]2025 May 6:107763. PMID: 40339965 -
Pharmacol Res
Sulforaphane attenuates microglia-mediated neuronal necroptosis through down-regulation of MAPK/NF-κB signaling pathways in LPS-activated BV-2 microglia. [Abstract]2018 Jul:133:218-235. PMID: 29391237 -
Cell Mol Biol Lett
Narciclasine enhances cisplatin-induced apoptotic cell death by inducing unfolded protein response-mediated regulation of NOXA and MCL1. [Abstract]2025 May 14;30(1):59. PMID: 40369444 -
Cancer Lett
Targeting MKK3/c-Myc interaction to overcome osimertinib acquired resistance in EGFR mutant lung cancer. [Abstract]2025 Aug 29:633:218010. PMID: 40886822 -
J Neuroinflammation
Inhibition of ANGPTL8 protects against diabetes-associated cognitive dysfunction by reducing synaptic loss via the PirB signaling pathway. [Abstract]2024 Aug 2;21(1):192. PMID: 39095838 -
J Neuroinflammation
The microRNA-211-5p/P2RX7/ERK/GPX4 axis regulates epilepsy-associated neuronal ferroptosis and oxidative stress. [Abstract]2024 Jan 8;21(1):13. PMID: 38191407 -
J Neuroinflammation
Hippocampal microRNA-26a-3p deficit contributes to neuroinflammation and behavioral disorders via p38 MAPK signaling pathway in rats. [Abstract]2022 Nov 24;19(1):283. PMID: 36434679 -
J Neuroinflammation
2020 Oct 28;17(1):321. PMID: 33109221 -
J Neuroinflammation
JNK-mediated microglial DICER degradation potentiates inflammatory responses to induce dopaminergic neuron loss. [Abstract]2018 Jun 15;15(1):184. PMID: 29907159
Adezmapimod purchased from MedChemExpress. Usage Cited in: J Neuroinflammation. 2018 Jun 15;15(1):184. [Abstract]
Representative immunoblots of total lysates from BV2 cells treated with MPP+or/and U0126 (10 μM), SP600125 (SP, 10 μM) and SB203580 (SB, 10 μM) using the antibodies against DICER.
-
Cancer Lett
VCPA, a novel synthetic derivative of α-tocopheryl succinate, sensitizes human gastric cancer to doxorubicin-induced apoptosis via ROS-dependent mitochondrial dysfunction. [Abstract]2017 May 1:393:22-32. PMID: 28216375
Adezmapimod purchased from MedChemExpress. Usage Cited in: Cancer Lett. 2017 May 1:393:22-32. [Abstract]
Effects of p38 MAPK inhibitor (SB203580), ERK inhibitor (U0126), JNK inhibitor (SP600125), caspase inhibitor (Z-VAD-FMK) and NAC on SGC-7901 and MGC-803 treated with DOX/VCPA combination treatment. VCPA pretreatment strategy is the same as above. SB203580 (20 μM), U0126 (10 μM), SP600125 (20 μM), Z-VAD-FMK (10 μM) and NAC (5 mM) are treated 2 h before DOX (2 μg/mL) added into the culture, respectively. MAPK pathway protein levels are determined.
-
Int J Biol Sci
Hypoxia-induced exosomes facilitate lung pre-metastatic niche formation in hepatocellular carcinoma through the miR-4508-RFX1-IL17A-p38 MAPK-NF-κB pathway. [Abstract]2023 Sep 4;19(15):4744-4762. PMID: 37781522 -
Int J Biol Sci
2022 May 1;18(8):3167-3177. PMID: 35637967 -
Environ Int
Low-level contamination of deoxynivalenol: A threat from environmental toxins to porcine epidemic diarrhea virus infection. [Abstract]2020 Oct;143:105949. PMID: 32673909 -
Adv Healthc Mater
Clinical-Inspired Design of Self-Assembled Albumin-CeO2 Nanozymes for Oxygen-Self-Sufficient and Targeted Sonodynamic-Chemotherapy in Triple-Negative Breast Cancer. [Abstract]2025 Dec 26:e04479. PMID: 41454512 -
Cell Death Dis
UHRF1-mediated epigenetic reprogramming regulates glycolysis to promote progression of B-cell acute lymphoblastic leukemia. [Abstract]2025 Apr 29;16(1):351. PMID: 40301374 -
Cell Death Dis
LINC00924-induced fatty acid metabolic reprogramming facilitates gastric cancer peritoneal metastasis via hnRNPC-regulated alternative splicing of Mnk2. [Abstract]2022 Nov 23;13(11):987. PMID: 36418856 -
Cell Death Dis
Inhibition of p38 MAPK or immunoproteasome overcomes resistance of chronic lymphocytic leukemia cells to Bcl-2 antagonist venetoclax. [Abstract]2022 Oct 8;13(10):860. PMID: 36209148 -
Cell Death Dis
Autophagic sequestration of SQSTM1 disrupts the aggresome formation of ubiquitinated proteins during proteasome inhibition. [Abstract]2022 Jul 15;13(7):615. PMID: 35840557 -
Cell Death Dis
ONECUT2 facilitates hepatocellular carcinoma metastasis by transcriptionally upregulating FGF2 and ACLY. [Abstract]2021 Nov 27;12(12):1113. PMID: 34839358 -
Cell Death Dis
SLC7A2 deficiency promotes hepatocellular carcinoma progression by enhancing recruitment of myeloid-derived suppressors cells. [Abstract]2021 Jun 2;12(6):570. PMID: 34108444 -
Cell Death Dis
Effects of short-chain fatty acids in inhibiting HDAC and activating p38 MAPK are critical for promoting B10 cell generation and function. [Abstract]2021 Jun 7;12(6):582. PMID: 34099635 -
Cell Death Dis
C1q-TNF-related protein-3 attenuates pressure overload-induced cardiac hypertrophy by suppressing the p38/CREB pathway and p38-induced ER stress. [Abstract]2019 Jul 8;10(7):520. PMID: 31285424 -
Cell Death Dis
β-Thujaplicin induces autophagic cell death, apoptosis, and cell cycle arrest through ROS-mediated Akt and p38/ERK MAPK signaling in human hepatocellular carcinoma. [Abstract]2019 Mar 15;10(4):255. PMID: 30874538 -
Cell Death Dis
Critical role of astrocytic interleukin-17 A in post-stroke survival and neuronal differentiation of neural precursor cells in adult mice. [Abstract]2016 Jun 23;7(6):e2273. PMID: 27336717 -
-
Genome Biol
The collateral activity of RfxCas13d can induce lethality in a RfxCas13d knock-in mouse model. [Abstract]2023 Feb 1;24(1):20. PMID: 36726140 -
Proc Natl Acad Sci U S A
Metabolic stress conditions dictate MAPKAPK2-dependent efficiency of MEK1/2 inhibition in colorectal carcinoma. [Abstract]2026 Feb 17;123(7):e2505331123. PMID: 41662531 -
Cell Commun Signal
Staphylococcus aureus vesicles impair cutaneous wound healing through p38 MAPK-MerTK cleavage-mediated inhibition of macrophage efferocytosis. [Abstract]2025 Jan 8;23(1):14. PMID: 39780180 -
Cell Commun Signal
Targeting the ERK1/2 and p38 MAPK pathways attenuates Golgi tethering factor golgin-97 depletion-induced cancer progression in breast cancer. [Abstract]2025 Jan 13;23(1):22. PMID: 39800687 -
Cell Commun Signal
Interleukin-22 receptor 1-mediated stimulation of T-type Ca2+ channels enhances sensory neuronal excitability through the tyrosine-protein kinase Lyn-dependent PKA pathway. [Abstract]2024 Jun 3;22(1):307. PMID: 38831315 -
Cell Commun Signal
Superbinder based phosphoproteomic landscape revealed PRKCD_pY313 mediates the activation of Src and p38 MAPK to promote TNBC progression. [Abstract]2024 Feb 12;22(1):115. PMID: 38347536 -
Chin Herb Med
Taxifolin attenuates inflammation via suppressing MAPK signal pathway in vitro and in silico analysis. [Abstract]2022 Sep 1;14(4):554-562. PMID: 36405054 -
Cell Commun Signal
Zinc-mediated activation of CREB pathway in proliferation of pulmonary artery smooth muscle cells in pulmonary hypertension. [Abstract]2021 Oct 11;19(1):103. PMID: 34635097 -
Int J Biol Macromol
Isolation, structural characterization and immunoregulatory activity of a novel acidic polysaccharide from Ganoderma sinense. [Abstract]2026 Mar 3:151196. PMID: 41786176 -
Int J Biol Macromol
λ-Carrageenan regulates antiviral responses by targeting classical NF-κB and IRF3-mediated signaling pathways. [Abstract]2025 Dec 17;338(Pt 2):149760. PMID: 41418949 -
Int J Biol Macromol
2025 Aug 25:326:147087. PMID: 40865829 -
Int J Biol Macromol
Fungal antitumor protein D1 is internalized via endocytosis and inhibits non-small cell lung cancer proliferation through MAPK signaling pathway. [Abstract]2023 Feb 1:227:45-57. PMID: 36521713 -
Int J Biol Macromol
Cordyceps militaris polysaccharide converts immunosuppressive macrophages into M1-like phenotype and activates T lymphocytes by inhibiting the PD-L1/PD-1 axis between TAMs and T lymphocytes. [Abstract]2020 May 1;150:261-280. PMID: 32044366 -
Acta Pharmacol Sin
Targeting PPARα activation sensitizes glioblastoma cells to temozolomide and reverses acquired resistance by inhibiting H3K18 lactylation. [Abstract]2025 Jun 11. PMID: 40500345 -
Acta Pharmacol Sin
The caspase-1 inhibitor VX765 upregulates connexin 43 expression and improves cell-cell communication after myocardial infarction via suppressing the IL-1β/p38 MAPK pathway. [Abstract]2022 Sep;43(9):2289-2301. PMID: 35132192 -
Acta Pharmacol Sin
Osthole pretreatment alleviates TNBS-induced colitis in mice via both cAMP/PKA-dependent and independent pathways. [Abstract]2017 Aug;38(8):1120-1128. PMID: 28603288 -
Phytomedicine
Network pharmacology and experimental validation of inflammation inhibition by ChuanKeZhi Injection in treating asthma. [Abstract]2025 May 21:143:156891. PMID: 40450983 -
EMBO Mol Med
Portimine A toxin causes skin inflammation through ZAKα-dependent NLRP1 inflammasome activation. [Abstract]2025 Mar;17(3):535-562. PMID: 39948420 -
Phytomedicine
Forsythoside A mitigates osteoarthritis and inhibits chondrocyte senescence by promoting mitophagy and suppressing NLRP3 inflammasome via the Nrf2 pathway. [Abstract]2024 Dec:135:156052. PMID: 39383631 -
EMBO Mol Med
PGF2α facilitates pathological retinal angiogenesis by modulating endothelial FOS-driven ELR+ CXC chemokine expression. [Abstract]2023 Jan 11;15(1):e16373. PMID: 36511116 -
Phytomedicine
Tangeretin suppresses osteoarthritis progression via the Nrf2/NF-κB and MAPK/NF-κB signaling pathways. [Abstract]2022 Apr:98:153928. PMID: 35104760 -
Phytomedicine
In vivo hepatoprotective activity and the underlying mechanism of chebulinic acid from Terminalia chebula fruit. [Abstract]2021 Mar:83:153479. PMID: 33561764 -
Phytomedicine
Gambogenic acid induces Noxa-mediated apoptosis in colorectal cancer through ROS-dependent activation of IRE1α/JNK. [Abstract]2020 Nov;78:153306. PMID: 32854039 -
Phytomedicine
Timosaponin AIII attenuates inflammatory injury in AGEs-induced osteoblast and alloxan-induced diabetic osteoporosis zebrafish by modulating the RAGE/MAPK signaling pathways. [Abstract]2020 May 24;75:153247. PMID: 32502823 -
Phytomedicine
Sweroside promotes osteoblastic differentiation and mineralization via interaction of membrane estrogen receptor-α and GPR30 mediated p38 signalling pathway on MC3T3-E1 cells. [Abstract]2020 Mar;68:153146. PMID: 32028183 -
-
Phytomedicine
Anti-inflammatory activity of Khayandirobilide A from Khaya senegalensis via NF-κB, AP-1 and p38 MAPK/Nrf2/HO-1 signaling pathways in lipopolysaccharide-stimulated RAW 264.7 and BV-2 cells. [Abstract]2018 Mar 15:42:152-163. PMID: 29655681
Adezmapimod purchased from MedChemExpress. Usage Cited in: Phytomedicine. 2018 Mar 15:42:152-163. [Abstract]
Cells are pretreated with SP600125 (20 μM), SB203580 (20 μM) or U0126 (20 μM) in presence or absence of KLA, then incubated with LPS (1 μg/mL) for certain time. Cell lysates are subjected to western blot.
-
NPJ Parkinsons Dis
Disruption of axonal transport in Parkinson's disease: the role of pathological α-Syn and AMPK/p38 MAPK signaling. [Abstract]2025 May 6;11(1):114. PMID: 40328804 -
Food Chem X
Immunoregulatory activity of a low-molecular-weight heteropolysaccharide from Ganoderma leucocontextum fruiting bodies in vitro and in vivo. [Abstract]2022 Apr 30;14:100321. PMID: 35571333 -
Food Chem X
Preparation, chemical structure, and immunostimulatory activity of a water-soluble heteropolysaccharide from Suillus granulatus fruiting bodies. [Abstract]2022 Jan 15:13:100211. PMID: 35498979 -
Free Radic Biol Med
Glucagon-like peptide-1 receptor activation maintains extracellular matrix integrity by inhibiting the activity of mitogen-activated protein kinases and activator protein-1. [Abstract]2021 Dec;177:247-259. PMID: 34737144 -
Free Radic Biol Med
p38 MAP-kinase inhibitor protects against platelet-activating factor-induced death in mice. [Abstract]2019 Nov 1:143:275-287. PMID: 31442556 -
Free Radic Biol Med
GL-V9 induced upregulation and mitochondrial localization of NAG-1 associates with ROS generation and cell death in hepatocellular carcinoma cells. [Abstract]2017 Nov:112:49-59. PMID: 28697922
Adezmapimod purchased from MedChemExpress. Usage Cited in: Free Radic Biol Med. 2017 Nov:112:49-59. [Abstract]
Cells are pre-treated with ERK (U1026) and p38 (SB203580) inhibitors, followed by GL-V9 treatment for 24 h. Western blot is performed to analyze NAG-1 expression.
-
New Phytol
LbSakA-mediated phosphorylation of the scaffolding protein LbNoxR in the ectomycorrhizal basidiomycete Laccaria bicolor regulates NADPH oxidase activity, ROS accumulation and symbiosis development. [Abstract]2024 May 13. PMID: 38741469 -
Apoptosis
Honokiol induces paraptosis-like cell death of acute promyelocytic leukemia via mTOR & MAPK signaling pathways activation. [Abstract]2021 Apr;26(3-4):195-208. PMID: 33550458 -
Chemosphere
Protective effects and molecular mechanisms of baicalein on thioacetamide-induced toxicity in zebrafish larvae. [Abstract]2020 Oct;256:127038. PMID: 32470728 -
Sci Total Environ
Chlorpyrifos induces placental oxidative stress and barrier dysfunction by mediating mitochondrial apoptosis via the ERK/MAPK signaling pathway: In vitro and in vivo studies. [Abstract]2023 Dec 10:903:166449. PMID: 37634732 -
J Eur Acad Dermatol Venereol
Recombinant Treponema pallidum protein Tp0136 promotes fibroblast migration by modulating MCP-1/CCR2 through TLR4. [Abstract]2020 Apr;34(4):862-872. PMID: 31856347 -
Haematologica
2020 Jan;105(1):124-135. PMID: 30948489 -
J Orthop Translat
Inhibiting the REV-ERBα expression protects against mechanical overloading-induced cartilage clock disruption and osteoarthritis progression. [Abstract]2025 Jun 18:53:112-125. PMID: 40606845 -
Br J Pharmacol
Spinal heat shock protein 27 participates in PDGFRβ-mediated morphine tolerance through PI3K/Akt and p38 MAPK signalling pathways. [Abstract]2020 Nov;177(22):5046-5062. PMID: 32559815 -
Br J Pharmacol
Zinc finger protein 91 positively regulates the production of IL-1β in macrophages by activation of MAPKs and non-canonical caspase-8 inflammasome. [Abstract]2018 Dec;175(23):4338-4352. PMID: 30182366
Adezmapimod purchased from MedChemExpress. Usage Cited in: Br J Pharmacol. 2018 Dec;175(23):4338-4352. [Abstract]
Treatment of macrophages with inhibitor of p38 (SB203580) or JNK (SP600125) inhibits the synthesis of pro-IL-1β in ZFP91-overexpressing THP-1 cells.
-
Brain Behav Immun
Dexamethasone attenuates neuropathic pain through spinal microglial expression of dynorphin A via the cAMP/PKA/p38 MAPK/CREB signaling pathway. [Abstract]2024 Jul:119:36-50. PMID: 38555991 -
Biomed Pharmacother
Lapatinib combined with doxorubicin causes dose-dependent cardiotoxicity partially through activating the p38MAPK signaling pathway in zebrafish embryos. [Abstract]2024 Jun:175:116637. PMID: 38653111 -
Biomed Pharmacother
Puerarin improves busulfan-induced disruption of spermatogenesis by inhibiting MAPK pathways. [Abstract]2023 Sep:165:115231. PMID: 37516022 -
Biomed Pharmacother
Colchicine prevents atrial fibrillation promotion by inhibiting IL-1β-induced IL-6 release and atrial fibrosis in the rat sterile pericarditis model. [Abstract]2020 Sep;129:110384. PMID: 32554248 -
Biomed Pharmacother
Oleanolic acid inhibits mouse spinal cord injury through suppressing inflammation and apoptosis via the blockage of p38 and JNK MAPKs. [Abstract]2020 Mar;123:109752. PMID: 31924596 -
Biomed Pharmacother
Involvement of the p38 MAPK-pHsp27 pathway in vascular hyporeactivity induced by obstructive jaundice in rats. [Abstract]2020 Jan;121:109304. PMID: 31810142 -
Biomed Pharmacother
CTRP3 acts as a novel regulator in depressive-like behavior associated inflammation and apoptosis by meditating p38 and JNK MAPK signaling. [Abstract]2019 Dec;120:109489. PMID: 31629950 -
J Transl Med
The protective role of microRNA-21 against coxsackievirus B3 infection through targeting the MAP2K3/P38 MAPK signaling pathway. [Abstract]2019 Oct 4;17(1):335. PMID: 31585536 -
Biomed Pharmacother
Mechanical stretch aggravates aortic dissection by regulating MAPK pathway and the expression of MMP-9 and inflammation factors. [Abstract]2018 Dec:108:1294-1302. PMID: 30372831
Adezmapimod purchased from MedChemExpress. Usage Cited in: Biomed Pharmacother. 2018 Dec:108:1294-1302. [Abstract]
The protein levels of IL-1β and TNF-α are sharply downregulated by the addition of inhibitors SB203580, SP600125, and U0126.
Adezmapimod purchased from MedChemExpress. Usage Cited in: Biomed Pharmacother. 2018 Dec:108:1294-1302. [Abstract]
The protein level of MMP-9 is downregulated by inhibitors SB203580, SP600125, and U0126.
Adezmapimod purchased from MedChemExpress. Usage Cited in: Biomed Pharmacother. 2018 Dec:108:1294-1302. [Abstract]
As for both 0 g and 3 g groups, the p-ERK1/2/ERK1/2 is notably reduced by inhibitors SB203580, SP600125, and U0126.
Adezmapimod purchased from MedChemExpress. Usage Cited in: Biomed Pharmacother. 2018 Dec:108:1294-1302. [Abstract]
As for both 0 g and 3 g groups, the p-p38&p38 is downregulated by inhibitors SB203580, SP600125, and U0126.
Adezmapimod purchased from MedChemExpress. Usage Cited in: Biomed Pharmacother. 2018 Dec:108:1294-1302. [Abstract]
As for both 0 g and 3 g groups, the p-JNK1&JNK1 is downregulated by inhibitors SB203580, SP600125, and U0126.
-
-
Chem Sci
Dual-targeting biomimetic delivery for anti-glioma activity via remodeling the tumor microenvironment and directing macrophage-mediated immunotherapy. [Abstract]2018 Jan 31;9(10):2674-2689. PMID: 29732051 -
Oncogene
The protection of UCK2 protein stability by GART maintains pyrimidine salvage synthesis for HCC growth under glucose limitation. [Abstract]2025 May;44(16):1078-1092. PMID: 39865175 -
Environ Pollut
Impacts of combined exposure to formaldehyde and PM2.5 at ambient concentrations on airway inflammation in mice. [Abstract]2022 Dec 15:315:120234. PMID: 36195197 -
Stem Cell Res Ther
The cannabinoid receptor I (CB1) enhanced the osteogenic differentiation of BMSCs by rescue impaired mitochondrial metabolism function under inflammatory condition. [Abstract]2022 Jan 21;13(1):22. PMID: 35063024 -
Oncogene
NRG1 regulates Fra-1 transcription and metastasis of triple-negative breast cancer cells via the c-Myc ubiquitination as manipulated by ERK1/2-mediated Fbxw7 phosphorylation. [Abstract]2022 Feb;41(6):907-919. PMID: 34992218 -
Stem Cell Res Ther
Conditioned medium from induced pluripotent stem cell-derived mesenchymal stem cells accelerates cutaneous wound healing through enhanced angiogenesis. [Abstract]2021 May 20;12(1):295. PMID: 34016178 -
Environ Pollut
BPA modulates the WDR5/TET2 complex to regulate ERβ expression in eutopic endometrium and drives the development of endometriosis. [Abstract]2021 Jan 1;268(Pt B):115748. PMID: 33022573 -
Environ Pollut
Exposure to both formaldehyde and high relative humidity exacerbates allergic asthma by activating the TRPV4-p38 MAPK pathway in Balb/c mice. [Abstract]2020 Jan;256:113375. PMID: 31662264 -
Oncogene
CXCL2/MIF-CXCR2 signaling promotes the recruitment of myeloid-derived suppressor cells and is correlated with prognosis in bladder cancer. [Abstract]2017 Apr;36(15):2095-2104. PMID: 27721403 -
PLoS Biol
2018 May 11;16(5):e2004225. PMID: 29750781
Adezmapimod purchased from MedChemExpress. Usage Cited in: PLoS Biol. 2018 May 11;16(5):e2004225. [Abstract]
Representative western blots of p-CREB (Ser133) and UCP-1 in iWAT from C57BL/6J mice after 4 wk of SB203580 treatment. These mice are exposed to cold for 2 d before analysis.
-
Aging Cell
2022 Jul;21(7):e13659. PMID: 35712918 -
Aging Cell
Testicular Lmcd1 regulates phagocytosis by Sertoli cells through modulation of NFAT1/Txlna signaling pathway. [Abstract]2020 Oct;19(10):e13217. PMID: 32840323 -
Cell Death Discov
Decreased miR-128-3p in serum exosomes from polycystic ovary syndrome induces ferroptosis in granulosa cells via the p38/JNK/SLC7A11 axis through targeting CSF1. [Abstract]2025 Feb 18;11(1):64. PMID: 39966422 -
Curr Res Food Sci
Apigenin and its octoic acid diester attenuated glycidol-induced autophagic-dependent apoptosis via inhibiting the ERK/JNK/p38 signaling pathways in human umbilical vein endothelial cells (HUVECs). [Abstract]2023 Jan 16:6:100447. PMID: 36699118 -
Cell Death Discov
Pristimerin induces apoptosis and autophagy via activation of ROS/ASK1/JNK pathway in human breast cancer in vitro and in vivo. [Abstract]2019 Aug 5:5:125. PMID: 31396402 -
Arch Toxicol
The tick saliva peptide HIDfsin2 promotes the tick-borne virus SFTSV replication in vitro by enhancing p38 signal pathway. [Abstract]2023 Jun;97(6):1783-1794. PMID: 37148319 -
Cell Rep
2022 Dec 27;41(13):111891. PMID: 36577384 -
Cell Rep
2022 Mar 15;38(11):110520. PMID: 35294872 -
Cell Rep
2020 Jan 14;30(2):497-509.e4. PMID: 31940492 -
Neural Regen Res
Macrophage migration inhibitory factor facilitates astrocytic production of the CCL2 chemokine following spinal cord injury. [Abstract]2023 Aug;18(8):1802-1808. PMID: 36751809 -
Antioxidants (Basel)
CASK Mediates Oxidative Stress-Induced Microglial Apoptosis-Inducing Factor-Independent Parthanatos Cell Death via Promoting PARP-1 Hyperactivation and Mitochondrial Dysfunction. [Abstract]2024 Mar 13;13(3):343. PMID: 38539876 -
Antioxidants (Basel)
Canagliflozin Delays Aging of HUVECs Induced by Palmitic Acid via the ROS/p38/JNK Pathway. [Abstract]2023 Mar 30;12(4):838. PMID: 37107212 -
Antioxidants (Basel)
Docosahexaenoic Acid Alleviates Palmitic Acid-Induced Inflammation of Macrophages via TLR22-MAPK-PPARγ/Nrf2 Pathway in Large Yellow Croaker ( Larimichthys crocea). [Abstract]2022 Mar 31;11(4):682. PMID: 35453367 -
Antioxidants (Basel)
Characterization of the Inducible and Slow-Releasing Hydrogen Sulfide and Persulfide Donor P*: Insights into Hydrogen Sulfide Signaling. [Abstract]2021 Jun 29;10(7):1049. PMID: 34209813 -
Antioxidants (Basel)
Tart Cherry Extract Containing Chlorogenic Acid, Quercetin, and Kaempferol Inhibits the Mitochondrial Apoptotic Cell Death Elicited by Airborne PM10 in Human Epidermal Keratinocytes. [Abstract]2021 Mar 13;10(3):443. PMID: 33805724 -
Int J Nanomedicine
Novel L-(CaP-ZnP)/SA Nanocomposite Hydrogel with Dual Anti-Inflammatory and Mineralization Effects for Efficient Vital Pulp Therapy. [Abstract]2024 Jul 3:19:6659-6676. PMID: 38975320 -
Int J Radiat Oncol Biol Phys
Docosahexaenoic Acid Attenuates Radiation-Induced Myocardial Fibrosis by Inhibiting the p38/ET-1 Pathway in Cardiomyocytes. [Abstract]2023 Apr 1;115(5):1229-1243. PMID: 36529557 -
J Cell Biol
2021 Feb 1;220(2):e201911025. PMID: 33404607 -
Elife
Lys29-linkage of ASK1 by Skp1-Cullin 1-Fbxo21 ubiquitin ligase complex is required for antiviral innate response. [Abstract]2016 Apr 11;5:e14087. PMID: 27063938 -
Phytother Res
Formosanin C Induces ROS/p38-Mediated Cell Death While Also Promoting Protective Autophagy in Pancreatic Cancer. [Abstract]2025 Oct 6. PMID: 41054182 -
Phytother Res
Chinese dragon's blood ethyl acetate extract suppresses gastric cancer progression through induction of apoptosis and autophagy mediated by activation of MAPK and downregulation of the mTOR-Beclin1 signalling cascade. [Abstract]2023 Feb;37(2):689-701. PMID: 36245270 -
J Agric Food Chem
Non-Sugar Sweetener Rubusoside Alleviates Lipid Metabolism Disorder In Vivo and In Vitro by Targeting PPARγ/α, Lgals3, and Mknk2. [Abstract]2024 Nov 20;72(46):25601-25619. PMID: 39508235 -
J Agric Food Chem
Dendrobine Ameliorates Glucocorticoid-Induced Osteoporosis by Promoting Osteogenesis through JNK/p38 MAPK Pathway Activation and GR Nuclear Translocation Inhibition. [Abstract]2024 Jul 31;72(30):16739-16748. PMID: 39033544 -
J Agric Food Chem
Molecular Mechanism Study of Dietary Fiber Lignin Intervention in Ulcerative Colitis through GPR37. [Abstract]2024 Jun 7. PMID: 38845410 -
Cell Mol Life Sci
Omentin-1 drives cardiomyocyte cell cycle arrest and metabolic maturation by interacting with BMP7. [Abstract]2023 Jun 21;80(7):186. PMID: 37344704 -
J Agric Food Chem
Chlorogenic Acid Alleviates Chronic Stress-Induced Intestinal Damage by Inhibiting the P38MAPK/NF-κB Pathway. [Abstract]2023 Jun 21;71(24):9381-9390. PMID: 37293923 -
J Agric Food Chem
Synergistic Combination of the Total Steroidal Saponins from the Berries of Black Nightshade and Adriamycin to Overcome Leukemia Multidrug Resistance. [Abstract]2023 Feb 8. PMID: 36752041 -
J Agric Food Chem
Isolation, Identification, and Immunomodulatory Mechanism of Peptides from Lepidium meyenii (Maca) Protein Hydrolysate. [Abstract]2022 Apr 13;70(14):4328-4341. PMID: 35357828 -
EMBO Rep
Sensing of mycobacterial arabinogalactan by galectin-9 exacerbates mycobacterial infection. [Abstract]2021 Jul 5;22(7):e51678. PMID: 33987949 -
Cell Mol Life Sci
HBeAg induces the expression of macrophage miR-155 to accelerate liver injury via promoting production of inflammatory cytokines. [Abstract]2018 Jul;75(14):2627-2641. PMID: 29349567 -
J Agric Food Chem
Attenuation of tert-Butyl Hydroperoxide ( t-BHP)-Induced Oxidative Damage in HepG2 Cells by Tangeretin: Relevance of the Nrf2-ARE and MAPK Signaling Pathways. [Abstract]2018 Jun 27;66(25):6317-6325. PMID: 29871486
Adezmapimod purchased from MedChemExpress. Usage Cited in: J Agric Food Chem. 2018 Jun 27;66(25):6317-6325. [Abstract]
HepG2 cells are pre-incubated with 20 µM SB203580, SP600125 and PD98059 for 1 h and then treated with tangeretin(20µM) for 24 h.
-
JCI Insight
ANGPTL8 links refeeding to monocyte dynamics and metabolic inflammation via the CCL5-CCR5 axis. [Abstract]2025 Nov 25:e196605. PMID: 41289013 -
Ecotoxicol Environ Saf
Integrating network toxicology, transcriptomics, and metabolomics uncovers the hepatotoxic mechanisms of okadaic acid in LO2 cells. [Abstract]2025 Jun 24:302:118576. PMID: 40561608 -
Ecotoxicol Environ Saf
2023 Sep 15:263:115247. PMID: 37453270 -
Ecotoxicol Environ Saf
Exposure to polystyrene microplastics causes reproductive toxicity through oxidative stress and activation of the p38 MAPK signaling pathway. [Abstract]2020 Mar 1;190:110133. PMID: 31896473 -
Cancer Cell Int
Construction of a lipid metabolism-based prognostic gene signature in cervical squamous cell carcinoma and validation of LIPG's oncogenic role. [Abstract]2025 Oct 14;25(1):349. PMID: 41088247 -
-
Front Immunol
Macrophage Polarization Modulated by Porcine Circovirus Type 2 Facilitates Bacterial Coinfection. [Abstract]2021 Jul 28:12:688294. PMID: 34394082 -
Front Immunol
Butorphanol Promotes Macrophage Phenotypic Transition to Inhibit Inflammatory Lung Injury via κ Receptors. [Abstract]2021 Jul 7:12:692286. PMID: 34305926 -
-
Front Immunol
2021 Apr 1:12:584097. PMID: 33868221 -
Front Immunol
Streptococcus Suis Serotype 2 Stimulates Neutrophil Extracellular Traps Formation via Activation of p38 MAPK and ERK1/2. [Abstract]2018 Dec 7:9:2854. PMID: 30581435
Adezmapimod purchased from MedChemExpress. Usage Cited in: Front Immunol. 2018 Dec 7:9:2854. [Abstract]
Neutrophils are pretreated with inhibitor of p38 MAPK (SB203580 (Adezmapimod)) and ERK1/2 (U0126), and the cells are then incubated with either SS2 ZY05719 or PMA for 3 h. Immunofluorescence is performed.
-
Front Immunol
Stimulator of Interferon Genes Promotes Host Resistance Against Pseudomonas aeruginosa Keratitis. [Abstract]2018 Jun 5:9:1225. PMID: 29922287 -
Front Immunol
Characterization of Rabbit Nucleotide-Binding Oligomerization Domain 1 (NOD1) and the Role of NOD1 Signaling Pathway during Bacterial Infection. [Abstract]2017 Oct 10:8:1278. PMID: 29067026 -
Int J Mol Med
2026 Jan;57(1):21. PMID: 41235659 -
Int J Mol Med
Inflammation and coagulation abnormalities via the activation of the HMGB1‑RAGE/NF‑κB and F2/Rho pathways in lung injury induced by acute hypoxia. [Abstract]2023 Aug;52(2):67. PMID: 37350396 -
Int J Mol Med
Echinacea polysaccharide attenuates lipopolysaccharide‑induced acute kidney injury via inhibiting inflammation, oxidative stress and the MAPK signaling pathway. [Abstract]2021 Jan;47(1):243-255. PMID: 33416087 -
Chin Med
Ferulic acid in combination with ginsenoside Rb1 alleviates myocardial no-reflow by inhibiting platelet HMGB1 release and NET formation. [Abstract]2026 Jan 8;21(1):16. PMID: 41501834 -
Chin Med
Inhibition of P2X7 receptor in satellite glial cells contributes to electroacupuncture's analgesia in rats with CFA-induced inflammatory pain. [Abstract]2025 Oct 5;20(1):159. PMID: 41046250 -
J Invest Dermatol
Advanced Glycation End Products Promote Melanogenesis by Activating NLRP3 Inflammasome in Human Dermal Fibroblasts. [Abstract]2022 Oct;142(10):2591-2602.e8. PMID: 35421403 -
J Invest Dermatol
LPCAT1 Promotes Cutaneous Squamous Cell Carcinoma via EGFR-Mediated Protein Kinase B/p38MAPK Signaling Pathways. [Abstract]2022 Feb;142(2):303-313.e9. PMID: 34358528 -
Chin Med
Corydalis saxicola Bunting total alkaloids attenuate paclitaxel-induced peripheral neuropathy through PKCε/p38 MAPK/TRPV1 signaling pathway. [Abstract]2021 Jul 19;16(1):58. PMID: 34281577 -
J Invest Dermatol
miR-146a Inhibits Biofilm-Derived Cutibacterium acnes-Induced Inflammatory Reactions in Human Keratinocytes. [Abstract]2019 Dec;139(12):2488-2496.e4. PMID: 31194941 -
Biochem Pharmacol
IL-18 potentiates platelet activation and thrombosis through IL-18Rα-dependent MAPKs and PI3K/Akt signaling. [Abstract]2025 Dec 18:245:117656. PMID: 41421453 -
Biochem Pharmacol
Molecular Dissection of the AHR-AREG driven EGFR-ERK1/2-CyclinD1 axis in acquired lenvatinib resistance of Hepatocellular carcinoma. [Abstract]2025 Jun 6:239:117032. PMID: 40482839 -
Biochem Pharmacol
Jolkinolide B synergistically potentiates the antitumor activity of GPX4 inhibitors via inhibiting TrxR1 in cisplatin-resistant bladder cancer cells. [Abstract]2024 May:223:116194. PMID: 38583812 -
Biochem Pharmacol
TP53R175H mutation promotes breast cancer cell proliferation through CORO1A-P38 MAPK pathway regulation. [Abstract]2024 Mar:221:116047. PMID: 38331350 -
Cell Prolif
FGF9 promotes mouse spermatogonial stem cell proliferation mediated by p38 MAPK signalling. [Abstract]2021 Jan;54(1):e12933. PMID: 33107118 -
Cell Prolif
CB1 enhanced the osteo/dentinogenic differentiation ability of periodontal ligament stem cells via p38 MAPK and JNK in an inflammatory environment. [Abstract]2019 Nov;52(6):e12691. PMID: 31599069 -
Acta Physiol (Oxf)
MICAL2 promotes breast cancer cell migration by maintaining epidermal growth factor receptor (EGFR) stability and EGFR/P38 signalling activation. [Abstract]2018 Feb;222(2). PMID: 28719045
Adezmapimod purchased from MedChemExpress. Usage Cited in: Acta Physiol (Oxf). 2018 Feb;222(2). [Abstract]
P38 inhibitor SB203580 (Adezmapimod) pretreatment also decreases p-HSP27 and MMP9 levels induced by MICAL2-overexpression.
-
Am J Chin Med
Nephroprotective Effects of Formononetin in Diabetic Kidney Disease: Mechanistic Insights and Therapeutic Potential. [Abstract]2025;53(7):2277-2305. PMID: 40947647 -
J Dent
Epigenetic modulation of odontoblast differentiation: implications for regenerative endodontics. [Abstract]2025 Oct:161:105978. PMID: 40669605 -
ACS Biomater Sci Eng
β-Elemene Attenuates Fibrosis after Esophageal Endoscopic Submucosal Dissection via Modulating the HIF-1α/HK2/p38-MAPK Signaling Axis. [Abstract]2021 Jul 12;7(7):3399-3408. PMID: 34109793 -
J Ethnopharmacol
Elephantopus scaber suppresses ConA-induced T cell activation by inhibiting NF-κB and Ca2+/NFAT signaling. [Abstract]2026 May 10:362:121364. PMID: 41687940 -
J Ethnopharmacol
Cedrol from Platycladus orientalis (L.) Franco regulates M1/M2 polarization of macrophages and promotes hair regeneration. [Abstract]2026 Apr 24:361:121268. PMID: 41611183 -
J Ethnopharmacol
Shenling Baizhu Powder and Betulin attenuate sepsis-induced intestinal injury by targeting GADD45B/TAOK1/p38 MAPK pathway. [Abstract]2025 Jul 11;353(Pt A):120282. PMID: 40653040 -
J Ethnopharmacol
Elephantopus scaber attenuates MC903-caused atopic dermatitis and decreases TNF-α/IFN-γ-induced chemokines by suppressing MKP-1-mediated AP-1 signaling in keratinocytes. [Abstract]2025 Aug 29:352:120267. PMID: 40633861 -
Inflamm Res
Exploring macrophage and nerve interaction in endometriosis-associated pain: the inductive role of IL-33. [Abstract]2025 Feb 19;74(1):42. PMID: 39969583 -
J Ethnopharmacol
Artemisia argyi volatile oil ameliorates allergic contact dermatitis via modulating TRPA1/CGRP signaling. [Abstract]2024 Jul 15:118580. PMID: 39019419 -
J Ethnopharmacol
Study on the anti-skin aging effect and mechanism of Sijunzi Tang based on network pharmacology and experimental validation. [Abstract]2024 Jun 14:118421. PMID: 38880400 -
J Ethnopharmacol
Baicalin suppresses macrophage JNK-mediated adipose tissue inflammation to mitigate insulin resistance in obesity. [Abstract]2024 May 16:118355. PMID: 38762213 -
J Ethnopharmacol
Multi-technology integrated network pharmacology-based study on phytochemicals, active metabolites, and molecular mechanism of Psoraleae Fructus to promote melanogenesis. [Abstract]2024 May 10:325:117755. PMID: 38218502 -
Chem Biol Interact
Loxoprofen enhances intestinal barrier function via generation of its active metabolite by carbonyl reductase 1 in differentiated Caco-2 cells. [Abstract]2021 Oct 1:348:109634. PMID: 34506768 -
J Ethnopharmacol
Drug-containing serum of rhubarb-astragalus capsule inhibits the epithelial-mesenchymal transformation of HK-2 by downregulating TGF-β1/p38MAPK/Smad2/3 pathway. [Abstract]2021 Nov 15:280:114414. PMID: 34314804 -
Food Funct
Hesperetin ameliorates hepatic oxidative stress and inflammation via the PI3K/AKT-Nrf2-ARE pathway in oleic acid-induced HepG2 cells and a rat model of high-fat diet-induced NAFLD. [Abstract]2021 May 11;12(9):3898-3918. PMID: 33977953 -
Mol Ther Oncolytics
Berberine inhibits carcinogenesis through antagonizing the ATX-LPA-LPAR2-p38-leptin axis in a mouse hepatoma model. [Abstract]2022 Aug 5:26:372-386. PMID: 36090480 -
Cells
Cannabinoids Reduce Extracellular Vesicle Release from HIV-1 Infected Myeloid Cells and Inhibit Viral Transcription. [Abstract]2022 Feb 18;11(4):723. PMID: 35203372 -
Cancer Immunol Immunother
CCL8-dependent recruitment of natural killer cells enhances the antitumor activity of neoadjuvant chemotherapy in gastric cancer. [Abstract]2026 Mar 17;75(4):112. PMID: 41843172 -
Commun Biol
P38α MAPK-induced senescence in cranial suture progenitor cells promotes craniosynostosis. [Abstract]2025 Dec 13. PMID: 41390905 -
Life Sci
Targeted inhibition of JMJD2C/MALAT1 axis compensates for the deficiency of metformin in reversing ovarian cancer platinum resistance. [Abstract]2025 Apr 23:123663. PMID: 40280301 -
Commun Biol
Retinol binding protein 4 restricts PCV2 replication via selective autophagy degradation of viral ORF1 protein. [Abstract]2024 Nov 5;7(1):1438. PMID: 39500783 -
Drug Des Devel Ther
The Therapeutic Potential of Pristimerin in Osteoarthritis: Mechanistic Insights from in vitro and in vivo Studies. [Abstract]2024 Nov 27:18:5445-5459. PMID: 39628956 -
Life Sci
A novel exosome-like nanovesicles from Cordyceps militaris potentiate immunomodulatory and anti-tumor effect by reprogramming macrophages. [Abstract]2024 Dec 1:358:123163. PMID: 39442867 -
Life Sci
AMPK activation reduces cancer cell aggressiveness via inhibition of monoamine oxidase A (MAO-A) expression/activity. [Abstract]2024 Jun 22:122857. PMID: 38914305 -
Commun Biol
Suppressing MTERF3 inhibits proliferation of human hepatocellular carcinoma via ROS-mediated p38 MAPK activation. [Abstract]2024 Jan 5;7(1):18. PMID: 38177713 -
Glia
Vascular endothelial growth factor promotes transdifferentiation of astrocytes into neurons via activation of the MAPK/Erk-Pax6 signal pathway. [Abstract]2023 Jul;71(7):1648-1666. PMID: 36960578 -
Commun Biol
mTOR contributes to endothelium-dependent vasorelaxation by promoting eNOS expression and preventing eNOS uncoupling. [Abstract]2022 Jul 22;5(1):726. PMID: 35869262 -
Life Sci
Inhibition of EZH2 ameliorates hyperoxaluria-induced kidney injury through the JNK/FoxO3a pathway. [Abstract]2022 Feb 15:291:120258. PMID: 34952043 -
J Clin Endocrinol Metab
Catecholestradiol Activation of Adrenergic Receptors Induces Endometrial Cell Survival via p38 MAPK Signaling. [Abstract]2021 Jan 23;106(2):337-350. PMID: 33247592 -
Life Sci
Peptide DR8 suppresses epithelial-to-mesenchymal transition via the TGF-β/MAPK signaling pathway in renal fibrosis. [Abstract]2020 Nov 15;261:118465. PMID: 32956665 -
Life Sci
Anterior gradient 2-derived peptide upregulates major histocompatibility complex class I-related chains A/B in hepatocellular carcinoma cells. [Abstract]2020 Apr 1;246:117396. PMID: 32035130 -
Inflammation
Role for IRAK-4 and p38 in Neutrophil Signaling in Response to Bacterial Lipoproteins from Staphylococcus aureus. [Abstract]2024 Sep 20. PMID: 39302496 -
Respir Res
2023 Apr 7;24(1):103. PMID: 37029363 -
Respir Res
Notch4 mediates vascular remodeling via ERK/JNK/P38 MAPK signaling pathways in hypoxic pulmonary hypertension. [Abstract]2022 Jan 11;23(1):6. PMID: 35016680 -
Respir Res
IL-1β augments TGF-β inducing epithelial-mesenchymal transition of epithelial cells and associates with poor pulmonary function improvement in neutrophilic asthmatics. [Abstract]2021 Aug 3;22(1):216. PMID: 34344357 -
CNS Neurosci Ther
Disruption of the GABAergic system contributes to the development of perioperative neurocognitive disorders after anesthesia and surgery in aged mice. [Abstract]2020 Sep;26(9):913-924. PMID: 32488976 -
PLoS Pathog
Retinol binding protein 4 enhances cellular cholesterol uptake to facilitate influenza A virus infection. [Abstract]2025 Oct 27;21(10):e1013623. PMID: 41144502 -
PLoS Pathog
Skin as outermost immune organ of vertebrates that elicits robust early immune responses after immunization with glycoprotein of spring viraemia of carp virus. [Abstract]2024 Dec 9;20(12):e1012744. PMID: 39652527 -
Int J Mol Sci
Neutrophil Extracellular Trap Formation Model Induced by Monosodium Urate and Phorbol Myristate Acetate: Involvement in MAPK Signaling Pathways. [Abstract]2024 Dec 27;26(1):143. PMID: 39796001 -
Int J Mol Sci
Involvement of the p38/MK2 Pathway in MCLR Hepatotoxicity Revealed through MAPK Pharmacological Inhibition and Phosphoproteomics in HepaRG Cells. [Abstract]2023 Jul 6;24(13):11168. PMID: 37446360 -
Chin J Nat Med
Bavachin induces apoptosis in colorectal cancer cells through Gadd45a via the MAPK signaling pathway. [Abstract]2023 Jan;21(1):36-46. PMID: 36641231 -
Int J Mol Sci
2022 Nov 25;23(23):14730. PMID: 36499060 -
Int J Mol Sci
Silencing P2X7R Alleviates Diabetic Neuropathic Pain Involving TRPV1 via PKCε/P38MAPK/NF-κB Signaling Pathway in Rats. [Abstract]2022 Nov 16;23(22):14141. PMID: 36430617 -
Int J Mol Sci
Androgen-Responsive Oncogenic lncRNA RP11-1023L17.1 Enhances c-Myc Protein Stability in Prostate Cancer. [Abstract]2022 Oct 13;23(20):12219. PMID: 36293081 -
Int J Mol Sci
Suppression of Cutibacterium acnes-Mediated Inflammatory Reactions by Fibroblast Growth Factor 21 in Skin. [Abstract]2022 Mar 25;23(7):3589. PMID: 35408949 -
Chin J Nat Med
Phytoglycoprotein isolated from Dioscorea batatas Decne promotes intestinal epithelial wound healing. [Abstract]2020 Oct;18(10):738-748. PMID: 33039053 -
Front Pharmacol
The volatile oil of Acorus tatarinowii schott significantly attenuates neuroinflammatory damage in a rat model of tourette syndrome by inhibiting the p38 MAPK/NLRP3/STAT3 signaling pathway. [Abstract]2025 Sep 25:16:1540092. PMID: 41079740 -
Front Pharmacol
Tanshinone I Inhibits Oxidative Stress-Induced Cardiomyocyte Injury by Modulating Nrf2 Signaling. [Abstract]2021 May 18;12:644116. PMID: 34084132 -
Front Pharmacol
Bellidifolin Ameliorates Isoprenaline-Induced Myocardial Fibrosis by Regulating TGF-β1/Smads and p38 Signaling and Preventing NR4A1 Cytoplasmic Localization. [Abstract]2021 Apr 30:12:644886. PMID: 33995055 -
Front Cell Infect Microbiol
Fosfomycin Protects Mice From Staphylococcus aureus Pneumonia Caused by α-Hemolysin in Extracellular Vesicles by Inhibiting MAPK-Regulated NLRP3 Inflammasomes. [Abstract]2019 Jul 15:9:253. PMID: 31380296 -
Int Immunopharmacol
Eicosapentaenoic acid attenuates hyperoxia-induced lung injury via p38 MAPK/NF-κB-mediated regulation of glycolytic reprogramming. [Abstract]2026 Jan 1;168(Pt 2):115903. PMID: 41270643 -
Eur J Pharmacol
Cilostazol and SB203580 combination: Targeting ER stress and p38MAPK signaling in Alzheimer's disease mouse model. [Abstract]2025 Sep 15:1003:177897. PMID: 40609614 -
Int Immunopharmacol
MIF regulates T helper 17 cell differentiation by activating the p38 MAPK signaling pathway to drive the pathogenesis of EAP. [Abstract]2025 May 28:159:114959. PMID: 40440956 -
Int Immunopharmacol
Berberine alleviates Alzheimer's disease by activating autophagy and inhibiting ferroptosis through the JNK-p38MAPK signaling pathway. [Abstract]2025 Apr 10:155:114550. PMID: 40215776 -
Int Immunopharmacol
LXA4 alleviates inflammation and ferroptosis in cigarette smoke induced chronic obstructive pulmonary disease via the ALX/FPR2 receptor. [Abstract]2025 Apr 4:151:114322. PMID: 40007378 -
Int Immunopharmacol
House dust mite induced mucosal barrier dysfunction and type 2 inflammatory responses via the MAPK/AP-1/IL-24 Signaling pathway in allergic rhinitis. [Abstract]2025 Jan 17:148:113972. PMID: 39826453 -
Int Immunopharmacol
The ellagitannin metabolite urolithin C attenuated cognitive impairment by inhibiting neuroinflammation via downregulation of MAPK/NF-kB signaling pathways in aging mice. [Abstract]2024 Sep 19;142(Pt B):113151. PMID: 39303538 -
Int Immunopharmacol
Escin alleviates cerebral ischemia-induced intestinal pyroptosis via the GR-dependent p38 MAPK/NF-κB signaling and NLRP3 inflammasome activation. [Abstract]2024 Jul 1:138:112592. PMID: 38955024 -
Int Immunopharmacol
Carnosol attenuates angiotensin II-induced cardiac remodeling and inflammation via directly binding to p38 and inhibiting p38 activation. [Abstract]2024 Jun 15:134:112143. PMID: 38692016 -
Int Immunopharmacol
2024 Jan 25:127:111355. PMID: 38157693 -
Am J Physiol Cell Physiol
2023 Nov 1;325(5):C1228-C1243. PMID: 37721000 -
Int Immunopharmacol
Parthenolide alleviates microglia-mediated neuroinflammation via MAPK/TRIM31/NLRP3 signaling to ameliorate cognitive disorder. [Abstract]2023 Jul:120:110287. PMID: 37182449 -
Am J Physiol Cell Physiol
DOCK2 contributes to pulmonary fibrosis by promoting lung fibroblast to myofibroblast transition. [Abstract]2022 Jul 1;323(1):C133-C144. PMID: 35584329 -
Eur J Pharmacol
Cyclosporin A up-regulated thromboxane A2 receptor through activation of MAPK and NF-κB pathways in rat mesenteric artery. [Abstract]2022 Jul 5:926:175034. PMID: 35588871 -
Int Immunopharmacol
Bone marrow mesenchymal stem cells modified with heme oxygenase-1 alleviate rejection of donation after circulatory death liver transplantation by inhibiting dendritic cell maturation in rats. [Abstract]2022 Jun:107:108643. PMID: 35240383 -
Int Immunopharmacol
Topoisomerase 2 inhibitor etoposide promotes interleukin-10 production in LPS-induced macrophages via upregulating transcription factor Maf and activating PI3K/Akt pathway. [Abstract]2021 Dec;101(Pt A):108264. PMID: 34715493 -
Eur J Pharmacol
Xanthine oxidoreductase promotes the progression of colitis-associated colorectal cancer by causing DNA damage and mediating macrophage M1 polarization. [Abstract]2021 Sep 5:906:174270. PMID: 34171392 -
Eur J Pharmacol
Carvacrol alleviates liver fibrosis by inhibiting TRPM7 and modulating the MAPK signaling pathway. [Abstract]2021 May 5:898:173982. PMID: 33647257 -
Int Immunopharmacol
Dihydroartemisinin prevents dextran sodium sulphate-induced colitisthrough inhibition of the activation of NLRP3 inflammasome and p38 MAPK signaling. [Abstract]2020 Nov;88:106949. PMID: 32892075 -
Int Immunopharmacol
Chebulanin exerts its anti-inflammatory and anti-arthritic effects via inhibiting NF-κB and MAPK activation in collagen-induced arthritis mice. [Abstract]2020 Nov;88:106823. PMID: 32795901 -
Invest Ophthalmol Vis Sci
Indoleamine 2,3-Dioxygenase Regulates Macrophage Recruitment, Polarization and Phagocytosis in Aspergillus Fumigatus Keratitis. [Abstract]2020 Jul 1;61(8):28. PMID: 32692841 -
Biosci Rep
p38 promoted retinal micro-angiogenesis through up-regulated RUNX1 expression in diabetic retinopathy. [Abstract]2020 May 29;40(5):BSR20193256. PMID: 32319515 -
Int Immunopharmacol
FCN-A mediates the inflammatory response and the macrophage polarization in Aspergillus fumigatus keratitis of mice by activating the MAPK signaling pathway. [Abstract]2020 Jun;83:106473. PMID: 32272397 -
Int Immunopharmacol
Macrophages-derived p38α promotes the experimental severe acute pancreatitis by regulating inflammation and autophagy. [Abstract]2019 Dec;77:105940. PMID: 31655340 -
Int Immunopharmacol
The immunomodulatory effect of Poria cocos polysaccharides is mediated by the Ca2+/PKC/p38/NF-κB signaling pathway in macrophages. [Abstract]2019 Jul:72:252-257. PMID: 31003002 -
Int J Cancer
Pharmacological inhibition of the Notch pathway enhances the efficacy of androgen deprivation therapy for prostate cancer. [Abstract]2018 Aug 1;143(3):645-656. PMID: 29488214 -
Am J Physiol Cell Physiol
Reversal of cisplatin resistance by microRNA-139-5p-independent RNF2 downregulation and MAPK inhibition in ovarian cancer. [Abstract]2018 Aug 1;315(2):C225-C235. PMID: 29719173
Adezmapimod purchased from MedChemExpress. Usage Cited in: Am J Physiol Cell Physiol. 2018 Aug 1;315(2):C225-C235. [Abstract]
Western blot analysis shows that inhibiting MAPK cannot completely reverse increased expression of RNF2 and CDDP resistance of OC cells.
-
J Mol Cell Cardiol
A critical role of cardiac fibroblast-derived exosomes in activating renin angiotensin system in cardiomyocytes. [Abstract]2015 Dec;89(Pt B):268-79. PMID: 26497614
Adezmapimod purchased from MedChemExpress. Usage Cited in: J Mol Cell Cardiol. 2015 Dec;89(Pt B):268-79. [Abstract]
Dose response of MAPK and Akt inhibitors on cardiac fibroblast-derived exosomes (Exo)-induced activation of MAPKs and Akt. Neonatal rat cardiomyocytes are treated with or without Exo (50 μg/mL), U0126, SP600125, MK-2206, and SB023580 for 20 min and subjected to Western blot analysis. The results are from 4 separate experiments.
-
Arthritis Res Ther
Roles of VWA1 and Rac2 in compensatory and decompensatory responses via FGF9/FGFR3 and p38 MAPK signaling pathways in condylar chondrocytes under distinct mechanical stress. [Abstract]2025 May 31;27(1):118. PMID: 40450276 -
Neuropharmacology
ACVR1 drives neuropathic pain by regulating NLRP3-Induced neuronal pyroptosis through the p38 and Smad1/5/8 pathways. [Abstract]2025 Apr 16:110469. PMID: 40250754 -
Molecules
Plant-Derived Molecule 4-Methylumbelliferone Suppresses FcεRI-Mediated Mast Cell Activation and Allergic Inflammation. [Abstract]2022 Feb 27;27(5):1577. PMID: 35268679 -
Front Endocrinol
Toll-Like Receptor 4 Inhibits Estradiol Secretion via NF-κB Signaling in Human Granulosa Cells. [Abstract]2021 Mar 12:12:629554. PMID: 33776924 -
Toxicology
Aspirin eugenol ester ameliorates paraquat-induced oxidative damage through ROS/p38-MAPK-mediated mitochondrial apoptosis pathway. [Abstract]2021 Apr 15:453:152721. PMID: 33592258 -
Artif Cell Nanomed B
The efficacy and potential mechanism of cnidium lactone to inhibit osteoclast differentiation. [Abstract]2019 Dec;47(1):3087-3093. PMID: 31343277 -
Artif Cells Nanomed Biotechnol
Plastin 3 down-regulation augments the sensitivity of MDA-MB-231 cells to paclitaxel via the p38 MAPK signalling pathway. [Abstract]2019 Dec;47(1):685-695. PMID: 30829071 -
J Dairy Sci
Immunomodulatory effects, digestive stability, and action mechanism of casein peptide SPAQILQW in activating macrophages via N-terminal serine. [Abstract]2025 Apr 28:S0022-0302(25)00284-X. PMID: 40306417 -
J Dairy Sci
Immunomodulatory activity and molecular mechanisms of action of peptides derived from casein hydrolysate by alcalase and flavourzyme based on virtual screening. [Abstract]2025 Mar;108(3):2152-2168. PMID: 39603497 -
-
J Dairy Sci
Sodium butyrate promotes lipopolysaccharide-induced innate immune responses by enhancing mitogen-activated protein kinase activation and histone acetylation in bovine mammary epithelial cells. [Abstract]2020 Dec;103(12):11636-11652. PMID: 33010913 -
Mol Neurobiol
GDF11 Regulates M1 and M2 Polarization of BV2 Microglial Cells via p38 MAPK Signaling Pathway. [Abstract]2025 Jul;62(7):9290-9305. PMID: 40100492 -
Front Cell Dev Biol
2021 Nov 5:9:741060. PMID: 34805150 -
Front Cell Dev Biol
Potential Mechanisms of the Impact of Hepatocyte Growth Factor Gene-Modified Tendon Stem Cells on Tendon Healing. [Abstract]2021 Jun 18;9:659389. PMID: 34222233 -
Front Cell Dev Biol
MiR-132-3p Modulates MEKK3-Dependent NF-κB and p38/JNK Signaling Pathways to Alleviate Spinal Cord Ischemia-Reperfusion Injury by Hindering M1 Polarization of Macrophages. [Abstract]2021 Feb 11:9:570451. PMID: 33644040 -
Aquat Toxicol
Microcystin-leucine arginine mediates apoptosis and engulfment of Leydig cell by testicular macrophages resulting in reduced serum testosterone levels. [Abstract]2018 Jun:199:116-126. PMID: 29621671 -
FASEB J
LncRNA DANCR Activates p38/mTOR-Mediated Autophagy via ANXA2 to Exacerbate Oxygen-Induced Retinal Neovascularization in Mice. [Abstract]2026 Jan 15;40(1):e71364. PMID: 41451441 -
Drug Dev Res
Kaurenoic Acid Suppresses Osteosarcoma Progression by Reprogramming Tumor-Associated Macrophages to M1 Phenotype. [Abstract]2025 Nov;86(7):e70183. PMID: 41158091 -
Poult Sci
Comparative analyses of dynamic transcriptome profiles reveal that DUSP1 regulates myogenic differentiation and muscle fiber type transformation. [Abstract]2025 Oct 3;104(12):105940. PMID: 41077031 -
FASEB J
Stem Cell Membrane Biomimetic Nano-Formulation Achieves the Delivery of MKP5 to Ameliorate Diabetic Kidney Disease via the P38 and ERK Pathway. [Abstract]2025 Sep 30;39(18):e71045. PMID: 40948363 -
FASEB J
USP44 Regulates Chemoresistance Induced by ROS and the MAPK/NF-κB Pathway Through the Stabilization of ITGB4 in Gastric Cancer. [Abstract]2025 Aug 31;39(16):e70945. PMID: 40824171 -
FASEB J
Activation of SIK2 inhibits gluconeogenesis and alleviates lipogenesis-induced inflammatory response by SIK2-CRTC2-ACC1 in hepatocytes of large yellow croaker (Larimichthys crocea). [Abstract]2025 Mar 31;39(6):e70393. PMID: 40067199 -
Poult Sci
MAPK signaling pathway participates in the regulation of intestinal phosphorus and calcium absorption in broiler chickens via 1,25-dihydroxyvitamin D3. [Abstract]2024 Oct;103(10):104052. PMID: 39067128 -
Drug Dev Res
Peimine-induced apoptosis and inhibition of migration by regulating reactive oxygen species-mediated MAPK/STAT3/NF-κB and Wnt/β-catenin signaling pathways in gastric cancer MKN-45 cells. [Abstract]2022 Nov;83(7):1683-1696. PMID: 36048972 -
Bioengineered
Echinococcus multilocularis drives the polarization of macrophages by regulating the RhoA-MAPK signaling pathway and thus affects liver fibrosis. [Abstract]2022 Apr;13(4):8747-8758. PMID: 35324411 -
Stem Cell Rev Rep
Dual-specificity Tyrosine Phosphorylation-regulated Kinase Inhibitor ID-8 Promotes Human Somatic Cell Reprogramming by Activating PDK4 Expression. [Abstract]2022 Aug;18(6):2074-2087. PMID: 35080746 -
Biochim Biophys Acta Mol Basis Dis
Myeloid differential protein-2 inhibition improves diabetic cardiomyopathy via p38MAPK inhibition and AMPK pathway activation. [Abstract]2022 May 1;1868(5):166369. PMID: 35176461 -
Mediators Inflamm
Expression Profiling of Long Noncoding RNA and Messenger RNA in a Cecal Ligation and Puncture-Induced Colon Injury Mouse Model. [Abstract]2020 Nov 3;2020:8925973. PMID: 33204219 -
FASEB J
Inhibition of α1-adrenoceptor reduces TGF-β1-induced epithelial-to-mesenchymal transition and attenuates UUO-induced renal fibrosis in mice. [Abstract]2020 Nov;34(11):14892-14904. PMID: 32939891 -
J Cell Mol Med
Negative feedback loop of ERK/CREB/miR-212-3p inhibits HBeAg-induced macrophage activation. [Abstract]2020 Sep;24(18):10935-10945. PMID: 32767729 -
J Cell Mol Med
MD1 deletion exaggerates cardiomyocyte autophagy induced by heart failure with preserved ejection fraction through ROS/MAPK signalling pathway. [Abstract]2020 Aug;24(16):9300-9312. PMID: 32648659 -
FASEB J
Pancreatic cancer-derived exosomes induce apoptosis of T lymphocytes through the p38 MAPK-mediated endoplasmic reticulum stress. [Abstract]2020 Jun;34(6):8442-8458. PMID: 32350913 -
Mol Nutr Food Res
Naringenin Exerts Cardiovascular Protective Effect in a Palmitate-Induced Human Umbilical Vein Endothelial Cell Injury Model via Autophagy Flux Improvement. [Abstract]2019 Dec;63(24):e1900601. PMID: 31622021 -
J Cell Mol Med
Ligustilide attenuates nitric oxide-induced apoptosis in rat chondrocytes and cartilage degradation via inhibiting JNK and p38 MAPK pathways. [Abstract]2019 May;23(5):3357-3368. PMID: 30770640 -
J Cell Mol Med
Plectin protects podocytes from adriamycin-induced apoptosis and F-actin cytoskeletal disruption through the integrin α6β4/FAK/p38 MAPK pathway. [Abstract]2018 Nov;22(11):5450-5467. PMID: 30187999
Adezmapimod purchased from MedChemExpress. Usage Cited in: J Cell Mol Med. 2018 Nov;22(11):5450-5467. [Abstract]
Treatment with SB203580 (Adezmapimod) significantly abolishes siPlectin-stimulated p38 activation.
-
FASEB J
Bile acids induce visceral hypersensitivity via mucosal mast cell-to-nociceptor signaling that involves the farnesoid X receptor/nerve growth factor/transient receptor potential vanilloid 1 axis. [Abstract]2019 Feb;33(2):2435-2450. PMID: 30260705
Adezmapimod purchased from MedChemExpress. Usage Cited in: FASEB J. 2019 Feb;33(2):2435-2450. [Abstract]
Bile acids (BAs) cause nuclear translocation of NF-kB p65, an effect that is abolished by SB203580.
-
iScience
Targeting USP14 enhances immunotherapy response by reprogramming tumor-associated macrophages in colon cancer. [Abstract]2026 Mar 13;29(5):115362. PMID: 42058892 -
iScience
TLR9 decreases FOXO3 expression to prevent excessive inflammation in macrophage activation syndrome. [Abstract]2025 Nov 17;28(12):114098. PMID: 41438053 -
iScience
Chemerin 15 enhances microglial phagocytosis to attenuate cerebral ischemia-reperfusion injury through the ChemR23/p38 MAPK pathway. [Abstract]2025 Aug 19;28(9):113396. PMID: 40970195 -
J Inflamm Res
Dual Effects of Sodium Houttuyfonate Against Acute Rhinosinusitis: Antibacterial Action and Epithelial Barrier Repair Through the p38 MAPK/ERK Pathway. [Abstract]2025 Sep 29:18:13433-13452. PMID: 41049072 -
iScience
The HDL-transporting scavenger receptor B1 promotes viral infection through endolysosomal acidification. [Abstract]2025 Apr 24;28(6):112501. PMID: 40475258 -
iScience
Epigenomic landscapes define differential Janus kinases inhibitor sensitivity in IFN-γ-primed human macrophages. [Abstract]2025 Apr 22;28(5):112502. PMID: 40491958 -
Toxics
Polyethylene Terephthalate Microplastic Exposure Induced Reproductive Toxicity Through Oxidative Stress and p38 Signaling Pathway Activation in Male Mice. [Abstract]2024 Oct 25;12(11):779. PMID: 39590959 -
iScience
2024 Sep 12;27(10):110873. PMID: 39398235 -
J Lipid Res
Natriuretic peptide receptor-C perturbs mitochondrial respiration in white adipose tissue. [Abstract]2024 Aug 16:100623. PMID: 39154732 -
Toxics
Ginsenoside Rg1 Mitigates Porcine Intestinal Tight Junction Disruptions Induced by LPS through the p38 MAPK/ NLRP3 Inflammasome Pathway. [Abstract]2022 May 27;10(6):285. PMID: 35736894 -
Nutr Metab
2021 Nov 21;18(1):100. PMID: 34802421 -
J Inflamm Res
CTRP9 Enhances Efferocytosis in Macrophages via MAPK/Drp1-Mediated Mitochondrial Fission and AdipoR1-Induced Immunometabolism. [Abstract]2021 Mar 23;14:1007-1017. PMID: 33790616 -
Eye Vis (Lond)
STING deficiency alleviates scar formation after glaucoma filtration surgery by suppressing p38 MAPK-induced inflammation in mice. [Abstract]2026 Feb 2;13(1):7. PMID: 41622229 -
Neurochem Int
Spinal p38 MAPK/PGC-1α/SIRT3 signaling pathway mediates remifentanil-induced hyperalgesia in rats via ROS release and NR2B activation. [Abstract]2025 Sep 26:106061. PMID: 41016638 -
Neurochem Int
DUSP1-mediated suppression of p38 MAPK signaling pathway reduces ferroptosis in cerebral ischemia-reperfusion injury. [Abstract]2025 Oct:189:106024. PMID: 40752646 -
Antiviral Res
HIV protease inhibitor attenuated astrocyte autophagy involvement in inflammation via p38 MAPK pathway. [Abstract]2022 Dec:208:105463. PMID: 36372295 -
AAPS PharmSciTech
One-Way Intestinal Perfusion of PVP/VA-Poloxamer 188-Curcuma longa L. Extract Solid Dispersion in Rats In Vivo and Its Effect on HSC-T6 Cell Proliferation. [Abstract]2022 Mar 14;23(3):83. PMID: 35288813 -
Toxins
Staphylococcal Enterotoxin A Induces Intestinal Barrier Dysfunction and Activates NLRP3 Inflammasome via NF-κB/MAPK Signaling Pathways in Mice. [Abstract]2022 Jan 1;14(1):29. PMID: 35051006 -
Neurochem Int
Kaemperfol alleviates pyroptosis and microglia-mediated neuroinflammation in Parkinson's disease via inhibiting p38MAPK/NF-κB signaling pathway. [Abstract]2022 Jan:152:105221. PMID: 34780806 -
Toxins
Combined Effect of Deoxynivalenol (DON) and Porcine Circovirus Type 2 (Pcv2) on Inflammatory Cytokine mRNA Expression. [Abstract]2021 Jun 13;13(6):422. PMID: 34199278 -
J Cell Physiol
Pak2 inhibition promotes resveratrol-mediated glioblastoma A172 cell apoptosis via modulating the AMPK-YAP signaling pathway. [Abstract]2020 Oct;235(10):6563-6573. PMID: 32017068 -
-
J Cell Physiol
LncRNA-ATB promotes TGF-β-induced glioma cells invasion through NF-κB and P38/MAPK pathway. [Abstract]2019 Dec;234(12):23302-23314. PMID: 31140621 -
Sci Rep
Emetine dihydrochloride suppresses the invasiveness and motility of hepatocellular carcinoma cells through MAPK pathway inhibition and Twist1 protein destabilization. [Abstract]2026 Jun 23. PMID: 42337289 -
Sci Rep
Key donor corneal factors governing successful expansion of human corneal endothelial cells. [Abstract]2026 May 11. PMID: 42115358 -
Sci Rep
Enhancement of melanoma aggressiveness via p38-MAPK, HIF-1α pathways, and metabolic reprogramming induced by Candida albicans. [Abstract]2025 Nov 17;15(1):40227. PMID: 41249785 -
Sci Rep
Deubiquitinating enzyme USP42 promotes breast cancer progression by inhibiting JNK/p38-mediated apoptosis. [Abstract]2025 Oct 21;15(1):36751. PMID: 41120683 -
-
JOR Spine
Apigetrin alleviates intervertebral disk degeneration by regulating nucleus pulposus cell autophagy. [Abstract]2024 Apr 17;7(2):e1325. PMID: 38633661 -
-
Aging (Albany NY)
Interleukin-17D promotes lung cancer progression by inducing tumor-associated macrophage infiltration via the p38 MAPK signaling pathway. [Abstract]2022 Aug 5;14(15):6149-6168. PMID: 35939336 -
Sci Rep
PD-L1 mediates lung fibroblast to myofibroblast transition through Smad3 and β-catenin signaling pathways. [Abstract]2022 Feb 23;12(1):3053. PMID: 35197539 -
Aging (Albany NY)
2021 May 6;13(10):13788-13806. PMID: 33962393 -
Aging (Albany NY)
2021 May 11;13(9):12780-12799. PMID: 33973871 -
Aging
2020 Nov 20;12(23):24208-24218. PMID: 33223507 -
Biomedicines
Exosome-Mediated Differentiation of Mouse Embryonic Fibroblasts and Exocrine Cells into β-Like Cells and the Identification of Key miRNAs for Differentiation. [Abstract]2020 Nov 9;8(11):485. PMID: 33182285 -
J Biol Chem
Polo-like kinase 4 maintains centriolar satellite integrity by phosphorylation of centrosomal protein 131 (CEP131). [Abstract]2019 Apr 19;294(16):6531-6549. PMID: 30804208 -
Sci Rep
Vector-independent transmembrane transport of oligodeoxyribonucleotides involves p38 mitogen activated protein kinase phosphorylation. [Abstract]2017 Oct 19;7(1):13571. PMID: 29051621 -
J Virol
The ASFV CD2v protein inhibits apoptosis by inducing proteasomal degradation of BimEL via activation of the TPL2-MEK-ERK signaling pathway. [Abstract]2026 Mar 24;100(3):e0195225. PMID: 41631827 -
J Pharmacol Exp Ther
Essential roles of mechanistic target of rapamycin in the induction of steroid resistance in group 2 innate lymphoid cells and severe asthma. [Abstract]2025 Oct 8;392(11):103744. PMID: 41172625 -
J Virol
The mRNA and protein of IL-8 oppositely regulate PRRSV replication via nucleoprotein and 14-3-3γ. [Abstract]2025 Aug 19;99(8):e0065525. PMID: 40704900 -
Food Sci Nutr
EGCG Alleviates H2O2-Induced Inflammatory Injury and Apoptosis in Bovine Mammary Epithelial Cells Through Nrf2 Pathway Activation and p38MAPK Pathway Inhibition. [Abstract]2025 Feb 25;13(3):e4687. PMID: 40008238 -
Neurochem Res
The P38MAPK Pathway Mediates the Destruction of the Blood-Brain Barrier in Anti-NMDAR Encephalitis Mice. [Abstract]2024 Nov 19;50(1):21. PMID: 39560818 -
J Virol
Phospho-eIF4E stimulation regulates coronavirus entry by selective expression of cell membrane-residential factors. [Abstract]2024 Feb 20;98(2):e0194823. PMID: 38299843 -
J Virol
Critical Role of Viral Protein Hexon in Hypervirulent Fowl Adenovirus Serotype-4-Induced Autophagy by Interaction with BAG3 and Promotion of Viral Replication in LMH Cells. [Abstract]2023 Jun 29;97(6):e0028423. PMID: 37255472 -
Chem Res Toxicol
P38 MAPK, NF-κB, and JAK-STAT3 Signaling Pathways Involved in Capecitabine-Induced Hand-Foot Syndrome via Interleukin 6 or Interleukin 8 Abnormal Expression. [Abstract]2022 Mar 21;35(3):422-430. PMID: 35147423 -
J Periodontol
Connective tissue growth factor promotes cell-to-cell communication in human periodontal ligament stem cells via MAPK and PI3K pathway. [Abstract]2022 Mar;93(3):e60-e72. PMID: 34532860 -
Neurochem Res
Polyphenols from Toona sinensiss Seeds Alleviate Neuroinflammation Induced by 6-Hydroxydopamine Through Suppressing p38 MAPK Signaling Pathway in a Rat Model of Parkinson's Disease. [Abstract]2020 Sep;45(9):2052-2064. PMID: 32556929 -
J Periodontol
Effect of interleukin-22 on osteogenic differentiation and the osteoclastogenic response of human periodontal ligament fibroblasts in vitro. [Abstract]2020 Aug;91(8):1085-1097. PMID: 31950496 -
J Photochem Photobiol B
Hydroxysafflower yellow a protects against UVA- and UVB-induced skin aging by suppressing cell apoptosis and SASP via targeting JNK and p38 MAPK pathway. [Abstract]2025 Dec 13:274:113340. PMID: 41421060 -
Cell Signal
ROCK1 drives colorectal cancer liver metastasis via PRKCH-mediated bioenergetic reprogramming. [Abstract]2025 Oct 18:112174. PMID: 41115563 -
ACS Pharmacol Transl Sci
Antineuroblastoma Activity Evaluation and Mechanism of Novel PD-L1 Small Molecule Inhibitors through Immune and Non-Immune Pathways. [Abstract]2025 Jul 7;8(8):2612-2629. PMID: 40810160 -
Cell Signal
Ubiquitin-editing enzyme A20 protects the inflammatory injury of human corneal epithelial cells against lipoteichoic acid. [Abstract]2025 Jun 25:111962. PMID: 40578588 -
Mol Cell Biochem
Activated TREM1-mediated MAPK signaling in endothelial cells caused by highly expressed STAT1 is associated with intracranial aneurysms occurrence and rupture. [Abstract]2025 May;480(5):3133-3145. PMID: 39661286 -
Cell Signal
Hyperlipidemia exacerbates acute pancreatitis via interactions between P38MAPK and oxidative stress. [Abstract]2025 Jan:125:111504. PMID: 39505288 -
Food Sci Anim Resour
Effect of Chicken Age on Proliferation and Differentiation Abilities of Muscle Stem Cells and Nutritional Characteristics of Cultured Meat Tissue. [Abstract]2024 Sep;44(5):1167-1180. PMID: 39246538 -
Biochim Biophys Acta Mol Cell Res
Treponema pallidum recombinant protein Tp47 enhanced interleukin-6 secretion in human dermal fibroblasts through the toll-like receptor 2 via the p38, PI3K/Akt, and NF-κB signalling pathways. [Abstract]2023 Oct;1870(7):119540. PMID: 37468070 -
Food Sci Anim Resour
2022 Nov;42(6):942-952. PMID: 36415580 -
Mol Cell Biochem
MiR-150-5p regulates the functions of type 2 innate lymphoid cells via the ICAM-1/p38 MAPK axis in allergic rhinitis. [Abstract]2022 Apr;477(4):1009-1022. PMID: 34988856 -
Cell Signal
YTHDF2 mediates LPS-induced osteoclastogenesis and inflammatory response via the NF-κB and MAPK signaling pathways. [Abstract]2021 Sep:85:110060. PMID: 34089814 -
Biochim Biophys Acta Mol Cell Res
TSLP-induced collagen type-I synthesis through STAT3 and PRMT1 is sensitive to calcitriol in human lung fibroblasts. [Abstract]2021 Sep;1868(10):119083. PMID: 34147561 -
Brain Res Bull
Progesterone Suppresses Cholesterol Esterification in APP/PS1 mice and a cell model of Alzheimer's Disease. [Abstract]2021 Aug:173:162-173. PMID: 34044033 -
Cytokine
Cyanidin attenuates IL-17A cytokine signaling mediated monocyte migration and differentiation into mature osteoclasts in rheumatoid arthritis. [Abstract]2021 Jun:142:155502. PMID: 33810944 -
Cell Signal
TRIM59 expression is regulated by Sp1 and Nrf1 in LPS-activated macrophages through JNK signaling pathway. [Abstract]2020 Mar;67:109522. PMID: 31883458 -
Cell Signal
The status of MAPK cascades contributes to the induction and activation of Gata4 and Nkx2.5 during the stepwise process of cardiac differentiation. [Abstract]2019 Feb:54:17-26. PMID: 30471465 -
Cell Signal
Cell confluence induces switching from proliferation to migratory signaling by site-selective phosphorylation of PDGF receptors on lipid raft platforms. [Abstract]2016 Feb;28(2):81-93. PMID: 26631574 -
Mol Cell Endocrinol
Adiponectin upregulates irisin expression through the APPL1/p38MAPK/PGC-1α signalling pathway in murine skeletal muscle. [Abstract]2026 Jun:616:112743. PMID: 41654165 -
Biol Trace Elem Res
Selenium Ameliorates Acetaminophen-Induced Oxidative Stress via MAPK and Nrf2 Pathways in Mice. [Abstract]2024 Jun;202(6):2598-2615. PMID: 37702962 -
Stem Cells
β-Arrestin 2 and Epac2 Cooperatively Mediate DRD1-Stimulated Proliferation of Human Neural Stem Cells and Growth of Human Cerebral Organoids. [Abstract]2022 Sep 26;40(9):857-869. PMID: 35772103 -
Stem Cells
DAPK1 Interacts with the p38 Isoform MAPK14, Preventing Its Nuclear Translocation and Stimulation of Bone Marrow Adipogenesis. [Abstract]2022 May 27;40(5):508-522. PMID: 35403694 -
J Proteome Res
Phosphoproteome Profiling Revealed the Importance of mTOR Inhibition on CDK1 Activation to Further Regulate Cell Cycle Progression. [Abstract]2021 May 7;20(5):2329-2339. PMID: 33797919 -
J Immunol Res
Chloroquine and Rapamycin Augment Interleukin-37 Expression via the LC3, ERK, and AP-1 Axis in the Presence of Lipopolysaccharides. [Abstract]2020 Feb 10;2020:6457879. PMID: 32104716 -
Stem Cells
SPARC promotes self-renewal of limbal epithelial stem cells and ocular surface restoration through JNK and p38-MAPK signaling pathways. [Abstract]2020 Jan;38(1):134-145. PMID: 31644832 -
Mol Cell Endocrinol
Rapid effect of bisphenol A on glutamate-induced Ca2+ influx in hippocampal neurons of rats. [Abstract]2019 Apr 5:485:35-43. PMID: 30707916 -
Mol Cell Endocrinol
Bisphenol A affects trophoblast invasion by inhibiting CXCL8 expression in decidual stromal cells. [Abstract]2018 Jul 15:470:38-47. PMID: 28736254 -
J Endod
2018 May;44(5):751-758. PMID: 29426641
Adezmapimod purchased from MedChemExpress. Usage Cited in: J Endod. 2018 May;44(5):751-758. [Abstract]
p38 MAPK inhibition enhances DPC-Exos–induced tube formation. (A) p38 MAPK activity is measured by detecting Phospho-p38 MAPK. The ratio between Phospho-p38 MAPK and the p38 MAPK band is used for quantification. (B) The effects of VEGF-A and KDR expression after p38 MAPK inhibitor SB203580 treatment on DPC-Exos-stimulated HUVECs.
-
Mol Hum Reprod
Cyclic stretch activates endometrial stromal cells to enhance migration and invasion via mechanosensitive p38 MAPK and F-actin in vitro. [Abstract]2026 Apr 11;32(2):gaag019. PMID: 41875408 -
J Endocrinol Invest
Bromocriptine sensitivity in bromocriptine-induced drug-resistant prolactinomas is restored by inhibiting FGF19/FGFR4/PRL. [Abstract]2025 Jan;48(1):67-80. PMID: 38926262 -
Food Chem Toxicol
L-theanine attenuates H2O2-induced inflammation and apoptosis in IPEC-J2 cells via inhibiting p38 MAPK signaling pathway. [Abstract]2024 Apr:186:114561. PMID: 38438008 -
Food Chem Toxicol
L-theanine attenuates porcine intestinal tight junction damage induced by LPS via p38 MAPK/NLRP3 signaling in IPEC-J2 cells. [Abstract]2023 Aug:178:113870. PMID: 37271275 -
Food Chem Toxicol
2023 Jun:176:113784. PMID: 37059385 -
Food Chem Toxicol
Pine pollen extract alleviates ethanol-induced oxidative stress and apoptosis in HepG2 cells via MAPK signaling. [Abstract]2023 Jan:171:113550. PMID: 36476398 -
Viruses
Inducible miR-150 Inhibits Porcine Reproductive and Respiratory Syndrome Virus Replication by Targeting Viral Genome and Suppressor of Cytokine Signaling 1. [Abstract]2022 Jul 7;14(7):1485. PMID: 35891465 -
Viruses
Pseudorabies Virus Tegument Protein UL13 Suppresses RLR-Mediated Antiviral Innate Immunity through Regulating Receptor Transcription. [Abstract]2022 Jul 2;14(7):1465. PMID: 35891444 -
Mol Med Rep
Neuroprotective effect of Ginsenoside Re against neurotoxin‑induced Parkinson's disease models via induction of Nrf2. [Abstract]2022 Jun;25(6):215. PMID: 35543148 -
Microb Pathog
Activation of TLR2 heterodimers-mediated NF-κB, MAPK, AKT signaling pathways is responsible for Vibrio alginolyticus triggered inflammatory response in vitro. [Abstract]2022 Jan:162:105219. PMID: 34601054 -
Vet Res
Glaesserella parasuis serotype 4 HPS4-YC disrupts the integrity of the swine tracheal epithelial barrier and facilitates bacterial translocation. [Abstract]2021 Oct 21;52(1):135. PMID: 34674760 -
Mol Med Rep
Metformin inhibits cholesterol‑induced adhesion molecule expression via activating the AMPK signaling pathway in vascular smooth muscle cells. [Abstract]2021 Oct;24(4):709. PMID: 34396446 -
Microb Pathog
C-terminal-truncated hepatitis B virus X protein promotes hepatocarcinogenesis by activating the MAPK pathway. [Abstract]2021 Oct:159:105136. PMID: 34390769 -
Parasit Vectors
Giardia duodenalis extracellular vesicles regulate the proinflammatory immune response in mouse macrophages in vitro via the MAPK, AKT and NF-κB pathways. [Abstract]2021 Jul 8;14(1):358. PMID: 34238339 -
Food Chem Toxicol
G-Rh4 improves pancreatic β-cells dysfunction in vivo and in vitro by increased expression of Nrf2 and its target genes. [Abstract]2021 Feb:148:111925. PMID: 33359794 -
Mol Med Rep
Juglone potentiates BRAF inhibitor‑induced apoptosis in melanoma through reactive oxygen species and the p38‑p53 pathway. [Abstract]2020 Jul;22(1):566-574. PMID: 32377702 -
Mol Med Rep
Quinalizarin induces ROS‑mediated apoptosis via the MAPK, STAT3 and NF‑κB signaling pathways in human breast cancer cells. [Abstract]2019 Nov;20(5):4576-4586. PMID: 31702038 -
Am J Physiol Renal Physiol
Loss of transcription factor ATOH8 activates TGF-β signaling and exacerbates glomerulosclerosis in podocytes. [Abstract]2026 Feb 1;330(2):F269-F284. PMID: 41545031 -
Andrology
Expression of IL-33 in rodent testes and its role in Leydig cell steroidogenesis and aging. [Abstract]2025 Jun 16. PMID: 40521800 -
Acta Biochim Biophys Sin (Shanghai)
2025 May 15. PMID: 40370197 -
J Immunol
Hyperosmotic Stress Induces Inflammation and Excessive Th17 Response to Blunt T-Cell Immunity in Tilapia. [Abstract]2024 Jun 15;212(12):1877-1890. PMID: 38700398 -
BMC Cancer
2023 Nov 14;23(1):1108. PMID: 37964204 -
BMC Complement Med Ther
Hinokiflavone induces apoptosis, cell cycle arrest and autophagy in chronic myeloid leukemia cells through MAPK/NF-κB signaling pathway. [Abstract]2022 Apr 6;22(1):100. PMID: 35387632 -
J Periodontal Res
Activation of GATA-binding protein 4 regulates monocyte chemoattractant protein-1 and chemotaxis in periodontal ligament cells. [Abstract]2022 Jan;57(1):195-204. PMID: 34773653 -
Toxicol Appl Pharmacol
Berberine-photodynamic therapy sensitizes melanoma cells to cisplatin-induced apoptosis through ROS-mediated P38 MAPK pathways. [Abstract]2021 May 1:418:115484. PMID: 33716044 -
Phytochemistry
Sesquiterpene coumarins from Ferula sinkiangensis K.M.Shen and their cytotoxic activities. [Abstract]2020 Dec;180:112531. PMID: 33010535 -
Nanotoxicology
Graphene oxide nanoparticles induce hepatic dysfunction through the regulation of innate immune signaling in zebrafish ( Danio rerio). [Abstract]2020 Jun;14(5):667-682. PMID: 32141807 -
Vaccines
Polyamine Transport Protein PotD Protects Mice against Haemophilus parasuis and Elevates the Secretion of Pro-Inflammatory Cytokines of Macrophage via JNK-MAPK and NF-κB Signal Pathways through TLR4. [Abstract]2019 Dec 14;7(4):216. PMID: 31847381 -
Toxicol Appl Pharmacol
Protective effect of peptide DR8 on bleomycin-induced pulmonary fibrosis by regulating the TGF-β/MAPK signaling pathway and oxidative stress. [Abstract]2019 Nov 1:382:114703. PMID: 31398421 -
BMC Complement Altern Med
Resveratrol induces apoptosis of benign prostatic hyperplasia epithelial cell line (BPH-1) through p38 MAPK-FOXO3a pathway. [Abstract]2019 Aug 29;19(1):233. PMID: 31464618 -
Toxicol Appl Pharmacol
M1 macrophage mediated increased reactive oxygen species (ROS) influence wound healing via the MAPK signaling in vitro and in vivo. [Abstract]2019 Mar 1:366:83-95. PMID: 30690042 -
Am J Physiol Gastrointest Liver Physiol
Regulatory T cells are induced by gut microbiota through differentially regulating costimulatory molecules of enteric glial cells. [Abstract]2026 May 1;330(5):G532-G548. PMID: 41711540 -
Front Oncol
Baoyuan Jiedu Decoction Alleviates Cancer-Induced Myotube Atrophy by Regulating Mitochondrial Dynamics Through p38 MAPK/PGC-1α Signaling Pathway. [Abstract]2020 Sep 30;10:523577. PMID: 33102208 -
J Pharm Pharmacol
Formononetin attenuates corticosterone-induced depressive-like behaviors and neuronal damage via ERα/ERK-CREB-BDNF signaling pathway. [Abstract]2026 Feb 7;78(2):rgag010. PMID: 41697882 -
J Physiol Sci
Acupuncture improves spatial learning and memory impairment caused by herpes simplex virus type-1 in rats through the p38 MAPK/CREB pathway. [Abstract]2024 Oct 3;74(1):49. PMID: 39363248 -
Environ Toxicol
The Novel Application of EUK-134 in Retinal Degeneration: Preventing Mitochondrial Oxidative Stress-Triggered Retinal Pigment Epithelial Cell Apoptosis by Suppressing MAPK/p53 Signaling Pathway. [Abstract]2025 Jan;40(1):88-100. PMID: 39268877 -
Environ Toxicol
2023 Nov;38(11):2621-2631. PMID: 37466199 -
J Pharm Pharmacol
Isoliquiritigenin regulates microglial M1/M2 polarisation by mediating the P38/MAPK pathway in cerebral stroke. [Abstract]2023 Jun 5;75(6):828-836. PMID: 37027320 -
Environ Toxicol
Thymoquinone induces apoptosis in temozolomide-resistant glioblastoma cells via the p38 mitogen-activated protein kinase signaling pathway. [Abstract]2023 Jan;38(1):90-100. PMID: 36176197 -
Nitric Oxide
Polysulfides derived from the hydrogen sulfide and persulfide donor P* inhibit IL-1β-mediated inducible nitric oxide synthase signaling in ATDC5 cells: are CCAAT/enhancer-binding proteins β and δ involved in the anti-inflammatory effects of hydrogen sulfide and polysulfides?. [Abstract]2022 Dec 1:129:41-52. PMID: 36216240 -
Pharmacology
Dexmedetomidine Attenuates Hypoxia/Reoxygenation Injury of H9C2 Myocardial Cells by Upregulating miR-146a Expression via the MAPK Signal Pathway. [Abstract]2022;107(1-2):14-27. PMID: 34718238 -
Environ Toxicol
Molecular mechanisms of quinalizarin induces apoptosis and G0/G1 cell cycle of human esophageal cancer HCE-4 cells depends on MAPK, STAT3, and NF-κB signaling pathways. [Abstract]2021 Feb;36(2):276-286. PMID: 33030807 -
J Neurol Sci
Attenuation of paraquat-induced inflammation by inhibitors of phosphorylation of mitogen-activated protein kinases in BV2 microglial cells. [Abstract]2020 Mar 15;410:116679. PMID: 31951835 -
Hum Mol Genet
BMP4 uses several different effector pathways to regulate proliferation and differentiation in the epithelial and mesenchymal tissue compartments of the developing mouse ureter. [Abstract]2017 Sep 15;26(18):3553-3563. PMID: 28655168
Adezmapimod purchased from MedChemExpress. Usage Cited in: Hum Mol Genet. 2017 Sep 15;26(18):3553-3563. [Abstract]
Immunofluorescence analysis for expression of the I-cell marker ΔNP63 on proximal sections of ureters explanted from E12.5 wildtype (control) embryos and cultured for 6 d in the presence of solvent (DMSO) (A), the AKT inhibitor (AKT-i) MK2206 (B), the P38 inhibitor (P38-i) SB203580 (C), the ERK1/2 inhibitor (ERK1/2-i) PD98059 (D) or combinations as indicated (E and F).
-
Front Biosci (Landmark Ed)
Bioinformatics-Based Identification and Clinical Validation of CHST1 as a Potential Prognostic Gene Associated With EMT in Gastric Cancer. [Abstract]2026 Mar 19;31(3):47627. PMID: 41914286 -
J Leukoc Biol
Nervonic acid mitigates IMQ-triggered psoriasis in mice via inhibiting Th17/γδT17 cell invasion and modulating the gut microbiota. [Abstract]2025 May 21:qiaf070. PMID: 40397706 -
Naunyn Schmiedebergs Arch Pharmacol
Polydatin protects against leukemia by inducing apoptosis and activating autophagy via p38-MAPK pathway. [Abstract]2025 Apr 14. PMID: 40229602 -
Front Biosci (Landmark Ed)
Scutellarin Attenuates Pro-Inflammatory Foam Cell Formation and Facilitates M2 Polarization in Microglia during Copper Homeostasis Imbalance via the MAPK Signaling Pathway. [Abstract]2025 Mar 6;30(3):36255. PMID: 40152387 -
Naunyn Schmiedebergs Arch Pharmacol
Kaempferol attenuates cyclosporine-induced renal tubular injury via inhibiting the ROS-ASK1-MAPK pathway. [Abstract]2025 Mar;398(3):3001-3014. PMID: 39316086 -
-
Front Biosci (Landmark Ed)
Maintenance of the Expression of c-FLIPL by Hsp70 to Resist Licochalcone A-Induced Anti-Colorectal Cancer Effect through ERK-Mediated Autophagy Induction. [Abstract]2023 Dec 1;28(12):325. PMID: 38179732 -
J Leukoc Biol
Transient receptor potential vanilloid 4 (TRPV4) in neutrophils enhances myocardial ischemia/reperfusion injury. [Abstract]2023 Sep 1;114(3):266-279. PMID: 37232941 -
Curr Issues Mol Biol
As2S2 Mediates the ROS/P38 MAPK Signaling Pathway to Induce Apoptosis and S-Phase Arrest in Myelodysplastic Syndrome Cells. [Abstract]2025 Apr 7;47(4):253. PMID: 40699652 -
Curr Issues Mol Biol
2024 Dec 31;47(1):16. PMID: 39852131 -
Arch Biochem Biophys
FFA intervention on LO2 cells mediates SNX-10 synthesis and regulates MMP9 secretion in LX2 cells via TGF-β1. [Abstract]2024 Dec 9:110255. PMID: 39662717 -
Curr Res Toxicol
Hydrogen sulfide donor NaHS inhibits formaldehyde-induced epithelial-mesenchymal transition in human lung epithelial cells via activating TGF-β1/Smad2/3 and MAPKs signaling pathways. [Abstract]2024 Oct 24:7:100199. PMID: 39524036 -
Arch Biochem Biophys
Mechanical stretch facilitates tenomodulin expression to induce tenocyte migration via MAPK signaling pathway. [Abstract]2023 Jan 15:734:109486. PMID: 36513131 -
Diabetes Metab Syndr Obes
RPS4Y1 Promotes High Glucose-Induced Endothelial Cell Apoptosis and Inflammation by Activation of the p38 MAPK Signaling. [Abstract]2021 Nov 12;14:4523-4534. PMID: 34803387 -
Mol Immunol
Dehydroepiandrosterone attenuates LPS-induced inflammatory responses via activation of Nrf2 in RAW264.7 macrophages. [Abstract]2021 Mar:131:97-111. PMID: 33461765 -
Bioorg Med Chem
Broad assessment of bioactivity of a collection of spiroindane pyrrolidines through "cell painting". [Abstract]2020 Jul 1;28(13):115547 PMID: 32546297 -
Mol Immunol
CD8+iTregs attenuate glomerular endothelial cell injury in lupus-prone mice through blocking the activation of p38 MAPK and NF-κB. [Abstract]2018 Nov:103:133-143. PMID: 30268079 -
Mol Immunol
TLR2 mediates autophagy through ERK signaling pathway in Mycoplasma gallisepticum-infected RAW264.7 cells. [Abstract]2017 Jul:87:161-170. PMID: 28478286 -
Free Radic Res
Thioredoxin improves contact dermatitis through an anti-inflammatory mechanism different from glucocorticoids. [Abstract]2025 May-Jul;59(6-7):518-530. PMID: 40679915 -
Cell Immunol
House dust mite allergen directly activates ILC2 cells via the TLR4 signaling pathway in allergic airway diseases. [Abstract]2024 Nov-Dec:405-406:104884. PMID: 39437527 -
Cell Immunol
2024 Jun 17:401-402:104843. PMID: 38905771 -
Toxicol Lett
Co-exposure to polystyrene microplastics and di-(2-ethylhexyl) phthalate aggravates allergic asthma through the TRPA1-p38 MAPK pathway. [Abstract]2023 Aug 1:384:73-85. PMID: 37500026 -
Mycopathologia
MiR-146a Negatively Regulates Aspergillus fumigatus-Induced TNF-α and IL-6 Secretion in THP-1 Macrophages. [Abstract]2021 Jun;186(3):341-354. PMID: 34089172 -
Endocrine
Inhibition of thioredoxin 2 by intracellular methylglyoxal accumulation leads to mitochondrial dysfunction and apoptosis in INS-1 cells. [Abstract]2020 Apr;68(1):103-115. PMID: 31939094 -
Peptides
2019 Sep:119:170120. PMID: 31351089 -
Mol Biol Rep
Nicotinamide mononucleotide and nicotinamide riboside attenuate cytokine production in human keratinocytes via suppression of p38 Pathway. [Abstract]2026 Mar 4;53(1):459. PMID: 41779073 -
J Appl Toxicol
Exposure to Polyethylene Terephthalate Microplastic Induces Mouse Liver Fibrosis Through Oxidative Stress and p38 MAPK/p65 NF-κB Signaling Pathway. [Abstract]2025 Sep;45(9):1694-1704. PMID: 40312270 -
Mol Biol Rep
2024 Nov 8;51(1):1134. PMID: 39514048 -
Brain Sci
The Role of p38 Mitogen-Activated Protein Kinase-Mediated F-Actin in the Acupuncture-Induced Mitigation of Inflammatory Pain in Arthritic Rats. [Abstract]2024 Apr 14;14(4):380. PMID: 38672029 -
Int J Biochem Cell Biol
Herb pair of Rhubarb-Astragalus mitigates renal interstitial fibrosis through downregulation of autophagy via p38-MAPK/TGF-β1 and p38-MAPK/smad2/3 pathways. [Abstract]2024 Apr:169:106549. PMID: 38340950 -
Brain Sci
Dexmedetomidine Improves Anxiety-like Behaviors in Sleep-Deprived Mice by Inhibiting the p38/MSK1/NFκB Pathway and Reducing Inflammation and Oxidative Stress. [Abstract]2023 Jul 11;13(7):1058. PMID: 37508990 -
Onco Targets Ther
18β-Glycyrrhetinic Acid Has Anti-Cancer Effects via Inducing Apoptosis and G2/M Cell Cycle Arrest, and Inhibiting Migration of A549 Lung Cancer Cells. [Abstract]2021 Oct 22;14:5131-5144. PMID: 34712051 -
Int J Biochem Cell Biol
Modified 5-aminolevulinic acid photodynamic therapy (M-PDT) inhibits cutaneous squamous cell carcinoma cell proliferation via targeting PP2A/PP5-mediated MAPK signaling pathway. [Abstract]2021 Aug:137:106036. PMID: 34217813 -
Int J Biochem Cell Biol
Activation of CD137 signaling promotes macrophage apoptosis dependent on p38 MAPK pathway-mediated mitochondrial fission. [Abstract]2021 Jul:136:106003. PMID: 33971320 -
Neuroscience
ATP Stimulation Promotes Functional Recovery after Intracerebral Haemorrhage by Increasing the mBDNF/proBDNF Ratio. [Abstract]2021 Apr 1:459:104-117. PMID: 33421569 -
Exp Physiol
Resistance of osteosarcoma cells to the proapoptotic effects of carfilzomib involves activation of mitogen activated protein kinase pathways. [Abstract]2021 Feb;106(2):438-449. PMID: 33336554 -
Infect Immun
Annexin A1 Attenuates Neutrophil Migration and IL-6 Expression through Fpr2 in a Mouse Model of Streptococcus suis-Induced Meningitis. [Abstract]2021 Feb 16;89(3):e00680-20. PMID: 33318141 -
J Cell Biochem
MicroRNA-543 promotes ovariectomy-induced osteoporosis through inhibition of AKT/p38 MAPK signaling pathway by targeting YAF2. [Abstract]2019 May;120(5):8561-8569. PMID: 30506950
Adezmapimod purchased from MedChemExpress. Usage Cited in: J Cell Biochem. 2019 May;120(5):8561-8569. [Abstract]
Western analysis of protein expression in the treatment of miR-543 and SB 203580.
-
J Cell Biochem
Epiregulin promotes the migration and chemotaxis ability of adipose-derived mesenchymal stem cells via mitogen-activated protein kinase signaling pathways. [Abstract]2018 Nov;119(10):8450-8459. PMID: 30011072
Adezmapimod purchased from MedChemExpress. Usage Cited in: J Cell Biochem. 2018 Nov;119(10):8450-8459. [Abstract]
Western blot results show a reduction in phosphorylated p38 MAPK in ADSCs after treatment with 20 μM SB203580, 20 μM SP600125, or 20 μM PD98059 for 1 hour.
-
BMC Pulm Med
Role of TLR4-p38 MAPK-Hsp27 signal pathway in LPS-induced pulmonary epithelial hyperpermeability. [Abstract]2018 Nov 27;18(1):178. PMID: 30482200
Adezmapimod purchased from MedChemExpress. Usage Cited in: BMC Pulm Med. 2018 Nov 27;18(1):178. [Abstract]
P-p38 and P-Hsp27 are detected by western blotting with the treatment of LPS, SB203580 and SB203580+ LPS.
Adezmapimod purchased from MedChemExpress. Usage Cited in: BMC Pulm Med. 2018 Nov 27;18(1):178. [Abstract]
P-p38 and P-Hsp27 are detected by western blotting with the treatment of LPS, SB203580 and SB203580+ LPS.
-
Vet Microbiol
AS-IV exhibits anti-SADS-CoV effects through the inhibition of the MAPK/JNK signaling pathway mediated by the S1 protein. [Abstract]2025 Dec 29:313:110858. PMID: 41477941 -
Vet Microbiol
Streptococcus suis employs the Ihk/Irr-PepO axis to subvert macrophage actin polymerization: A novel anti-phagocytic strategy enhancing bacterial virulence. [Abstract]2025 Sep 11:310:110726. PMID: 40946614 -
Immun Inflamm Dis
Mycobacterium tuberculosis protein Rv2652c enhances intracellular survival by inhibiting host immune responses. [Abstract]2024 Sep;12(9):e70012. PMID: 39240051 -
BMC Immunol
Tacrolimus reverses pemphigus vulgaris serum-induced depletion of desmoglein in HaCaT cells via inhibition of heat shock protein 27 phosphorylation. [Abstract]2023 Nov 8;24(1):43. PMID: 37940861 -
Exp Eye Res
2023 Mar:228:109388. PMID: 36652968 -
Anal Cell Pathol
Transgelin-2 Involves in the Apoptosis of Colorectal Cancer Cells Induced by Tanshinone-IIA. [Abstract]2022 Sep 27;2022:9358583. PMID: 36204303 -
Vet Microbiol
Highly pathogenic porcine reproductive and respiratory syndrome virus (HP-PRRSV) induces IL-6 production through TAK-1/JNK/AP-1 and TAK-1/NF-κB signaling pathways. [Abstract]2021 May:256:109061. PMID: 33836390 -
DNA Cell Biol
Histidine Kinase QseC in Glaesserella parasuis Enhances the Secretion of Proinflammatory Cytokines by Macrophages via the p38 and NF-κB Signaling Pathways. [Abstract]2024 Sep;43(9):474-481. PMID: 39049814 -
Int J Immunopathol Pharmacol
Low-dose metformin suppresses hepatocellular carcinoma metastasis via the AMPK/JNK/IL-8 pathway. [Abstract]2024 Jan-Dec:38:3946320241249445. PMID: 38679570 -
Acupunct Med
Electroacupuncture alleviates the transition from acute to chronic pain through the p38 MAPK/TNF-α signalling pathway in the spinal dorsal horn. [Abstract]2021 Dec;39(6):708-715. PMID: 34308662 -
J Microbiol
NF-κB/ROS and ERK pathways regulate NLRP3 inflammasome activation in Listeria monocytogenes infected BV2 microglia cells. [Abstract]2021 Aug;59(8):771-781. PMID: 34061343 -
PLoS One
Mechanical stretching of pulmonary vein stimulates matrix metalloproteinase-9 and transforming growth factor-β1 through stretch-activated channel/MAPK pathways in pulmonary hypertension due to left heart disease model rats. [Abstract]2020 Sep 3;15(9):e0235824. PMID: 32881898 -
Theriogenology
2025 Dec 18:252:117791. PMID: 41420899 -
Tissue Cell
Momordica cochinchinensis extract alleviates oxidative stress and skin damage caused by fine particulate matter. [Abstract]2024 Jul 25:90:102496. PMID: 39098256 -
Chin J Integr Med
p38 Signaling Mediates Naringin-Induced Osteogenic Differentiation of Porcine Metanephric Mesenchymal Cells. [Abstract]2024 Sep;30(9):818-825. PMID: 38850479 -
Fundam Clin Pharmacol
Activation of RAW264.7 macrophage by Exopolysaccharide from Aphanothece halaphytica (EPSAH) and the underlying mechanisms. [Abstract]2020 Oct;34(5):591-602. PMID: 32083746 -
Chem Biodivers
Pristimerin Induces Autophagy-Mediated Cell Death in K562 Cells through the ROS/JNK Signaling Pathway. [Abstract]2019 Aug;16(8):e1900325. PMID: 31290253 -
Toxicon
Dimethyl ester of bilirubin ameliorates Naja naja snake venom-induced lung toxicity in mice via inhibiting NLRP3 inflammasome and MAPKs activation. [Abstract]2024 May 11:244:107757. PMID: 38740099 -
PeerJ
2023 Aug 23:11:e15890. PMID: 37637169 -
Dev Comp Immunol
Vibrio harveyi infections induce production of proinflammatory cytokines in murine peritoneal macrophages via activation of p38 MAPK and NF-κB pathways, but reversed by PI3K/AKT pathways. [Abstract]2022 Feb:127:104292. PMID: 34656643 -
Virology
2017 Aug:508:150-158. PMID: 28545002 -
J Oral Pathol Med
Angiopoietin-like 4 is upregulated by amphiregulin and activates cell proliferation and migration through p38 kinase in head and neck squamous cell carcinoma. [Abstract]2024 May 19. PMID: 38763759 -
Exp Ther Med
LPS inhibits TRIM65 expression in macrophages and C57BL/6J mouse by activating the ERK1/2 signaling pathway. [Abstract]2023 Mar 14;25(4):188. PMID: 37021067 -
Exp Ther Med
Theaflavin-3,3'-digallate attenuates cigarette smoke extract-induced pulmonary emphysema in mice by suppressing necroptosis. [Abstract]2022 Jan;23(1):11. PMID: 34815763 -
Exp Ther Med
Vicenin 3 ameliorates ECM degradation by regulating the MAPK pathway in SW1353 chondrocytes. [Abstract]2021 Dec;22(6):1461. PMID: 34737801 -
Exp Ther Med
Low-doses of aspirin promote the growth of human PC-9 lung cancer cells through activation of the MAPK family. [Abstract]2021 Dec;22(6):1440. PMID: 34721682 -
Exp Ther Med
Quercetin suppresses apoptosis of chondrocytes induced by IL-1β via inactivation of p38 MAPK signaling pathway. [Abstract]2021 May;21(5):468. PMID: 33767763 -
Exp Ther Med
CTRP3 induces an intermediate switch of CD14++CD16+ monocyte subset with anti-inflammatory phenotype. [Abstract]2020 Mar;19(3):2243-2251. PMID: 32104290 -
Exp Ther Med
Resveratrol inhibits LPS-induced inflammation through suppressing the signaling cascades of TLR4-NF-κB/MAPKs/IRF3. [Abstract]2020 Mar;19(3):1824-1834. PMID: 32104238 -
FEBS Open Bio
Low-intensity pulsed ultrasound inhibits VEGFA expression in chondrocytes and protects against cartilage degeneration in experimental osteoarthritis. [Abstract]2020 Mar;10(3):434-443. PMID: 31975545 -
Biomed Res Int
2019 Jul 10:2019:5347804. PMID: 31380428 -
J Mol Histol
Neferine induces cell growth inhibition and apoptosis via ROS-mediated activation of p38 in pancreatic ductal adenocarcinoma cells. [Abstract]2025 Jul 31;56(4):246. PMID: 40742573 -
Anticancer Drugs
WDR62 mediates MAPK/ERK pathway to stimulate DNA damage repair and attenuate cisplatin sensitivity in lung adenocarcinoma. [Abstract]2025 Apr 1;36(4):319-327. PMID: 39808528 -
Biochem Bioph Res Co
ROS/p38MAPK-induced lamin B1 accumulation promotes chronic kidney disease-associated vascular smooth muscle cells senescence. [Abstract]2020 Oct 15;531(2):187-194. PMID: 32788068 -
Oncol Lett
2020 Apr;19(4):3269-3277. PMID: 32256822 -
Eur Arch Otorhinolaryngol
Heat shock protein 70 is induced by pepsin via MAPK signaling in human nasal epithelial cells. [Abstract]2019 Mar;276(3):767-774. PMID: 30600344 -
Arch Oral Biol
Investigating the mechanism of berberine in inhibiting periodontitis progression using machine learning, molecular docking, and experimental validation. [Abstract]2026 Mar:183:106496. PMID: 41544413 -
Future Sci OA
TWEAK/Fn14 axis may promote vascular smooth muscle cell senescence via p38 signaling pathway: preliminary evidence. [Abstract]2025 Dec;11(1):2455906. PMID: 39840833 -
Connect Tissue Res
Neferine alleviates ovariectomy-induced osteoporosis by enhancing osteogenic differentiation of bone marrow mesenchymal stem cells via regulation of the p38MAPK pathway. [Abstract]2024 May 16:1-12. PMID: 38753365 -
Can Respir J
Effects of Different Intervention Factors on Vascular Endothelial Growth Factor-Induced Human Airway Smooth Muscle Cell Migration. [Abstract]2022 Oct 10:2022:6879539. PMID: 36262381 -
Med Sci Monit
Reelin Promotes Cisplatin Resistance by Induction of Epithelial-Mesenchymal Transition via p38/GSK3β/Snail Signaling in Non-Small Cell Lung Cancer. [Abstract]2020 Aug 7:26:e925298. PMID: 32764530 -
Med Sci Monit
Improvement of Gut Microbiota by Inhibition of P38 Mitogen-Activated Protein Kinase (MAPK) Signaling Pathway in Rats with Severe Acute Pancreatitis. [Abstract]2019 Jun 21:25:4609-4616. PMID: 31226101 -
Biochem Cell Biol
Promoting effect of lactoferrin on barrier function and epithelial differentiation of human keratinocytes. [Abstract]2017 Feb;95(1):64-68. PMID: 28165292
Adezmapimod purchased from MedChemExpress. Usage Cited in: Biochem Cell Biol. 2017 Feb;95(1):64-68. [Abstract]
The involvement of the p38 MAPK signaling pathways in lactoferrin-induced differentiation of HaCaT keratinocytes. HaCaT cells are differentiated in the presence or absence of 10 μM bovine Lactoferrin for 5 days. PD98059 (40 μM), SB203580 (10 μM), or LY294002 (10 μM) are added at the same time. Cell differentiation is evaluated by the expression levels of Involucrin and Filaggrin. GAPDH is used as a loading control.
-
Neurosci Lett
Electroacupuncture prevents the development or establishment of chronic pain via IL-33/ST2 signaling in hyperalgesic priming model rats. [Abstract]2024 Jan 18:820:137611. PMID: 38142925 -
Cell Physiol Biochem
Clostridium Tyrobutyricum Protect Intestinal Barrier Function from LPS-Induced Apoptosis via P38/JNK Signaling Pathway in IPEC-J2 Cells. [Abstract]2018;46(5):1779-1792. PMID: 29705796
Adezmapimod purchased from MedChemExpress. Usage Cited in: Cell Physiol Biochem. 2018;46(5):1779-1792. [Abstract]
Western blot bands of p38, phospho-p38, ZO-1, Clau-din-1, and Occludin. JNK inhibitor SP600125 and p38 inhibitor SB203580 are used.
-
Cancer Rep (Hoboken)
RALYL Overexpression Suppresses Colorectal Cancer via Modulating HNRNPC-Mediated MNK2 Alternative Splicing. [Abstract]2025 Mar;8(3):e70179. PMID: 40052233 -
J Interferon Cytokine Res
2021 Dec;41(12):439-449. PMID: 34935488 -
J Clin Neurosci
Effects of p38 MAPK signaling pathway on cognitive function and recovery of neuronal function after hypoxic-ischemic brain injury in newborn rats. [Abstract]2020 Aug;78:365-370. PMID: 32360159 -
J Interferon Cytokine Res
MCP-1/CCL2 Mediated by Autocrine Loop of PDGF-BB Promotes Invasion of Lung Cancer Cell by Recruitment of Macrophages Via CCL2-CCR2 Axis. [Abstract]2019 Apr;39(4):224-232. PMID: 30730243 -
Genes Genomics
TSTA3 promotes the malignant progression of bladder cancer by regulating LAMP2 and MAPK signaling pathway-mediated epithelial-mesenchymal transition. [Abstract]2026 Jan 14. PMID: 41533307 -
Cytotechnology
Panax notoginseng-Bletilla striata ameliorates reflux esophagitis by modulating NLRP3 inflammasomes and p38 MAPK pathway. [Abstract]2026 Feb;78(1):3. PMID: 41280658 -
-
J Surg Res
Hypoxia Postconditioning Attenuates Hypoxia-Induced Inflammation and Endothelial Barrier Dysfunction. [Abstract]2024 Jul 22:301:413-422. PMID: 39042975 -
Cell J
2022 Dec 1;24(12):732-740. PMID: 36527345 -
Biol Pharm Bull
Phosphatidylserine-Specific Phospholipase A1 Alleviates Lipopolysaccharide-Induced Macrophage Inflammation by Inhibiting MAPKs Activation. [Abstract]2022 Aug 1;45(8):1061-1068. PMID: 35650027 -
Reprod Domest Anim
Vitamin E regulates bovine granulosa cell apoptosis via NRF2-mediated defence mechanism by activating PI3K/AKT and ERK1/2 signalling pathways. [Abstract]2021 Aug;56(8):1066-1084. PMID: 33978262 -
Am J Transl Res
Platelet-derived PDGF promotes the invasion and metastasis of cholangiocarcinoma by upregulating MMP2/MMP9 expression and inducing EMT via the p38/MAPK signalling pathway. [Abstract]2020 Jul 15;12(7):3577-3595. PMID: 32774720 -
Am J Transl Res
Fatty acid extracts facilitate cutaneous wound healing through activating AKT, ERK, and TGF-β/Smad3 signaling and promoting angiogenesis. [Abstract]2020 Feb 15;12(2):478-492. PMID: 32194897 -
Cell Microbiol
Streptococcal sagA activates a proinflammatory response in mast cells by a sublytic mechanism. [Abstract]2019 Sep;21(9):e13064. PMID: 31155820 -
Am J Transl Res
SXBX pill suppresses homocysteine-induced vascular smooth muscle cells dedifferentiation by inhibiting NLRP3 inflammasomes activation via ERK/p38 MAPK pathways. [Abstract]2019 Feb 15;11(2):806-818. PMID: 30899381 -
J Vet Sci
Subcutaneous Streptococcus dysgalactiae GAPDH vaccine in mice induces a proficient innate immune response. [Abstract]2023 Sep;24(5):e72. PMID: 38031651 -
J Cardiothorac Surg
Mechanical stretching of the pulmonary vein mediates pulmonary hypertension due to left heart disease by regulating SAC/MAPK pathway and the expression of IL-6 and TNF-α. [Abstract]2021 May 10;16(1):127. PMID: 33971931 -
Mol Cell Toxicol (2019) 15:209-219
-
J Asian Nat Prod Res
Endoplasmic reticulum stress mediated the xanthohumol induced murine melanoma B16-F10 cell death. [Abstract]2020 Sep;22(9):850-863. PMID: 31345059 -
Adezmapimod purchased from MedChemExpress. Usage Cited in: Biomed Res. 2017; 28 (8): 3383-3386
Effects of various protease inhibitors on HO-1 and P-gp protein expressions.
-
J Vet Med Sci
2023 Jul 1;85(7):721-726. PMID: 37225449 -
-
Adezmapimod purchased from MedChemExpress. Usage Cited in: Int J Clin Exp Med. 2017;10(9):13542-13549.
SB203580 decreases the expression ratio of p-p38 and p38 to inhibit activation of p38 MARK pathway.
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
bioRxiv
2023 Sep 29:2023.09.27.559864. PMID: 37808846 -
-
-
-
-
-
-
-
-
-
Oxid Med Cell Longev
HSPA12A Stimulates p38/ERK-AP-1 Signaling to Promote Angiogenesis and Is Required for Functional Recovery Postmyocardial Infarction. [Abstract]2022 Jun 22:2022:2333848. PMID: 35783189 -
-
Oxid Med Cell Longev
Human Papillomavirus Type 16 Early Protein E7 Activates Autophagy through Inhibition of Dual-Specificity Phosphatase 5. [Abstract]2022 Mar 10:2022:1863098. PMID: 35368866 -
Int J Biol Sci
Cancer-associated adipocytes promote the invasion and metastasis in breast cancer through LIF/CXCLs positive feedback loop. [Abstract]2022 Jan 16;18(4):1363-1380. PMID: 35280694 -
-
-
-
-
-
-
-
-
-
-
-
-
-
Ann Transl Med
Upregulated miR-155 inhibits inflammatory response induced by C. albicans in human monocytes derived dendritic cells via targeting p65 and BCL-10. [Abstract]2019 Dec;7(23):758. PMID: 32042774 -
Eur Rev Med Pharmacol Sci
Melatonin inhibits the inflammation and apoptosis in rats with diabetic retinopathy via MAPK pathway. [Abstract]2019 Aug;23(3 Suppl):1-8. PMID: 31389568 -
-
Dis Markers
Knockdown of Heparanase Suppresses Invasion of Human Trophoblasts by Activating p38 MAPK Signaling Pathway. [Abstract]2018 Apr 17:2018:7413027. PMID: 29849826 -
-
-
Oncotarget
Tomentodione M sensitizes multidrug resistant cancer cells by decreasing P-glycoprotein via inhibition of p38 MAPK signaling. [Abstract]2017 Oct 19;8(60):101965-101983. PMID: 29254218
Adezmapimod purchased from MedChemExpress. Usage Cited in: Oncotarget. 2017 Oct 19;8(60):101965-101983. [Abstract]
Representative western blot analysis of P-gp, p38 MAPK and phospho-p38 MAPK expression in MCF-7/MDR and K562/MDR cells treated with 10 μM SB203580 for 48 hr.
-
-
Oxid Med Cell Longev
Capsular Polysaccharide of Mycoplasma ovipneumoniae Induces Sheep Airway Epithelial Cell Apoptosis via ROS-Dependent JNK/P38 MAPK Pathways. [Abstract]2017:2017:6175841. PMID: 28367270
Adezmapimod purchased from MedChemExpress. Usage Cited in: Oxid Med Cell Longev. 2017:2017:6175841. [Abstract]
Involvements of MAPK signaling pathway in CPS-induced apoptosis in ALI cultures of sheep bronchial epithelial cells. Cells are pretreated with SB203580 (a P38 inhibitor, 20 μM) for 1 h, followed by exposure to CPS (100 ng/mL) or MO (MOI = 30) for 48 h. Cell lysates are subjected to Western blotting analysis using indicated antibodies.
-
Adezmapimod purchased from MedChemExpress. Usage Cited in: China Biotechnology. 2017, 37(12): 40-48.
The Western blot analysis of HOG1 and Phospho-HOG1.
-
Adezmapimod purchased from MedChemExpress. Usage Cited in: Chin Arch Otolaryngol Head Neck Surg. 2016,23(01):49-52.
Effect of p38MAPK inhibitor on the soft palate reconstruction of the rats with chronic intermittent hypoxia.
Lösungsmittel & Löslichkeit
DMSO : 20 mg/mL (52.99 mM; ultrasonic and warming and heat to 60°C; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)
Select the appropriate dissolution method based on your experimental animal and administration route.
- For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
- To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for In Vivo experiments, it is recommended to prepare freshly and use it on the same day.
- The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.
Add each solvent one by one: 10% DMSO 40% PEG300 5% Tween-80 45% Saline
Solubility: 2 mg/mL (5.30 mM); Clear solution; Need ultrasonic
This protocol yields a clear solution of 2 mg/mL.
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (20.0 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.
Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
Add each solvent one by one: 10% DMSO 90% (20% SBE-β-CD in Saline)
Solubility: 2 mg/mL (5.30 mM); Clear solution; Need ultrasonic
This protocol yields a clear solution of 2 mg/mL.
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (20.0 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.
For the following dissolution methods, please prepare the working solution directly:
It is recommended to prepare fresh solutions and use them promptly within a short period of time.
The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.
Please enter the basic information of animal experiments:
-
-
-
-
Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Please enter your animal formula composition:
-
%DMSO +
Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
-
%+
-
+%Tween-80 + +
-
%Saline +
The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
Working solution concentration: 0.22 mg/mL
Method for preparing stock solution: mg drug dissolved in μL DMSO. Stock solution concentration: mg/mL.
1. Take μL DMSO stock solution;
2. Add μL .
μL , mix evenly;
3. Then add μL Tween 80, mix evenly;
4. Then add μL
Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
Reinheit & Dokumentation
-
Data Sheet (281 KB)
-
SDS (394 KB)
- English - EN (394 KB)
- Français - FR (394 KB)
- Deutsch - DE (394 KB)
- Norwegian - NO (394 KB)
- Español - ES (394 KB)
- Swedish - SV (394 KB)
- Italian - IT (394 KB)
- Portuguese - PT (394 KB)
-
Handling Instructions (2659 KB)
Verweise
[1]. Davies SP, et al. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J. 2000 Oct 1;351(Pt 1):95-105. [Content Brief]
[2]. Lali FV, et al. The pyridinyl imidazole inhibitor SB203580 blocks phosphoinositide-dependent protein kinase activity, protein kinase B phosphorylation, and retinoblastoma hyperphosphorylation in interleukin-2-stimulated T cells independently of p38 mitogen-activated protein kinase. J Biol Chem. 2000 Mar 10;275(10):7395-402. [Content Brief]
[3]. Leelahavanichkul K, et al. A role for p38 MAPK in head and neck cancer cell growth and tumor-induced angiogenesis and lymphangiogenesis. Mol Oncol. 2014 Feb;8(1):105-18. [Content Brief]
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 2.6495 mL | 13.2475 mL | 26.4950 mL | 66.2374 mL |
| 5 mM | 0.5299 mL | 2.6495 mL | 5.2990 mL | 13.2475 mL | |
| 10 mM | 0.2649 mL | 1.3247 mL | 2.6495 mL | 6.6237 mL | |
| 15 mM | 0.1766 mL | 0.8832 mL | 1.7663 mL | 4.4158 mL | |
| 20 mM | 0.1325 mL | 0.6624 mL | 1.3247 mL | 3.3119 mL | |
| 25 mM | 0.1060 mL | 0.5299 mL | 1.0598 mL | 2.6495 mL | |
| 30 mM | 0.0883 mL | 0.4416 mL | 0.8832 mL | 2.2079 mL | |
| 40 mM | 0.0662 mL | 0.3312 mL | 0.6624 mL | 1.6559 mL | |
| 50 mM | 0.0530 mL | 0.2649 mL | 0.5299 mL | 1.3247 mL |